UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 26, 2013

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

(Exact name of registrant as specified in its charter)

 

Maryland

 

1-12993

 

95-4502084

(State or other jurisdiction of
incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

 

 

 

385 East Colorado Boulevard, Suite 299

 

 

Pasadena, California

 

91101

(Address of principal executive offices)

 

(Zip Code)

 

 

Registrant’s telephone number, including area code: (626) 578-0777

 


 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o               Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o               Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o               Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o               Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4 (c))

 



 

Item 1.01.  Entry into a Material Definitive Agreement.

 

On July 26, 2013, Alexandria Real Estate Equities, Inc. and Alexandria Real Estate Equities, L.P. (collectively, the “Company”) entered into a Second Amended and Restated Term Loan Agreement with Citibank, N.A., as administrative agent, Citigroup Global Markets Inc., RBC Capital Markets and RBS Securities Inc., as joint lead arrangers and joint book running managers, and certain financial institutions party thereto as lenders (the “Amended Term Loan Agreement”).  The Amended Term Loan Agreement amends and restates that certain Amended and Restated Term Loan Agreement, dated June 30, 2011, as amended on April 30, 2012, among the Company, Citibank N.A. and certain financial institutions party thereto as lenders (the “Prior Term Loan Agreement”) to, among other things, decrease the applicable interest rate margins in respect of the loan thereunder (the “Loan”) and extend the maturity date of the loan originally provided under the Prior Term Loan Agreement from June 30, 2015, to July 31, 2015, subject to the Company’s sole option to extend the maturity date up to two times for an additional term of six months each time upon the satisfaction of certain conditions.

 

Under the Amended Term Loan Agreement, the Loan will bear interest at a “Eurodollar Rate” or a “Base Rate” specified in the Amended Term Loan Agreement, plus, in either case, a margin specified in the Amended Term Loan Agreement.  The margin at closing was 1.20% and was applied to the Eurodollar Rate.

 

The “Eurodollar Rate” is the rate per annum equal to the British Bankers Association (or any other person which takes over the administration of that rate) LIBOR Rate, or if such rate is not available at the time of determination, the rate per annum determined by the administrative agent to be the rate at which deposits in US dollars for delivery on the date of determination in same day funds in the approximate amount of the borrowing would be offered by Citibank’s London Branch to major banks in the London interbank Eurodollar market at their request.  The “Base Rate” means for any day a fluctuating rate per annum equal to the highest of (a) the federal funds rate plus 1/2 of 1%, (b) the rate of interest in effect for such day as publicly announced from time to time by Citibank as its “base rate,” and (c) the Eurodollar Rate plus 1.00%.

 

Under the Amended Term Loan Agreement, the financial covenants under the Prior Term Loan Agreement were not amended and are identical to the financial covenants required under the Company’s existing unsecured credit facility.  The Company must not, as of the last day of any fiscal quarter, permit its:

 

·                  leverage ratio to exceed 60.0%, except for four calculation dates immediately following any acquisition in which the assets acquired exceed 5% of the Company’s total assets (a “Material Acquisition”), in which case its leverage ratio is not to exceed 65.0%

·                  unsecured leverage ratio to exceed 60.0%, except for four calculation dates immediately following any Material Acquisition, in which case its unsecured leverage ratio is not to exceed 65.0%

·                  unsecured interest coverage ratio to be less than 1.75 to 1.00

·                  secured debt ratio to exceed 40.0%, except for four calculation dates immediately following any Material Acquisition, in which case its secured debt ratio is not to exceed 45.0%

·                  fixed charge coverage ratio to be less than 1.50:1.00

·                  minimum book value to be less than the sum of $2.0 billion and 50% of the net proceeds of equity offerings after January 28, 2011

 

The Company may, upon notice to the administrative agent, at any time or from time to time voluntarily prepay the Loan in whole or in part without premium or penalty; provided that any prepayment shall be in a principal amount of at least $500,000 or, if less, the entire principal amount thereof then outstanding.

 

The foregoing summary of the Amended Term Loan Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Amended Term Loan Agreement, a copy of which will be filed as an exhibit to the Company’s quarterly report on Form 10-Q for the quarter ended September 30, 2013.

 

Item 2.02.  Results of Operations and Financial Condition.

 

On July 29, 2013, the Company issued a press release entitled “Alexandria Real Estate Equities, Inc. Reports Second Quarter Ended June 30, 2013 Financial and Operating Results” which sets forth the Company’s results of operations and financial condition for the second quarter ended June 30, 2013.  The press release referred to certain supplemental information that is available on the Company’s website at www.are.com.  Copies of the press release and supplemental information are attached hereto as Exhibits 99.1 and 99.2, respectively.

 

2



 

The information contained in this Item 2.02, including the exhibits referenced herein, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section.  Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

Item 2.03.  Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information included in Item 1.01 is incorporated herein by reference.

 

Item 9.01.  Financial Statements and Exhibits.

 

(d)  Exhibits.

 

99.1                Press Release dated July 29, 2013.

 

99.2                Alexandria Real Estate Equities, Inc.’s Earnings Press Release and Supplemental Information for the Second Quarter Ended June 30, 2013.

 

Forward-looking Statements

 

This current report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These statements include words such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “intends,” “plans,” “estimates,” or “anticipates,” or the negative of these words or similar words, and include (without limitation) statements regarding the anticipated maturity date of the Amended Term Loan Agreement.  Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in each such statement.  A number of important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking statements, including, but not limited to, the factors described in the Company’s filings with the Securities and Exchange Commission, including the Company’s most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.  The Company does not undertake any responsibility to update any of these factors or to announce publicly any revisions to any of the forward-looking statements contained in this or any other document, whether as a result of new information, future events, or otherwise.

 

3



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

 

 

 

 

 

 

July 30, 2013

 

By:

/s/ Joel S. Marcus

 

 

 

 

Joel S. Marcus

 

 

 

 

Chairman/Chief Executive Officer

 

 

 

 

(Principal Executive Officer)

 

 

 

 

 

 

 

 

 

By:

/s/ Dean A. Shigenaga

 

 

 

 

Dean A. Shigenaga

 

 

 

 

Chief Financial Officer

 

 

 

 

(Principal Financial Officer)

 

 

4



 

EXHIBIT INDEX

 

Exhibit
Number

 

Exhibit Title

99.1

 

Press Release dated July 29, 2013.

 

 

 

99.2

 

Alexandria Real Estate Equities, Inc.’s Earnings Press Release and Supplemental Information for the Second Quarter Ended June 30, 2013.

 

5


Exhibit 99.1

 

GRAPHIC

 

Contact:

 

Joel S. Marcus

 

 

Chairman, Chief Executive Officer, & Founder

 

 

Alexandria Real Estate Equities, Inc.

 

 

(626) 578-9693

 

 

Alexandria Real Estate Equities, Inc.

Reports

 

Second Quarter Ended June 30, 2013

Financial and Operating Results

 

FFO Per Share – Diluted, as Adjusted, of $1.07 for 2Q13

AFFO Per Share – Diluted of $1.00 for 2Q13

EPS Per Share – Diluted of $0.38 for 2Q13

Total Revenues of $154.2 Million for 2Q13

NOI of $107.9 Million for 2Q13

Continued Solid Life Science Space Demand in Key Cluster Submarkets

 

PASADENA, CA. – July 29, 2013 – Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced financial and operating results for the second quarter ended June 30, 2013.

 

Second quarter ended June 30, 2013, highlights

 

Results

 

·       Funds from operations (“FFO”) attributable to Alexandria Real Estate Equities, Inc.’s (“Alexandria’s”) common stockholders – diluted, as adjusted:

·       $71.6 million, or $1.07 per share, for 2Q13 compared to $65.8 million, or $1.07 per share, for 2Q12

·       $141.6 million, or $2.18 per share, for YTD 2Q13 compared to $132.0 million, or $2.14 per share, for YTD 2Q12

·       Adjusted funds from operations (“AFFO”) attributable to Alexandria’s common stockholders – diluted:

·       $66.8 million, or $1.00 per share, for 2Q13 compared to $64.0 million, or $1.04 per share, for 2Q12

·       $134.7 million, or $2.07 per share, for YTD 2Q13 compared to $126.4 million, or $2.05 per share, for YTD 2Q12

·       Net income attributable to Alexandria’s common stockholders – diluted:

·       $25.5 million, or $0.38 per share, for 2Q13 compared to $17.6 million, or $0.29 per share, for 2Q12

·       $47.9 million, or $0.74 per share, for YTD 2Q13 compared to $36.0 million, or $0.58 per share, for YTD 2Q12

 

Core operating metrics

 

·       Total revenues from continuing operations:

·       $154.2 million for 2Q13, up 5.9%, compared to $145.6 million for 2Q12

·       $304.6 million YTD 2Q13, up 8.3%, compared to $281.3 million for YTD 2Q12

·       Net operating income (“NOI”) from continuing operations:

·       $107.9 million for 2Q13, up 4.3%, compared to $103.5 million for 2Q12

·       $213.1 million for YTD 2Q13, up 7.2%, compared to $198.7 million for YTD 2Q12

·       Same property NOI performance:

·       7.2% and 3.2% increases on a cash and GAAP basis, respectively, for 2Q13 compared to 2Q12

·       8.3% and 2.0% increases on a cash and GAAP basis, respectively, for YTD 2Q13 compared to YTD 2Q12

·       Leasing activity solid during the three months ended June 30, 2013:

·       Executed 66 leases for 768,000 rentable square feet (“RSF”), including 270,000 RSF of development and redevelopment space

·       Rental rate increase of 6.7% and 12.7% on a cash and GAAP basis, respectively, on renewed/re-leased space

·       Key life science space leasing:

·       Investment-grade entity leased 121,632 RSF at 430 East 29th Street development in the Greater NYC market

·       Illumina, Inc. leased 97,702 RSF at 499 Illinois Street development in the San Francisco Bay Area market

·       Sarepta Therapeutics, Inc. leased 46,376 RSF at 215 First Street in the Greater Boston market

·       Eli Lilly and Company leased 27,950 RSF at 620 Professional Drive in the Suburban Washington, D.C. market

·       Nominal remaining expiring leases in 2013 of 410,254 RSF, or 3% of total operating RSF

·       Occupancy for North American Properties, as of June 30, 2013:

·       94.6% for operating properties and 92.9% for operating and redevelopment properties, up 40 bps and 110 bps, respectively, since March 31, 2013

·       Operating margins remained steady at 70% for 2Q13 and YTD 2Q13

·       Investment-grade client tenants represented 46% of total annualized base rent (“ABR”)

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Second Quarter Ended June 30, 2013

Financial and Operating Results

 

Core operating metrics (continued)

 

·       Investment-grade client tenants represented 72% of ABR from our top 10 client tenants

·       Contractual annual rent escalations in 95% of our leases

 

Balance sheet

 

·        Completed in 2Q13 secondary offering of 7.6 million shares of common stock at a price of $73.50 per share.  The net proceeds of $535.5 million were used to repay outstanding balances under our unsecured senior line of credit.

·        Completed in 2Q13 $500 million 3.90% 10-year unsecured senior notes payable offering.  Net proceeds of $495.3 million were used to reduce outstanding variable rate bank debt, including a $150 million partial repayment of our $750 million 2016 Unsecured Senior Bank Term Loan and to increase our available cash balance.  In connection with the partial repayment of our 2016 Unsecured Senior Bank Term Loan, we recognized a loss on the early extinguishment of debt related to the write-off of unamortized loan fees totaling $0.6 million, or $0.01 per share.

·        Liquidity of $1.8 billion, including $1.5 billion available under our unsecured senior line of credit and $302.2 million in cash and cash equivalents as of June 30, 2013.

·        Closed in 2Q13 secured construction loan, with aggregate commitments of $36 million at a rate of LIBOR + 1.40%, for 100% pre-leased development project at 269 East Grand Avenue in the San Francisco Bay Area market.

·        Net debt to EBITDA of 6.6x for the twelve months ended June 30, 2013.

·        Fixed charge coverage ratio of 2.7x for the twelve months ended June 30, 2013.

·        Unhedged variable rate debt totaling 11% of total consolidated debt as of June 30, 2013.

·       Completed in 2Q13 $22.5 million of real estate property sales, at a gain of $1.0 million, as follows:

·       $4.4 million of non-strategic income producing assets at a gain of $0.2 million

·       $18.1 million of non-income-producing land at a gain of $0.8 million

 

Subsequent events

 

Ariad Pharmaceuticals, Inc. expansion

 

On July 3, 2013, Ariad Pharmaceuticals, Inc. executed an LOI to lease an additional 139,374 RSF for a 15 year term at our 75/125 Binney Street development in the Cambridge submarket of Greater Boston.  An amendment to their lease is under negotiation to increase their lease to 383,497 RSF, or 99% of the total RSF of the project.

 

Sale of land parcel at 1600 Owens Street

 

On July 8, 2013, we executed a purchase and sale agreement to dispose of our land parcel at 1600 Owens Street in the Mission Bay submarket of the San Francisco Bay Area for an aggregate sales price of $55.2 million, inclusive of certain parking spaces.  Ownership of the parcel was strategically important to the buyer and we will earn a fee to manage the construction of the building.  This sale is expected to close in December 2013.

 

Acquisition of 10121/10151 Barnes Canyon Road

 

On July 5, 2013, we acquired 10121/10151 Barnes Canyon Road, an approximate 116,000 RSF office property located in the Sorrento Mesa submarket of San Diego, for a total purchase price of $13.1 million.  The acquisition will be funded in two installments:  i) $5.4 million to be funded in August, 2013 (which will earn a 7% return until the next payment is made), and ii) $7.7 million to be funded no later than October 2014.  The property is currently 100% occupied with leases that expire in 2014 and 2015. We intend to convert the existing office space into laboratory space through redevelopment when the space becomes available. Initial stabilized yields will be provided in the future upon commencement of the redevelopment.

 

Unsecured senior bank loan financings

 

On July 26, 2013, we amended our $600 million 2016 Unsecured Senior Bank Term Loan to reduce our interest rate on outstanding borrowings.  We did not extend the maturity of this loan as we expect to repay the loan over the next one to three years.  In addition, we expect to complete amendments to our $1.5 billion unsecured senior line of credit and our $600 million 2017 Unsecured Senior Bank Term Loan in the third quarter of 2013 to reduce our interest rate on outstanding borrowings, extend the maturity dates and amend certain financial covenants.  The commitments available for each facility will not change.

 

 

 

 

 

Maturity Date (including extensions)

 

Applicable Rate

 

Facility Fee

 

Facility

 

Status

 

Prior/
Current

 

Extended/
Proposed

 

Prior/
Current

 

Extended/
Proposed

 

Prior/
Current

 

Extended/
Proposed

 

$600 million 2016 Unsecured Senior Bank Term Loan

 

Complete

 

June 2016

 

July 2016

 

L +1.75%

 

L +1.20%

 

N/A

 

N/A

 

$600 million 2017 Unsecured Senior Bank Term Loan

 

In Progress

 

January 2017

 

January 2019

 

L +1.50%

 

L +1.20%

 

N/A

 

N/A

 

$1.5 billion unsecured senior line of credit

 

In Progress

 

April 2017

 

January 2019

 

L +1.20%

 

L +1.10%

 

0.25%

 

0.20%

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

2

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Guidance

 

Based on our current view of existing market conditions and certain current assumptions, we have updated guidance for earnings per share attributable to Alexandria’s common stockholders – diluted and FFO per share attributable to Alexandria’s common stockholders – diluted for the year ended December 31, 2013, as set forth in the table below.  The table below provides a reconciliation of FFO per share, a non-GAAP measure, to earnings per share, the most directly comparable GAAP measure, as well as other key assumptions included in our guidance for the year ended December 31, 2013.  To the extent our full year earnings guidance is updated during the year, we will provide additional disclosure supporting reasons for any significant changes to such guidance.

 

Guidance for the Year Ended December 31, 2013

 

Reported on July 29, 2013

 

Reported on May 13, 2013

Earnings per share attributable to Alexandria’s common stockholders – diluted

 

$1.53 to $1.63

 

$1.50 to $1.60

Depreciation and amortization

 

$2.76 to $2.86

 

$2.80 to $2.90

(Gain) loss on sale of real estate

 

$(0.01)

 

$0.01

Other

 

$(0.01)

 

$(0.01)

FFO per share attributable to Alexandria’s common stockholders – diluted

 

$4.32 to $4.42

 

$4.35 to $4.45

Add back: actual 2Q13 per share loss on early extinguishment of debt (1)

 

$0.01

 

N/A

Add back: projected 3Q13 per share loss on early extinguishment of debt (1)

 

$0.02

 

N/A

FFO per share attributable to Alexandria’s common stockholders - diluted, as adjusted

 

$4.35 to $4.45

 

$4.35 to $4.45

 

 

 

 

 

Key projection assumptions:

 

 

 

 

Same property NOI growth – cash basis

 

5% to 7%

 

5% to 7%

Same property NOI growth – GAAP basis

 

1% to 3%

 

1% to 3%

Rental rate steps on lease renewals and re-leasing of space – cash basis

 

3% to 5%

 

1% to 3%

Rental rate steps on lease renewals and re-leasing of space – GAAP basis

 

11% to 13%

 

7% to 12%

Occupancy percentage for all operating properties at December 31, 2013

 

94.3% to 94.7%

 

94.3% to 94.7%

Straight-line rents

 

$24 to $26 million

 

$24 to $26 million

Amortization of above and below market leases

 

$3 to $4 million

 

$3 to $4 million

General and administrative expenses

 

$48 to $51 million

 

$48 to $51 million

Capitalization of interest

 

$51 to $57 million

 

$51 to $57 million

Interest expense, net

 

$71 to $81 million

 

$71 to $81 million

Net debt to adjusted EBITDA for the annualized three months ended December 31, 2013

 

6.5x

 

6.5x

Fixed charge coverage ratio for the annualized three months ended December 31, 2013

 

3.0x

 

3.0x

Non-income-producing land as a percentage of gross real estate by December 31, 2013

 

15% to 17%

 

15% to 17%

 

(1)             Represents loss on early extinguishment of debt related to the write-off of unamortized loan fees of $0.01 per share as a result of the $150 million partial repayment of our 2016 Unsecured Senior Bank Term Loan during the three months ended June 30, 2013, and the estimated loss on early extinguishment of debt related to the write-off of unamortized loan fees of $0.02 per share as a result of amendments of our 2016 Unsecured Senior Bank Term Loan, 2017 Unsecured Senior Bank Term Loan, and $1.5 billion unsecured senior line of credit which we expect to complete in the third quarter of 2013.

 

We expect that our principal liquidity needs for the year ended December 31, 2013, will be satisfied by the following multiple sources of capital as shown in the table below.  There can be no assurance that our sources and uses of capital will not be materially higher or lower than these expectations.

 

 

 

Reported on
July 29, 2013

 

Reported on
May 13, 2013

 

Sources and Uses of Capital for the Year Ended December 31, 2013 (in millions)

 

Completed

 

Projected

 

Total

 

Total

 

Sources of capital:

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities less dividends

 

$

66

 

$

64 - 84

 

$

130 - 150

 

$

130 - 150

 

Non-income-producing land sales

 

18

 

131 - 171

(1)

149 - 189

 

149 - 189

 

Income producing asset sales

 

129

 

0 - 5

 

129 - 134

 

125 - 138

 

Secured construction loan borrowings

 

26

 

19 - 39

 

45 - 65

 

45 - 55

 

Unsecured senior notes payable

 

500

 

 

500

 

350 - 450

 

Common stock offering

 

536

 

 

536

 

415 - 490

 

Available cash and borrowings on unsecured senior line of credit (2)

 

 

324 - 369

 

324 - 369

 

 

Total sources of capital

 

$

1,275

 

$

538 - 668

 

$

1,813 - 1,943

 

$

1,214 - 1,472

 

 

 

 

 

 

 

 

 

 

 

Uses of capital:

 

 

 

 

 

 

 

 

 

Development, redevelopment, and construction

 

$

253

 

$

346 - 376

 

$

599 - 629

 

$

617 - 667

 

Seller financing of asset sales

 

39

 

 

39

 

39

 

Acquisitions:

 

 

 

 

 

 

 

 

 

Completed/in process acquisitions

 

13

 

64

 

77

 

 

Additional acquisitions

 

-

 

123 - 223

 

123 - 223

 

200 - 300

 

Secured notes payable repayments

 

32

 

5

 

37

 

37

 

Unsecured senior bank term loan repayment

 

150

 

 

150

 

125 - 175

 

Excess cash retained from issuance of unsecured senior notes payable/pay down of unsecured senior line of credit

 

788

 

 

788

 

196 - 254

 

Total uses of capital

 

$

1,275

 

$

538 - 668

 

$

1,813 - 1,943

 

$

1,214 - 1,472

 

 

(1)             See Balance Sheet section of our Supplemental Package for additional information.

 

(2)             We had $302.2 million in cash and cash equivalents as of June 30, 2013.

 

The key assumptions behind the sources and uses of capital in the table are a favorable capital market environment and performance of our core operations in areas such as delivery of current and future development and redevelopment projects, leasing activity, and renewals.  Our expected sources and uses of capital are subject to a number of variables and uncertainties, including those discussed under the “Forward-looking statements” section under Part I, the “Risk Factors” section under Item 1A, and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section under Item 7, of our annual report on Form 10-K for the year ended December 31, 2012.  We expect to update our forecast of sources and uses of capital on a quarterly basis.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

3

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Earnings Call Information

 

We will host a conference call on Tuesday, July 30, 2013, at 3:00 p.m. Eastern Time (“ET”)/12:00 p.m. noon Pacific Time (“PT”) that is open to the general public to discuss our financial and operating results for the three months ended June 30, 2013.  To participate in this conference call, dial (888) 724-9493 or (913) 312-1456 and confirmation code 7393551, shortly before 3:00 p.m. ET/12:00 p.m. noon PT.  The audio web cast can be accessed at: www.are.com, in the “For Investors” section.  A replay of the call will be available for a limited time from 6:00 p.m. ET/3:00 p.m. PT on Tuesday, July 30, 2013.  The replay number is (888) 203-1112 or (719) 457-0820 and the confirmation code is 7393551.

 

Additionally, a copy of this Earnings Press Release and Supplemental Information for the second quarter ended June 30, 2013, is available in the “For Investors” section of our website at www.are.com or by following this link: http://www.are.com/fs/2013q2.pdf.

 

About the Company

 

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed investment-grade REIT, is the largest and leading REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry.  Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in the core life science cluster locations including Greater Boston, the San Francisco Bay Area, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park.  Alexandria’s high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies.  As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity, collaboration, and innovation through its best-in-class laboratory and office space adjacent to leading academic medical research centers, unparalleled life science real estate expertise and services, and a longstanding and expansive network in the life science community.  We believe these advantages result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.  For additional information on Alexandria, please visit www.are.com.

 

***********

 

This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Such forward-looking statements include, without limitation, statements regarding our 2013 earnings per share attributable to Alexandria’s common stockholders – diluted, 2013 FFO per share attributable to Alexandria’s common stockholders – diluted, NOI and our projected sources and uses of capital for the year ended December 31, 2013.  These forward-looking statements are based on our current expectations, beliefs, projections, future plans, strategies, anticipated events, trends, and similar expressions concerning matters that are not historical facts, as well as a number of assumptions concerning future events.  These statements are subject to risks, uncertainties, assumptions and other important factors that could cause actual results to differ materially from the results discussed in the forward-looking statements.  Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets, our failure to successfully complete and lease our existing space held for redevelopment and new properties acquired for that purpose and any properties undergoing development, our failure to successfully operate or lease acquired properties, decreased rental rates or increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by client tenants, general and local economic conditions, and other risks and uncertainties detailed in our filings with the SEC.  Accordingly, you are cautioned not to place undue reliance on such forward-looking statements.  All forward-looking statements are made as of the date of this press release, and we assume no obligation to update this information and expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.  For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

4

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Consolidated Statements of Income

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

6/30/13

 

3/31/13

 

12/31/12

 

9/30/12

 

6/30/12

 

6/30/13

 

6/30/12

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental

 

$

114,743

 

$

111,776

 

$

112,048

 

$

106,216

 

$

104,329

 

$

226,519

 

$

205,530

 

Tenant recoveries

 

35,923

 

35,611

 

35,721

 

34,006

 

31,881

 

71,534

 

63,763

 

Other income

 

3,569

 

2,993

 

3,785

 

2,628

 

9,383

 

6,562

 

12,011

 

Total revenues

 

154,235

 

150,380

 

151,554

 

142,850

 

145,593

 

304,615

 

281,304

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental operations

 

46,323

 

45,224

 

46,176

 

44,203

 

42,102

 

91,547

 

82,555

 

General and administrative

 

12,472

 

11,648

 

12,635

 

12,470

 

12,298

 

24,120

 

22,655

 

Interest

 

15,978

 

18,020

 

17,941

 

17,092

 

17,922

 

33,998

 

34,148

 

Depreciation and amortization

 

46,580

 

46,065

 

47,515

 

46,584

 

50,741

 

92,645

 

92,527

 

Impairment of land parcel

 

 

 

2,050

 

 

 

 

 

Loss on early extinguishment of debt

 

560

 

 

 

 

1,602

 

560

 

2,225

 

Total expenses

 

121,913

 

120,957

 

126,317

 

120,349

 

124,665

 

242,870

 

234,110

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from continuing operations

 

32,322

 

29,423

 

25,237

 

22,501

 

20,928

 

61,745

 

47,194

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from discontinued operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from discontinued operations before impairment of real estate

 

243

 

814

 

5,171

 

5,603

 

4,713

 

1,057

 

9,358

 

Impairment of real estate

 

 

 

(1,601

)

(9,799

)

 

 

 

Income (loss) from discontinued operations, net

 

243

 

814

 

3,570

 

(4,196

)

4,713

 

1,057

 

9,358

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on sale of land parcel

 

772

 

 

 

 

 

772

 

1,864

 

Net income

 

33,337

 

30,237

 

28,807

 

18,305

 

25,641

 

63,574

 

58,416

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to noncontrolling interests

 

980

 

982

 

1,012

 

828

 

851

 

1,962

 

1,562

 

Dividends on preferred stock

 

6,471

 

6,471

 

6,471

 

6,471

 

6,903

 

12,942

 

14,386

 

Preferred stock redemption charge

 

 

 

 

 

 

 

5,978

 

Net income attributable to unvested restricted stock awards

 

403

 

342

 

324

 

360

 

271

 

745

 

506

 

Net income attributable to Alexandria’s common stockholders

 

$

25,483

 

$

22,442

 

$

21,000

 

$

10,646

 

$

17,616

 

$

47,925

 

$

35,984

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share attributable to Alexandria’s common stockholders – basic and diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.38

 

$

0.35

 

$

0.27

 

$

0.24

 

$

0.21

 

$

0.72

 

$

0.43

 

Discontinued operations, net

 

 

0.01

 

0.06

 

(0.07

)

0.08

 

0.02

 

0.15

 

Earnings per share – basic and diluted

 

$

0.38

 

$

0.36

 

$

0.33

 

$

0.17

 

$

0.29

 

$

0.74

 

$

0.58

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock outstanding for calculating earnings per share attributable to Alexandria’s common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

– Basic

 

66,973

 

63,161

 

63,092

 

62,364

 

61,663

 

65,078

 

61,586

 

– Diluted

 

66,973

 

63,161

 

63,092

 

62,364

 

61,664

 

65,078

 

61,586

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

5

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Consolidated Balance Sheets

(In thousands)

(Unaudited)

 

 

 

June 30,

 

March 31,

 

December 31,

 

September 30,

 

June 30,

 

 

 

2013

 

2013

 

2012

 

2012

 

2012

 

Assets

 

 

 

 

 

 

 

 

 

 

 

Investments in real estate, net

 

$

6,453,379

 

$

6,375,182

 

$

6,424,578

 

$

6,300,027

 

$

6,208,354

 

Cash and cash equivalents

 

302,205

 

87,001

 

140,971

 

94,904

 

80,937

 

Restricted cash

 

30,914

 

30,008

 

39,947

 

44,863

 

41,897

 

Tenant receivables

 

7,577

 

9,261

 

8,449

 

10,124

 

6,143

 

Deferred rent

 

177,507

 

170,100

 

170,396

 

160,914

 

155,295

 

Deferred leasing and financing costs, net

 

164,362

 

159,872

 

160,048

 

152,021

 

151,355

 

Investments

 

122,605

 

123,543

 

115,048

 

107,808

 

104,454

 

Other assets

 

120,740

 

135,952

 

90,679

 

94,356

 

93,304

 

Total assets

 

$

7,379,289

 

$

7,090,919

 

$

7,150,116

 

$

6,965,017

 

$

6,841,739

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities, Noncontrolling Interests, and Equity

 

 

 

 

 

 

 

 

 

 

 

Secured notes payable

 

$

711,029

 

$

730,714

 

$

716,144

 

$

719,350

 

$

719,977

 

Unsecured senior notes payable

 

1,048,395

 

549,816

 

549,805

 

549,794

 

549,783

 

Unsecured senior line of credit

 

 

554,000

 

566,000

 

413,000

 

379,000

 

Unsecured senior bank term loans

 

1,200,000

 

1,350,000

 

1,350,000

 

1,350,000

 

1,350,000

 

Accounts payable, accrued expenses, and tenant security deposits

 

368,249

 

367,153

 

423,708

 

376,785

 

348,037

 

Dividends payable

 

52,141

 

43,955

 

41,401

 

39,468

 

38,357

 

Total liabilities

 

3,379,814

 

3,595,638

 

3,647,058

 

3,448,397

 

3,385,154

 

 

 

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redeemable noncontrolling interests

 

14,505

 

14,534

 

14,564

 

15,610

 

15,817

 

 

 

 

 

 

 

 

 

 

 

 

 

Alexandria Real Estate Equities, Inc.’s stockholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

Series D Cumulative Convertible Preferred Stock

 

250,000

 

250,000

 

250,000

 

250,000

 

250,000

 

Series E Cumulative Redeemable Preferred Stock

 

130,000

 

130,000

 

130,000

 

130,000

 

130,000

 

Common stock

 

710

 

633

 

632

 

632

 

622

 

Additional paid-in capital

 

3,596,477

 

3,075,860

 

3,086,052

 

3,094,987

 

3,053,269

 

Accumulated other comprehensive loss

 

(39,565

)

(22,890

)

(24,833

)

(19,729

)

(37,370

)

Alexandria’s stockholders’ equity

 

3,937,622

 

3,433,603

 

3,441,851

 

3,455,890

 

3,396,521

 

Noncontrolling interests

 

47,348

 

47,144

 

46,643

 

45,120

 

44,247

 

Total equity

 

3,984,970

 

3,480,747

 

3,488,494

 

3,501,010

 

3,440,768

 

Total liabilities, noncontrolling interests, and equity

 

$

7,379,289

 

$

7,090,919

 

$

7,150,116

 

$

6,965,017

 

$

6,841,739

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

6

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Funds From Operations and Adjusted Funds From Operations

(In thousands, except per share amounts)

(Unaudited)

 

The following table presents a reconciliation of net income attributable to Alexandria’s common stockholders – basic, the most directly comparable financial measure presented in accordance with GAAP, to FFO attributable to Alexandria’s common stockholders – diluted, FFO attributable to Alexandria’s common stockholders – diluted, as adjusted, and AFFO attributable to Alexandria’s common stockholders – diluted, for the periods below:

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

6/30/13

 

3/31/13

 

12/31/12

 

9/30/12

 

6/30/12

 

6/30/13

 

6/30/12

 

Net income attributable to Alexandria’s common stockholders – basic

 

$

25,483

 

$

22,442

 

$

21,000

 

$

10,646

 

$

17,616

 

$

47,925

 

$

35,984

 

Depreciation and amortization

 

46,580

 

46,995

 

48,072

 

48,173

 

52,355

 

93,575

 

95,760

 

Loss (gain) on sale of real estate

 

(219

)

340

 

 

(1,562

)

(2

)

121

 

(2

)

Impairment of real estate

 

 

 

1,601

 

9,799

 

 

 

 

Gain on sale of land parcel

 

(772

)

 

 

 

 

(772

)

(1,864

)

Amount attributable to noncontrolling interests/unvested restricted stock awards:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

1,383

 

1,324

 

1,336

 

1,188

 

1,122

 

2,707

 

2,068

 

FFO

 

(1,437

)

(1,064

)

(1,109

)

(1,148

)

(1,133

)

(2,501

)

(2,305

)

FFO attributable to Alexandria’s common stockholders – basic

 

71,018

 

70,037

 

70,900

 

67,096

 

69,958

 

141,055

 

129,641

 

Assumed conversion of 8.00% Unsecured Senior Convertible Notes

 

5

 

5

 

5

 

5

 

6

 

10

 

11

 

FFO attributable to Alexandria’s common stockholders – diluted

 

71,023

 

70,042

 

70,905

 

67,101

 

69,964

 

141,065

 

129,652

 

Realized gain on equity investment primarily related to one non-tenant life science entity

 

 

 

 

 

(5,811

)

 

(5,811

)

Impairment of land parcel

 

 

 

2,050

 

 

 

 

 

Loss on early extinguishment of debt

 

560

 

 

 

 

1,602

 

560

 

2,225

 

Preferred stock redemption charge

 

 

 

 

 

 

 

5,978

 

Allocation to unvested restricted stock awards

 

(12

)

 

(19

)

 

35

 

(12

)

(20

)

FFO attributable to Alexandria’s common stockholders – diluted, as adjusted

 

71,571

 

70,042

 

72,936

 

67,101

 

65,790

 

141,613

 

132,024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-revenue-enhancing capital expenditures:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Maintenance building improvements

 

(337

)

(596

)

(329

)

(935

)

(594

)

(933

)

(804

)

Tenant improvements and leasing commissions

 

(2,990

)

(882

)

(3,170

)

(1,844

)

(2,148

)

(3,872

)

(4,167

)

Straight-line rent revenue

 

(8,239

)

(6,198

)

(9,240

)

(5,225

)

(5,195

)

(14,437

)

(13,991

)

Straight-line rent expense on ground leases

 

539

 

538

 

471

 

201

 

1,207

 

1,077

 

2,613

 

Capitalized income from development projects

 

9

 

22

 

45

 

50

 

72

 

31

 

550

 

Amortization of acquired above and below market leases

 

(830

)

(830

)

(844

)

(778

)

(778

)

(1,660

)

(1,578

)

Amortization of loan fees

 

2,427

 

2,386

 

2,505

 

2,470

 

2,214

 

4,813

 

4,857

 

Amortization of debt premiums/discounts

 

115

 

115

 

110

 

112

 

110

 

230

 

289

 

Stock compensation

 

4,463

 

3,349

 

3,748

 

3,845

 

3,274

 

7,812

 

6,567

 

Allocation to unvested restricted stock awards

 

50

 

19

 

63

 

19

 

15

 

69

 

48

 

AFFO attributable to Alexandria’s common stockholders – diluted

 

$

66,778

 

$

67,965

 

$

66,295

 

$

65,016

 

$

63,967

 

$

134,743

 

$

126,408

 

 

The following table presents a reconciliation of net income per share attributable to Alexandria’s common stockholders – basic, to FFO per share attributable to Alexandria’s common stockholders – diluted, FFO per share attributable to Alexandria’s common stockholders – diluted, as adjusted, and AFFO per share attributable to Alexandria’s common stockholders – diluted, for the periods below.  For the computation of the weighted average shares used to compute the per share information, refer to the “Definitions and Other Information” section in our supplemental information:

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

6/30/13

 

3/31/13

 

12/31/12

 

9/30/12

 

6/30/12

 

6/30/13

 

6/30/12

 

Net income per share attributable to Alexandria’s common stockholders – basic

 

$

0.38

 

$

0.36

 

$

0.33

 

$

0.17

 

$

0.29

 

$

0.74

 

$

0.58

 

Depreciation and amortization

 

0.69

 

0.74

 

0.76

 

0.78

 

0.84

 

1.43

 

1.56

 

Loss (gain) on sale of real estate

 

 

0.01

 

 

(0.03

)

 

0.01

 

 

Impairment of real estate

 

 

 

0.03

 

0.16

 

 

 

 

Gain on sale of land parcel

 

(0.01

)

 

 

 

 

(0.01

)

(0.03

)

Amount attributable to noncontrolling interests/unvested restricted stock awards:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

0.02

 

0.02

 

0.02

 

0.02

 

0.02

 

0.04

 

0.03

 

FFO

 

(0.02

)

(0.02

)

(0.02

)

(0.02

)

(0.02

)

(0.04

)

(0.04

)

FFO per share attributable to Alexandria’s common stockholders – basic

 

1.06

 

1.11

 

1.12

 

1.08

 

1.13

 

2.17

 

2.11

 

Assumed conversion of 8.00% Unsecured Senior Convertible Notes

 

 

 

 

 

 

 

 

FFO per share attributable to Alexandria’s common stockholders – diluted

 

1.06

 

1.11

 

1.12

 

1.08

 

1.13

 

2.17

 

2.11

 

Realized gain on equity investment primarily related to one non-tenant life science entity

 

 

 

 

 

(0.09

)

 

(0.09

)

Impairment of land parcel

 

 

 

0.04

 

 

 

 

 

Loss on early extinguishment of debt

 

0.01

 

 

 

 

0.03

 

0.01

 

0.03

 

Preferred stock redemption charge

 

 

 

 

 

 

 

0.10

 

Allocation to unvested restricted stock awards

 

 

 

 

 

 

 

 

FFO per share attributable to Alexandria’s common stockholders – diluted, as adjusted

 

1.07

 

1.11

 

1.16

 

1.08

 

1.07

 

2.18

 

2.14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-revenue-enhancing capital expenditures:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Maintenance building improvements

 

(0.01

)

(0.01

)

(0.01

)

(0.01

)

(0.01

)

(0.01

)

(0.01

)

Tenant improvements and leasing commissions

 

(0.04

)

(0.01

)

(0.05

)

(0.03

)

(0.03

)

(0.06

)

(0.07

)

Straight-line rent revenue

 

(0.12

)

(0.10

)

(0.15

)

(0.08

)

(0.08

)

(0.22

)

(0.23

)

Straight-line rent expense on ground leases

 

0.01

 

0.01

 

0.01

 

 

0.02

 

0.02

 

0.04

 

Amortization of acquired above and below market leases

 

(0.01

)

(0.01

)

(0.01

)

(0.01

)

(0.01

)

(0.03

)

(0.03

)

Amortization of loan fees

 

0.03

 

0.04

 

0.04

 

0.03

 

0.03

 

0.07

 

0.09

 

Stock compensation

 

0.07

 

0.05

 

0.06

 

0.06

 

0.05

 

0.12

 

0.11

 

Allocation to unvested restricted stock awards

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

0.01

 

AFFO per share attributable to Alexandria’s common stockholders – diluted

 

$

1.00

 

$

1.08

 

$

1.05

 

$

1.04

 

$

1.04

 

$

2.07

 

$

2.05

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

7

 

 


Exhibit 99.2

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Table of Contents

 

 

Page

EARNINGS PRESS RELEASE

 

Second Quarter Ended June 30, 2013, Financial and Operating Results

1

Guidance

3

Earnings Call Information

4

Consolidated Statements of Income

5

Consolidated Balance Sheets

6

Funds From Operations and Adjusted Funds From Operations

7

 

 

SUPPLEMENTAL INFORMATION

 

Company Profile

9

Company and Investor Information

10

Financial and Asset Base Highlights

11

 

 

Core Operating Metrics

 

Core Operating Metrics

13

Summary of Same Property Comparisons

14

Same Property Performance Historical Results

15

Summary of Leasing Activity

16

Summary of Lease Expirations

17

Summary of Properties and Occupancy

18

Top 20 Client Tenants and Client Tenant Mix

19

Property Listing

20

 

 

Value-Added Opportunities and External Growth

 

Summary of Investments in Real Estate

24

Summary of Capital Expenditures

25

All Active Development Projects in North America

26

All Active Redevelopment Projects in North America

28

Future Value-Added Projects in North America

31

Summary of Real Estate Investment in Asia

43

 

 

Balance Sheet

 

Credit Metrics

45

Summary of Debt

46

Assets Held for Sale and Summary of Real Estate Sales

48

 

 

Definitions and Other Information

 

Definitions and Other Information

50

 

 

This document includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  You can identify the forward-looking statements by their use of forward-looking words, such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “intends,” “plans,” “estimates,” or “anticipates,” or the negative of those words or similar words.  These forward-looking statements are based on our current expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts, as well as a number of assumptions concerning future events.  These statements are subject to risks, uncertainties, assumptions and other important factors that could cause actual results to differ materially from the results discussed in the forward-looking statements.  Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets, our failure to successfully complete and lease our existing space held for redevelopment and new properties acquired for that purpose and any properties undergoing development, our failure to successfully operate or lease acquired properties, decreased rental rates or increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by client tenants, general and local economic conditions, and other risks and uncertainties detailed in our filings with the Securities and Exchange Commission (“SEC”).  Accordingly, you are cautioned not to place undue reliance on such forward-looking statements.  All forward-looking statements are made as of July 29, 2013, the date this document was first made available on our website, and we assume no obligation to update this information and expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.  For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.  Note that certain figures are rounded throughout this document, which may impact footing and/or crossfooting of totals and subtotals.

 

This document is not an offer to sell or solicitation to buy securities of Alexandria Real Estate Equities, Inc.  Any offers to sell or solicitations to buy securities of Alexandria Real Estate Equities, Inc. shall be made only by means of a prospectus approved for that purpose.  Unless otherwise indicated, the “Company,” “Alexandria,” “we,” “us,” and “our” refer to Alexandria Real Estate Equities, Inc. and its consolidated subsidiaries.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

i

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EARNINGS PRESS RELEASE

 

SECOND QUARTER ENDED

JUNE 30, 2013

FINANCIAL

AND

OPERATING RESULTS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

Contact:

Joel S. Marcus

 

Chairman, Chief Executive Officer, & Founder

 

Alexandria Real Estate Equities, Inc.

 

(626) 578-9693

 

Alexandria Real Estate Equities, Inc.

Reports

 

Second Quarter Ended June 30, 2013

Financial and Operating Results

 

FFO Per Share – Diluted, as Adjusted, of $1.07 for 2Q13

AFFO Per Share – Diluted of $1.00 for 2Q13

EPS Per Share – Diluted of $0.38 for 2Q13

Total Revenues of $154.2 Million for 2Q13

NOI of $107.9 Million for 2Q13

Continued Solid Life Science Space Demand in Key Cluster Submarkets

 

PASADENA, CA. – July 29, 2013 – Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced financial and operating results for the second quarter ended June 30, 2013.

 

Second quarter ended June 30, 2013, highlights

 

Results

 

·       Funds from operations (“FFO”) attributable to Alexandria Real Estate Equities, Inc.’s (“Alexandria’s”) common stockholders – diluted, as adjusted:

·       $71.6 million, or $1.07 per share, for 2Q13 compared to $65.8 million, or $1.07 per share, for 2Q12

·       $141.6 million, or $2.18 per share, for YTD 2Q13 compared to $132.0 million, or $2.14 per share, for YTD 2Q12

·       Adjusted funds from operations (“AFFO”) attributable to Alexandria’s common stockholders – diluted:

·       $66.8 million, or $1.00 per share, for 2Q13 compared to $64.0 million, or $1.04 per share, for 2Q12

·       $134.7 million, or $2.07 per share, for YTD 2Q13 compared to $126.4 million, or $2.05 per share, for YTD 2Q12

·       Net income attributable to Alexandria’s common stockholders – diluted:

·       $25.5 million, or $0.38 per share, for 2Q13 compared to $17.6 million, or $0.29 per share, for 2Q12

·       $47.9 million, or $0.74 per share, for YTD 2Q13 compared to $36.0 million, or $0.58 per share, for YTD 2Q12

Core operating metrics

 

·       Total revenues from continuing operations:

·       $154.2 million for 2Q13, up 5.9%, compared to $145.6 million for 2Q12

·       $304.6 million YTD 2Q13, up 8.3%, compared to $281.3 million for YTD 2Q12

·       Net operating income (“NOI”) from continuing operations:

·       $107.9 million for 2Q13, up 4.3%, compared to $103.5 million for 2Q12

·       $213.1 million for YTD 2Q13, up 7.2%, compared to $198.7 million for YTD 2Q12

·       Same property NOI performance:

·       7.2% and 3.2% increases on a cash and GAAP basis, respectively, for 2Q13 compared to 2Q12

·       8.3% and 2.0% increases on a cash and GAAP basis, respectively, for YTD 2Q13 compared to YTD 2Q12

·       Leasing activity solid during the three months ended June 30, 2013:

·       Executed 66 leases for 768,000 rentable square feet (“RSF”), including 270,000 RSF of development and redevelopment space

·       Rental rate increase of 6.7% and 12.7% on a cash and GAAP basis, respectively, on renewed/re-leased space

·       Key life science space leasing:

·       Investment-grade entity leased 121,632 RSF at 430 East 29th Street development in the Greater NYC market

·       Illumina, Inc. leased 97,702 RSF at 499 Illinois Street development in the San Francisco Bay Area market

·       Sarepta Therapeutics, Inc. leased 46,376 RSF at 215 First Street in the Greater Boston market

·       Eli Lilly and Company leased 27,950 RSF at 620 Professional Drive in the Suburban Washington, D.C. market

·       Nominal remaining expiring leases in 2013 of 410,254 RSF, or 3% of total operating RSF

·       Occupancy for North American Properties, as of June 30, 2013:

·       94.6% for operating properties and 92.9% for operating and redevelopment properties, up 40 bps and 110 bps, respectively, since March 31, 2013

·       Operating margins remained steady at 70% for 2Q13 and YTD 2Q13

·       Investment-grade client tenants represented 46% of total annualized base rent (“ABR”)

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

1

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Second Quarter Ended June 30, 2013

Financial and Operating Results

 

Core operating metrics (continued)

 

·       Investment-grade client tenants represented 72% of ABR from our top 10 client tenants

·       Contractual annual rent escalations in 95% of our leases

 

Balance sheet

 

·        Completed in 2Q13 secondary offering of 7.6 million shares of common stock at a price of $73.50 per share.  The net proceeds of $535.5 million were used to repay outstanding balances under our unsecured senior line of credit.

·        Completed in 2Q13 $500 million 3.90% 10-year unsecured senior notes payable offering.  Net proceeds of $495.3 million were used to reduce outstanding variable rate bank debt, including a $150 million partial repayment of our $750 million 2016 Unsecured Senior Bank Term Loan and to increase our available cash balance.  In connection with the partial repayment of our 2016 Unsecured Senior Bank Term Loan, we recognized a loss on the early extinguishment of debt related to the write-off of unamortized loan fees totaling $0.6 million, or $0.01 per share.

·        Liquidity of $1.8 billion, including $1.5 billion available under our unsecured senior line of credit and $302.2 million in cash and cash equivalents as of June 30, 2013.

·        Closed in 2Q13 secured construction loan, with aggregate commitments of $36 million at a rate of LIBOR + 1.40%, for 100% pre-leased development project at 269 East Grand Avenue in the San Francisco Bay Area market.

·        Net debt to EBITDA of 6.6x for the twelve months ended June 30, 2013.

·        Fixed charge coverage ratio of 2.7x for the twelve months ended June 30, 2013.

·        Unhedged variable rate debt totaling 11% of total consolidated debt as of June 30, 2013.

·       Completed in 2Q13 $22.5 million of real estate property sales, at a gain of $1.0 million, as follows:

·       $4.4 million of non-strategic income producing assets at a gain of $0.2 million

·       $18.1 million of non-income-producing land at a gain of $0.8 million

 

Subsequent events

 

Ariad Pharmaceuticals, Inc. expansion

 

On July 3, 2013, Ariad Pharmaceuticals, Inc. executed an LOI to lease an additional 139,374 RSF for a 15 year term at our 75/125 Binney Street development in the Cambridge submarket of Greater Boston.  An amendment to their lease is under negotiation to increase their lease to 383,497 RSF, or 99% of the total RSF of the project.

 

Sale of land parcel at 1600 Owens Street

 

On July 8, 2013, we executed a purchase and sale agreement to dispose of our land parcel at 1600 Owens Street in the Mission Bay submarket of the San Francisco Bay Area for an aggregate sales price of $55.2 million, inclusive of certain parking spaces.  Ownership of the parcel was strategically important to the buyer and we will earn a fee to manage the construction of the building.  This sale is expected to close in December 2013.

 

Acquisition of 10121/10151 Barnes Canyon Road

 

On July 5, 2013, we acquired 10121/10151 Barnes Canyon Road, an approximate 116,000 RSF office property located in the Sorrento Mesa submarket of San Diego, for a total purchase price of $13.1 million.  The acquisition will be funded in two installments:  i) $5.4 million to be funded in August, 2013 (which will earn a 7% return until the next payment is made), and ii) $7.7 million to be funded no later than October 2014.  The property is currently 100% occupied with leases that expire in 2014 and 2015. We intend to convert the existing office space into laboratory space through redevelopment when the space becomes available. Initial stabilized yields will be provided in the future upon commencement of the redevelopment.

 

Unsecured senior bank loan financings

 

On July 26, 2013, we amended our $600 million 2016 Unsecured Senior Bank Term Loan to reduce our interest rate on outstanding borrowings.  We did not extend the maturity of this loan as we expect to repay the loan over the next one to three years.  In addition, we expect to complete amendments to our $1.5 billion unsecured senior line of credit and our $600 million 2017 Unsecured Senior Bank Term Loan in the third quarter of 2013 to reduce our interest rate on outstanding borrowings, extend the maturity dates and amend certain financial covenants.  The commitments available for each facility will not change.

 

 

 

 

 

Maturity Date (including extensions)

 

Applicable Rate

 

Facility Fee

 

Facility

 

Status

 

Prior/
Current

 

Extended/
Proposed

 

Prior/
Current

 

Extended/
Proposed

 

Prior/
Current

 

Extended/
Proposed

 

$600 million 2016 Unsecured Senior Bank Term Loan

 

Complete

 

June 2016

 

July 2016

 

L +1.75%

 

L +1.20%

 

N/A

 

N/A

 

$600 million 2017 Unsecured Senior Bank Term Loan

 

In Progress

 

January 2017

 

January 2019

 

L +1.50%

 

L +1.20%

 

N/A

 

N/A

 

$1.5 billion unsecured senior line of credit

 

In Progress

 

April 2017

 

January 2019

 

L +1.20%

 

L +1.10%

 

0.25%

 

0.20%

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

2

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Guidance

 

Based on our current view of existing market conditions and certain current assumptions, we have updated guidance for earnings per share attributable to Alexandria’s common stockholders – diluted and FFO per share attributable to Alexandria’s common stockholders – diluted for the year ended December 31, 2013, as set forth in the table below.  The table below provides a reconciliation of FFO per share, a non-GAAP measure, to earnings per share, the most directly comparable GAAP measure, as well as other key assumptions included in our guidance for the year ended December 31, 2013.  To the extent our full year earnings guidance is updated during the year, we will provide additional disclosure supporting reasons for any significant changes to such guidance.

 

Guidance for the Year Ended December 31, 2013

 

Reported on July 29, 2013

 

Reported on May 13, 2013

 

Earnings per share attributable to Alexandria’s common stockholders – diluted

 

$1.53 to $1.63

 

$1.50 to $1.60

 

Depreciation and amortization

 

$2.76 to $2.86

 

$2.80 to $2.90

 

(Gain) loss on sale of real estate

 

$(0.01)

 

$0.01

 

Other

 

$(0.01)

 

$(0.01)

 

FFO per share attributable to Alexandria’s common stockholders – diluted

 

$4.32 to $4.42

 

$4.35 to $4.45

 

Add back: actual 2Q13 per share loss on early extinguishment of debt (1)

 

$0.01

 

N/A

 

Add back: projected 3Q13 per share loss on early extinguishment of debt (1)

 

$0.02

 

N/A

 

FFO per share attributable to Alexandria’s common stockholders - diluted, as adjusted

 

$4.35 to $4.45

 

$4.35 to $4.45

 

 

 

 

 

 

 

Key projection assumptions:

 

 

 

 

 

Same property NOI growth – cash basis

 

5% to 7%

 

5% to 7%

 

Same property NOI growth – GAAP basis

 

1% to 3%

 

1% to 3%

 

Rental rate steps on lease renewals and re-leasing of space – cash basis

 

3% to 5%

 

1% to 3%

 

Rental rate steps on lease renewals and re-leasing of space – GAAP basis

 

11% to 13%

 

7% to 12%

 

Occupancy percentage for all operating properties at December 31, 2013

 

94.3% to 94.7%

 

94.3% to 94.7%

 

Straight-line rents

 

$24 to $26 million

 

$24 to $26 million

 

Amortization of above and below market leases

 

$3 to $4 million

 

$3 to $4 million

 

General and administrative expenses

 

$48 to $51 million

 

$48 to $51 million

 

Capitalization of interest

 

$51 to $57 million

 

$51 to $57 million

 

Interest expense, net

 

$71 to $81 million

 

$71 to $81 million

 

Net debt to adjusted EBITDA for the annualized three months ended December 31, 2013

 

6.5x

 

6.5x

 

Fixed charge coverage ratio for the annualized three months ended December 31, 2013

 

3.0x

 

3.0x

 

Non-income-producing land as a percentage of gross real estate by December 31, 2013

 

15% to 17%

 

15% to 17%

 

 

(1)          Represents loss on early extinguishment of debt related to the write-off of unamortized loan fees of $0.01 per share as a result of the $150 million partial repayment of our 2016 Unsecured Senior Bank Term Loan during the three months ended June 30, 2013, and the estimated loss on early extinguishment of debt related to the write-off of unamortized loan fees of $0.02 per share as a result of amendments of our 2016 Unsecured Senior Bank Term Loan, 2017 Unsecured Senior Bank Term Loan, and $1.5 billion unsecured senior line of credit which we expect to complete in the third quarter of 2013.

 

We expect that our principal liquidity needs for the year ended December 31, 2013, will be satisfied by the following multiple sources of capital as shown in the table below.  There can be no assurance that our sources and uses of capital will not be materially higher or lower than these expectations.

 

 

 

Reported on
July 29, 2013

 

Reported on
May 13, 2013

 

Sources and Uses of Capital for the Year Ended December 31, 2013 (in millions)

 

Completed

 

Projected

 

Total

 

Total

 

Sources of capital:

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities less dividends

 

$

66

 

$

64 - 84

 

$

130 - 150

 

$

130 - 150

 

Non-income-producing land sales

 

18

 

131 - 171

(1)

149 - 189

 

149 - 189

 

Income producing asset sales

 

129

 

0 - 5

 

129 - 134

 

125 - 138

 

Secured construction loan borrowings

 

26

 

19 - 39

 

45 - 65

 

45 - 55

 

Unsecured senior notes payable

 

500

 

 

500

 

350 - 450

 

Common stock offering

 

536

 

 

536

 

415 - 490

 

Available cash and borrowings on unsecured senior line of credit (2)

 

 

324 - 369

 

324 - 369

 

 

Total sources of capital

 

$

1,275

 

$

538 - 668

 

$

1,813 - 1,943

 

$

1,214 - 1,472

 

 

 

 

 

 

 

 

 

 

 

Uses of capital:

 

 

 

 

 

 

 

 

 

Development, redevelopment, and construction

 

$

253

 

$

346 - 376

 

$

599 - 629

 

$

617 - 667

 

Seller financing of asset sales

 

39

 

 

39

 

39

 

Acquisitions:

 

 

 

 

 

 

 

 

 

Completed/in process acquisitions

 

13

 

64

 

77

 

 

Additional acquisitions

 

-

 

123 - 223

 

123 - 223

 

200 - 300

 

Secured notes payable repayments

 

32

 

5

 

37

 

37

 

Unsecured senior bank term loan repayment

 

150

 

 

150

 

125 - 175

 

Excess cash retained from issuance of unsecured senior notes payable/pay down of unsecured senior line of credit

 

788

 

 

788

 

196 - 254

 

Total uses of capital

 

$

1,275

 

$

538 - 668

 

$

1,813 - 1,943

 

$

1,214 - 1,472

 

 

(1)          See Balance Sheet section of our Supplemental Package for additional information.

(2)          We had $302.2 million in cash and cash equivalents as of June 30, 2013.

 

The key assumptions behind the sources and uses of capital in the table on the prior page are a favorable capital market environment and performance of our core operations in areas such as delivery of current and future development and redevelopment projects, leasing activity, and renewals.  Our expected sources and uses of capital are subject to a number of variables and uncertainties, including those discussed under the “Forward-looking statements” section under Part I, the “Risk Factors” section under Item 1A, and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section under Item 7, of our annual report on Form 10-K for the year ended December 31, 2012.  We expect to update our forecast of sources and uses of capital on a quarterly basis.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

3

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Earnings Call Information

 

We will host a conference call on Tuesday, July 30, 2013, at 3:00 p.m. Eastern Time (“ET”)/12:00 p.m. noon Pacific Time (“PT”) that is open to the general public to discuss our financial and operating results for the three months ended June 30, 2013.  To participate in this conference call, dial (888) 724-9493 or (913) 312-1456 and confirmation code 7393551, shortly before 3:00 p.m. ET/12:00 p.m. noon PT.  The audio web cast can be accessed at: www.are.com, in the “For Investors” section.  A replay of the call will be available for a limited time from 6:00 p.m. ET/3:00 p.m. PT on Tuesday, July 30, 2013.  The replay number is (888) 203-1112 or (719) 457-0820 and the confirmation code is 7393551.

 

Additionally, a copy of this Earnings Press Release and Supplemental Information for the second quarter ended June 30, 2013, is available in the “For Investors” section of our website at www.are.com or by following this link: http://www.are.com/fs/2013q2.pdf.

 

About the Company

 

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed investment-grade REIT, is the largest and leading REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry.  Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in the core life science cluster locations including Greater Boston, the San Francisco Bay Area, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park.  Alexandria’s high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies.  As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity, collaboration, and innovation through its best-in-class laboratory and office space adjacent to leading academic medical research centers, unparalleled life science real estate expertise and services, and a longstanding and expansive network in the life science community.  We believe these advantages result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.  For additional information on Alexandria, please visit www.are.com.

 

***********

 

This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Such forward-looking statements include, without limitation, statements regarding our 2013 earnings per share attributable to Alexandria’s common stockholders – diluted, 2013 FFO per share attributable to Alexandria’s common stockholders – diluted, NOI and our projected sources and uses of capital for the year ended December 31, 2013.  These forward-looking statements are based on our current expectations, beliefs, projections, future plans, strategies, anticipated events, trends, and similar expressions concerning matters that are not historical facts, as well as a number of assumptions concerning future events.  These statements are subject to risks, uncertainties, assumptions and other important factors that could cause actual results to differ materially from the results discussed in the forward-looking statements.  Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets, our failure to successfully complete and lease our existing space held for redevelopment and new properties acquired for that purpose and any properties undergoing development, our failure to successfully operate or lease acquired properties, decreased rental rates or increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by client tenants, general and local economic conditions, and other risks and uncertainties detailed in our filings with the SEC.  Accordingly, you are cautioned not to place undue reliance on such forward-looking statements.  All forward-looking statements are made as of the date of this press release, and we assume no obligation to update this information and expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.  For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

4

 

 


 


 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Consolidated Statements of Income

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

6/30/13

 

3/31/13

 

12/31/12

 

9/30/12

 

6/30/12

 

6/30/13

 

6/30/12

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental

 

$

114,743

 

$

111,776

 

$

112,048

 

$

106,216

 

$

104,329

 

$

226,519

 

$

205,530

 

Tenant recoveries

 

35,923

 

35,611

 

35,721

 

34,006

 

31,881

 

71,534

 

63,763

 

Other income

 

3,569

 

2,993

 

3,785

 

2,628

 

9,383

 

6,562

 

12,011

 

Total revenues

 

154,235

 

150,380

 

151,554

 

142,850

 

145,593

 

304,615

 

281,304

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental operations

 

46,323

 

45,224

 

46,176

 

44,203

 

42,102

 

91,547

 

82,555

 

General and administrative

 

12,472

 

11,648

 

12,635

 

12,470

 

12,298

 

24,120

 

22,655

 

Interest

 

15,978

 

18,020

 

17,941

 

17,092

 

17,922

 

33,998

 

34,148

 

Depreciation and amortization

 

46,580

 

46,065

 

47,515

 

46,584

 

50,741

 

92,645

 

92,527

 

Impairment of land parcel

 

 

 

2,050

 

 

 

 

 

Loss on early extinguishment of debt

 

560

 

 

 

 

1,602

 

560

 

2,225

 

Total expenses

 

121,913

 

120,957

 

126,317

 

120,349

 

124,665

 

242,870

 

234,110

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from continuing operations

 

32,322

 

29,423

 

25,237

 

22,501

 

20,928

 

61,745

 

47,194

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from discontinued operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from discontinued operations before impairment of real estate

 

243

 

814

 

5,171

 

5,603

 

4,713

 

1,057

 

9,358

 

Impairment of real estate

 

 

 

(1,601

)

(9,799

)

 

 

 

Income (loss) from discontinued operations, net

 

243

 

814

 

3,570

 

(4,196

)

4,713

 

1,057

 

9,358

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on sale of land parcel

 

772

 

 

 

 

 

772

 

1,864

 

Net income

 

33,337

 

30,237

 

28,807

 

18,305

 

25,641

 

63,574

 

58,416

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to noncontrolling interests

 

980

 

982

 

1,012

 

828

 

851

 

1,962

 

1,562

 

Dividends on preferred stock

 

6,471

 

6,471

 

6,471

 

6,471

 

6,903

 

12,942

 

14,386

 

Preferred stock redemption charge

 

 

 

 

 

 

 

5,978

 

Net income attributable to unvested restricted stock awards

 

403

 

342

 

324

 

360

 

271

 

745

 

506

 

Net income attributable to Alexandria’s common stockholders

 

$

25,483

 

$

22,442

 

$

21,000

 

$

10,646

 

$

17,616

 

$

47,925

 

$

35,984

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share attributable to Alexandria’s common stockholders – basic and diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.38

 

$

0.35

 

$

0.27

 

$

0.24

 

$

0.21

 

$

0.72

 

$

0.43

 

Discontinued operations, net

 

 

0.01

 

0.06

 

(0.07

)

0.08

 

0.02

 

0.15

 

Earnings per share – basic and diluted

 

$

0.38

 

$

0.36

 

$

0.33

 

$

0.17

 

$

0.29

 

$

0.74

 

$

0.58

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock outstanding for calculating earnings per share attributable to Alexandria’s common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

– Basic

 

66,973

 

63,161

 

63,092

 

62,364

 

61,663

 

65,078

 

61,586

 

– Diluted

 

66,973

 

63,161

 

63,092

 

62,364

 

61,664

 

65,078

 

61,586

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2013

5

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Consolidated Balance Sheets

(In thousands)

(Unaudited)

 

 

 

June 30,

 

March 31,

 

December 31,

 

September 30,

 

June 30,

 

 

 

2013

 

2013

 

2012

 

2012

 

2012

 

Assets

 

 

 

 

 

 

 

 

 

 

 

Investments in real estate, net

 

$

6,453,379

 

$

6,375,182

 

$

6,424,578

 

$

6,300,027

 

$

6,208,354

 

Cash and cash equivalents

 

302,205

 

87,001

 

140,971

 

94,904

 

80,937

 

Restricted cash

 

30,914

 

30,008

 

39,947

 

44,863

 

41,897

 

Tenant receivables

 

7,577

 

9,261

 

8,449

 

10,124

 

6,143

 

Deferred rent

 

177,507

 

170,100

 

170,396

 

160,914

 

155,295

 

Deferred leasing and financing costs, net

 

164,362

 

159,872

 

160,048

 

152,021

 

151,355

 

Investments

 

122,605

 

123,543

 

115,048

 

107,808

 

104,454

 

Other assets

 

120,740

 

135,952

 

90,679

 

94,356

 

93,304

 

Total assets

 

$

7,379,289

 

$

7,090,919

 

$

7,150,116

 

$

6,965,017

 

$

6,841,739

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities, Noncontrolling Interests, and Equity

 

 

 

 

 

 

 

 

 

 

 

Secured notes payable

 

$

711,029

 

$

730,714

 

$

716,144

 

$

719,350

 

$

719,977

 

Unsecured senior notes payable

 

1,048,395

 

549,816

 

549,805

 

549,794

 

549,783

 

Unsecured senior line of credit

 

 

554,000

 

566,000

 

413,000

 

379,000

 

Unsecured senior bank term loans

 

1,200,000

 

1,350,000

 

1,350,000

 

1,350,000

 

1,350,000

 

Accounts payable, accrued expenses, and tenant security deposits

 

368,249

 

367,153

 

423,708

 

376,785

 

348,037

 

Dividends payable

 

52,141

 

43,955

 

41,401

 

39,468

 

38,357

 

Total liabilities

 

3,379,814

 

3,595,638

 

3,647,058

 

3,448,397

 

3,385,154

 

 

 

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redeemable noncontrolling interests

 

14,505

 

14,534

 

14,564

 

15,610

 

15,817

 

 

 

 

 

 

 

 

 

 

 

 

 

Alexandria Real Estate Equities, Inc.’s stockholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

Series D Cumulative Convertible Preferred Stock

 

250,000

 

250,000

 

250,000

 

250,000

 

250,000

 

Series E Cumulative Redeemable Preferred Stock

 

130,000

 

130,000

 

130,000

 

130,000

 

130,000

 

Common stock

 

710

 

633

 

632

 

632

 

622

 

Additional paid-in capital

 

3,596,477

 

3,075,860

 

3,086,052

 

3,094,987

 

3,053,269

 

Accumulated other comprehensive loss

 

(39,565

)

(22,890

)

(24,833

)

(19,729

)

(37,370

)

Alexandria’s stockholders’ equity

 

3,937,622

 

3,433,603

 

3,441,851

 

3,455,890

 

3,396,521

 

Noncontrolling interests

 

47,348

 

47,144

 

46,643

 

45,120

 

44,247

 

Total equity

 

3,984,970

 

3,480,747

 

3,488,494

 

3,501,010

 

3,440,768

 

Total liabilities, noncontrolling interests, and equity

 

$

7,379,289

 

$

7,090,919

 

$

7,150,116

 

$

6,965,017

 

$

6,841,739

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2013

6

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Funds From Operations and Adjusted Funds From Operations

(In thousands, except per share amounts)

(Unaudited)

 

The following table presents a reconciliation of net income attributable to Alexandria’s common stockholders – basic, the most directly comparable financial measure presented in accordance with GAAP, to FFO attributable to Alexandria’s common stockholders – diluted, FFO attributable to Alexandria’s common stockholders – diluted, as adjusted, and AFFO attributable to Alexandria’s common stockholders – diluted, for the periods below:

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

6/30/13

 

3/31/13

 

12/31/12

 

9/30/12

 

6/30/12

 

6/30/13

 

6/30/12

 

Net income attributable to Alexandria’s common stockholders – basic

 

$

25,483

 

$

22,442

 

$

21,000

 

$

10,646

 

$

17,616

 

$

47,925

 

$

35,984

 

Depreciation and amortization

 

46,580

 

46,995

 

48,072

 

48,173

 

52,355

 

93,575

 

95,760

 

Loss (gain) on sale of real estate

 

(219

)

340

 

 

(1,562

)

(2

)

121

 

(2

)

Impairment of real estate

 

 

 

1,601

 

9,799

 

 

 

 

Gain on sale of land parcel

 

(772

)

 

 

 

 

(772

)

(1,864

)

Amount attributable to noncontrolling interests/unvested restricted stock awards:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

1,383

 

1,324

 

1,336

 

1,188

 

1,122

 

2,707

 

2,068

 

FFO

 

(1,437

)

(1,064

)

(1,109

)

(1,148

)

(1,133

)

(2,501

)

(2,305

)

FFO attributable to Alexandria’s common stockholders – basic

 

71,018

 

70,037

 

70,900

 

67,096

 

69,958

 

141,055

 

129,641

 

Assumed conversion of 8.00% Unsecured Senior Convertible Notes

 

5

 

5

 

5

 

5

 

6

 

10

 

11

 

FFO attributable to Alexandria’s common stockholders – diluted

 

71,023

 

70,042

 

70,905

 

67,101

 

69,964

 

141,065

 

129,652

 

Realized gain on equity investment primarily related to one non-tenant life science entity

 

 

 

 

 

(5,811

)

 

(5,811

)

Impairment of land parcel

 

 

 

2,050

 

 

 

 

 

Loss on early extinguishment of debt

 

560

 

 

 

 

1,602

 

560

 

2,225

 

Preferred stock redemption charge

 

 

 

 

 

 

 

5,978

 

Allocation to unvested restricted stock awards

 

(12

)

 

(19

)

 

35

 

(12

)

(20

)

FFO attributable to Alexandria’s common stockholders – diluted, as adjusted

 

71,571

 

70,042

 

72,936

 

67,101

 

65,790

 

141,613

 

132,024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-revenue-enhancing capital expenditures:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Maintenance building improvements

 

(337

)

(596

)

(329

)

(935

)

(594

)

(933

)

(804

)

Tenant improvements and leasing commissions

 

(2,990

)

(882

)

(3,170

)

(1,844

)

(2,148

)

(3,872

)

(4,167

)

Straight-line rent revenue

 

(8,239

)

(6,198

)

(9,240

)

(5,225

)

(5,195

)

(14,437

)

(13,991

)

Straight-line rent expense on ground leases

 

539

 

538

 

471

 

201

 

1,207

 

1,077

 

2,613

 

Capitalized income from development projects

 

9

 

22

 

45

 

50

 

72

 

31

 

550

 

Amortization of acquired above and below market leases

 

(830

)

(830

)

(844

)

(778

)

(778

)

(1,660

)

(1,578

)

Amortization of loan fees

 

2,427

 

2,386

 

2,505

 

2,470

 

2,214

 

4,813

 

4,857

 

Amortization of debt premiums/discounts

 

115

 

115

 

110

 

112

 

110

 

230

 

289

 

Stock compensation

 

4,463

 

3,349

 

3,748

 

3,845

 

3,274

 

7,812

 

6,567

 

Allocation to unvested restricted stock awards

 

50

 

19

 

63

 

19

 

15

 

69

 

48

 

AFFO attributable to Alexandria’s common stockholders – diluted

 

$

66,778

 

$

67,965

 

$

66,295

 

$

65,016

 

$

63,967

 

$

134,743

 

$

126,408

 

 

The following table presents a reconciliation of net income per share attributable to Alexandria’s common stockholders - basic, to FFO per share attributable to Alexandria’s common stockholders – diluted, FFO per share attributable to Alexandria’s common stockholders – diluted, as adjusted, and AFFO per share attributable to Alexandria’s common stockholders – diluted, for the periods below.  For the computation of the weighted average shares used to compute the per share information, refer to the “Definitions and Other Information” section in our supplemental information:

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

6/30/13

 

3/31/13

 

12/31/12

 

9/30/12

 

6/30/12

 

6/30/13

 

6/30/12

 

Net income per share attributable to Alexandria’s common stockholders – basic

 

$

0.38

 

$

0.36

 

$

0.33

 

$

0.17

 

$

0.29

 

$

0.74

 

$

0.58

 

Depreciation and amortization

 

0.69

 

0.74

 

0.76

 

0.78

 

0.84

 

1.43

 

1.56

 

Loss (gain) on sale of real estate

 

 

0.01

 

 

(0.03

)

 

0.01

 

 

Impairment of real estate

 

 

 

0.03

 

0.16

 

 

 

 

Gain on sale of land parcel

 

(0.01

)

 

 

 

 

(0.01

)

(0.03

)

Amount attributable to noncontrolling interests/unvested restricted stock awards:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

0.02

 

0.02

 

0.02

 

0.02

 

0.02

 

0.04

 

0.03

 

FFO

 

(0.02

)

(0.02

)

(0.02

)

(0.02

)

(0.02

)

(0.04

)

(0.04

)

FFO per share attributable to Alexandria’s common stockholders – basic

 

1.06

 

1.11

 

1.12

 

1.08

 

1.13

 

2.17

 

2.11

 

Assumed conversion of 8.00% Unsecured Senior Convertible Notes

 

 

 

 

 

 

 

 

FFO per share attributable to Alexandria’s common stockholders – diluted

 

1.06

 

1.11

 

1.12

 

1.08

 

1.13

 

2.17

 

2.11

 

Realized gain on equity investment primarily related to one non-tenant life science entity

 

 

 

 

 

(0.09

)

 

(0.09

)

Impairment of land parcel

 

 

 

0.04

 

 

 

 

 

Loss on early extinguishment of debt

 

0.01

 

 

 

 

0.03

 

0.01

 

0.03

 

Preferred stock redemption charge

 

 

 

 

 

 

 

0.10

 

Allocation to unvested restricted stock awards

 

 

 

 

 

 

 

 

FFO per share attributable to Alexandria’s common stockholders – diluted, as adjusted

 

1.07

 

1.11

 

1.16

 

1.08

 

1.07

 

2.18

 

2.14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-revenue-enhancing capital expenditures:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Maintenance building improvements

 

(0.01

)

(0.01

)

(0.01

)

(0.01

)

(0.01

)

(0.01

)

(0.01

)

Tenant improvements and leasing commissions

 

(0.04

)

(0.01

)

(0.05

)

(0.03

)

(0.03

)

(0.06

)

(0.07

)

Straight-line rent revenue

 

(0.12

)

(0.10

)

(0.15

)

(0.08

)

(0.08

)

(0.22

)

(0.23

)

Straight-line rent expense on ground leases

 

0.01

 

0.01

 

0.01

 

 

0.02

 

0.02

 

0.04

 

Amortization of acquired above and below market leases

 

(0.01

)

(0.01

)

(0.01

)

(0.01

)

(0.01

)

(0.03

)

(0.03

)

Amortization of loan fees

 

0.03

 

0.04

 

0.04

 

0.03

 

0.03

 

0.07

 

0.09

 

Stock compensation

 

0.07

 

0.05

 

0.06

 

0.06

 

0.05

 

0.12

 

0.11

 

Allocation to unvested restricted stock awards

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

0.01

 

AFFO per share attributable to Alexandria’s common stockholders – diluted

 

$

1.00

 

$

1.08

 

$

1.05

 

$

1.04

 

$

1.04

 

$

2.07

 

$

2.05

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2013

7

 

 



 

 

 

 

 

 

 

 

 

SUPPLEMENTAL

INFORMATION

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Company Profile

 

The Company

 

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed investment-grade real estate investment trust (“REIT”), is the largest and leading REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry.  Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in the core life science cluster locations including Greater Boston, the San Francisco Bay Area, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park.  Alexandria’s high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies.  As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity, collaboration, and innovation through its best-in-class laboratory and office space adjacent to leading academic medical research centers, unparalleled life science real estate expertise and services, and longstanding and expansive network in the life science community.  We believe these advantages result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.  For additional information on Alexandria, please visit www.are.com.

 

Unique Niche Strategy

 

Alexandria’s primary business objective is to maximize stockholder value by providing its stockholders with the greatest possible total return and long-term asset value based on a multifaceted platform of internal and external growth.  The key elements to our strategy include our consistent focus on high-quality assets and operations in the top life science cluster locations with our properties located adjacent to life science entities, driving growth and technological advances within each cluster.  These adjacency locations are characterized by high barriers to entry for new landlords, high barriers to exit for client tenants, and limited supply of available space.  They represent highly desirable locations for tenancy by life science entities because of the close proximity to concentrations of specialized skills, knowledge, institutions, and related businesses.  Alexandria’s strategy also includes drawing upon our deep and broad life science and real estate relationships in order to attract new and leading life science client tenants and value-added real estate.  Alexandria was founded in 1994 by Jerry M. Sudarsky and Joel S. Marcus.  Alexandria executed its initial public offering in 1997 and received its investment-grade ratings in 2011.

 

Management

 

Alexandria’s executive and senior management team is highly experienced in the REIT industry (uniquely with life science and real estate development, construction, operations, ownership, and expertise) and is the most accomplished team focused on providing high-quality, environmentally sustainable real estate, technical infrastructure, and unique expertise to the broad and diverse life science industry.  Our deep and talented team has decades of life science industry experience.  Our management team also includes highly experienced regional market directors averaging over 21 years of real estate experience, including approximately 11 years with Alexandria.  We believe that our expertise, experience, reputation, and key life science relationships provide Alexandria significant competitive advantages in attracting new business opportunities.

 

Client Tenant Base

 

The quality, diversity, breadth, and depth of our significant relationships with our life science client tenants provide Alexandria with solid and stable cash flows.  Investment-grade client tenants represented 46% of Alexandria’s total annualized base rent as of June 30, 2013.  Additionally, investment-grade client tenants represented 72% of Alexandria’s top 10 client tenants by annualized base rent as of June 30, 2013.  As of June 30, 2013, our multinational pharmaceutical client tenants represented approximately 26.1% of our annualized base rent, led by Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., and Roche; revenue producing life science product and service, medical device, and industrial biotech companies represented approximately 22.1%, led by Illumina, Inc., Laboratory Corporation of America Holdings, Monsanto Company, and Quest Diagnostics Incorporated; non-profit, renowned medical and research institutions, and government agencies represented approximately 17.6% and included Fred Hutchinson Cancer Research Center, Massachusetts Institute of Technology, The Regents of the University of California, Sanford-Burnham Medical Research Institute, The Scripps Research Institute, the United States Government, and University of Washington; public biotechnology companies represented approximately 17.1% and included Amgen Inc., Biogen Idec Inc., Celgene Corporation, Gilead Sciences, Inc., and Onyx Pharmaceuticals, Inc.; private biotechnology companies represented approximately 13.0% and included high-quality, leading-edge companies with blue-chip venture and institutional investors, including Constellation Pharmaceuticals, Inc., FibroGen, Inc., and FORMA Therapeutics, Inc.; and the remaining approximately 4.1% consisted of traditional office client tenants.  Alexandria’s strong life science underwriting skills, long-term life science industry relationships, and sophisticated management with both real estate and life science operating expertise positively distinguish Alexandria from all other publicly traded real estate investment trusts and real estate companies.

 

 

Executive/Senior Management

Joel S. Marcus

 

Chairman, Chief Executive Officer, & Founder

 

Thomas J. Andrews

 

EVP – Regional Market Director-Greater Boston

Dean A. Shigenaga

 

Chief Financial Officer, EVP, & Treasurer

 

Daniel J. Ryan

 

EVP – Regional Market Director-San Diego & Strategic Operations

Stephen A. Richardson

 

Chief Operating Officer & Regional Market Director-San Francisco Bay Area

 

John J. Cox

 

SVP – Regional Market Director-Seattle

Peter M. Moglia

 

Chief Investment Officer

 

John H. Cunningham

 

SVP – Regional Market Director-NY & Strategic Operations

Jennifer J. Banks

 

SVP, General Counsel, & Corporate Secretary

 

Larry J. Diamond

 

SVP – Regional Market Director-Mid Atlantic

Marc E. Binda

 

SVP – Finance

 

Vincent R. Ciruzzi

 

SVP – Construction & Development

Andres R. Gavinet

 

Chief Accounting Officer

 

 

 

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

9

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Company Information

 

Corporate Headquarters

 

Trading Symbols

 

Information Requests

385 East Colorado Boulevard, Suite 299

 

New York Stock Exchange

 

Phone:

(626) 396-4828

Pasadena, California 91101

 

Common stock: ARE

 

E-mail:

[email protected]

 

 

Series E preferred stock: ARE–E

 

Web:

www.are.com

 

Summary Data

 

Cluster Markets

 

Total Properties

 

Total Rentable
Square Feet

Greater Boston, San Francisco Bay Area, San Diego, Greater NYC, Suburban Washington, D.C., Seattle, Research Triangle Park, Canada, India, and China

 

173

 

17.0 million

 

Common Stock Data

 

 

 

2Q13

 

1Q13

 

4Q12

 

3Q12

 

2Q12

High/low trading price

 

$

78.43/61.20

 

$

73.51/69.77

 

$

74.59/64.09

 

$

77.10/70.97

 

$

76.50/67.40

Closing stock price, average for period

 

$

70.68

 

$

71.98

 

$

69.88

 

$

73.65

 

$

71.67

Closing stock price, at the end of the quarter

 

$

65.72

 

$

70.98

 

$

69.32

 

$

73.52

 

$

72.72

Dividend per share – quarter/annualized

 

$

0.65/2.60

 

$

0.60/2.40

 

$

0.56/2.24

 

$

0.53/2.12

 

$

0.51/2.04

Closing dividend yield – annualized

 

4.0%

 

3.4%

 

3.2%

 

2.9%

 

2.8%

Common shares outstanding, at the end of the quarter (in thousands)

 

70,997

 

63,317

 

63,245

 

63,161

 

62,250

Closing market value of outstanding common shares (in thousands)

 

$

4,665,948

 

$

4,494,262

 

$

4,384,119

 

$

4,643,610

 

$

4,526,818

Total market capitalization (in thousands)

 

$

8,005,581

 

$

8,066,072

 

$

7,953,348

 

$

8,064,386

 

$

7,912,286

 

Investor Information

 

Equity Research Coverage

 

Alexandria is currently covered by the following research analysts.  This list may not be complete and is subject to change as firms initiate or discontinue coverage of our company.  Please note that any opinions, estimates, or forecasts regarding our historical or predicted performance made by these analysts are theirs alone and do not represent opinions, forecasts, or predictions of Alexandria or its management.  Alexandria does not by its reference below or distribution imply its endorsement of or concurrence with such information, conclusions, or recommendations.  Interested persons may obtain copies of analysts’ reports on their own as we do not distribute these reports.  Several of these firms may from time-to-time own our stock and/or hold other long or short positions in our stock, and may provide compensated services to us.

 

Argus Research Group, Inc.

 

 

 

Evercore Partners

 

 

 

RBC Capital Markets

 

 

William Eddleman, Jr.

 

(212) 425-7500

 

Sheila McGrath

 

(212) 497-0882

 

Michael Carroll

 

(440) 715-2649

 

 

 

 

Nathan Crossett

 

(212) 497-0870

 

Rich Moore

 

(440) 715-2646

 

 

 

 

 

 

 

 

 

 

 

Bank of America Merrill Lynch

 

 

 

Green Street Advisors, Inc.

 

 

 

Robert W. Baird & Company

James Feldman

 

(646) 855-5808

 

Jeff Theiler

 

(949) 640-8780

 

David Rodgers

 

(216) 737-7341

Jeffrey Spector

 

(646) 855-1363

 

John Hornbeak

 

(949) 640-8780

 

Mathew R. Spencer

 

(414) 298-5053

Stephen Sihelnik

 

(646) 855-1829

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Barclays Capital Inc.

 

 

 

International Strategy & Investment Group Inc.

 

Standard & Poor’s

 

 

Ross L. Smotrich

 

(212) 526-2306

 

George Auerbach

 

(212) 446-9459

 

Roy Shepard

 

(212) 438-1947

Michael R. Lewis

 

(212) 526-3098

 

Steve Sakwa

 

(212) 446-9462

 

 

 

 

 

 

 

 

Gwen Clark

 

(212) 446-5611

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Citigroup Global Markets Inc.

 

 

 

JMP Securities – JMP Group, Inc.

 

 

 

UBS Financial Services Inc.

 

 

Michael Bilerman

 

(212) 816-1383

 

William C. Marks

 

(415) 835-8944

 

Ross Nussbaum

 

(212) 713-2484

Quentin Velleley

 

(212) 816-6981

 

Whitney Stevenson

 

(415) 835-8948

 

Gabriel Hilmoe

 

(212) 713-3876

Emmanuel Korchman

 

(212) 816-1382

 

 

 

 

 

Weina Hou

 

(212) 713-4057

 

 

 

 

 

 

 

 

 

 

 

Cowen and Company, LLC

 

 

 

J.P. Morgan Securities LLC

 

 

 

 

 

 

James Sullivan

 

(646) 562-1380

 

Anthony Paolone

 

(212) 622-6682

 

 

 

 

Tom Catherwood

 

(646) 562-1382

 

Joseph Dazio

 

(212) 622-6416

 

 

 

 

 

Rating Agencies

Moody’s Investors Service

 

 

 

Rating

 

  Standard & Poor’s

 

 

 

Rating

Philip Kibel

 

(212) 553-4569

 

Baa2

 

  George Skoufis

 

(212) 438-2608

 

BBB-

Maria Maslovsky

 

(212) 553-4831

 

Stable Outlook

 

  Jaime Gitler

 

(212) 438-5049

 

Stable Outlook

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

10

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Financial and Asset Base Highlights

(Dollars in thousands, except per share amounts)

(Unaudited)

 

 

 

Three Months Ended (unless stated otherwise)

 

Key Credit Metrics

 

6/30/13

 

3/31/13

 

12/31/12

 

9/30/12

 

6/30/12

 

Unencumbered NOI as a percentage of total NOI

 

70%

 

68%

 

71%

 

72%

 

72%

 

Percentage outstanding on unsecured senior line of credit at end of period

 

0%

 

37%

 

38%

 

28%

 

25%

 

Net debt to gross assets at end of period

 

33%

 

39%

 

38%

 

38%

 

38%

 

Net debt to Adjusted EBITDA – quarter annualized

 

6.6x

 

7.8x

 

7.3x

 

7.6x

 

7.1x

 

Net debt to Adjusted EBITDA – trailing 12 months

 

6.6x

 

7.7x

 

7.6x

 

7.5x

 

7.5x

 

Fixed charge coverage ratio – quarter annualized

 

2.8x

 

2.7x

 

2.8x

 

2.5x

 

2.6x

 

Fixed charge coverage ratio – trailing 12 months

 

2.7x

 

2.7x

 

2.6x

 

2.6x

 

2.7x

 

Interest coverage ratio – quarter annualized

 

3.4x

 

3.3x

 

3.4x

 

3.1x

 

3.2x

 

Dividend payout ratio (common stock)

 

65%

 

55%

 

49%

 

50%

 

49%

 

 

 

 

 

 

 

 

 

 

 

 

 

Selected Balance Sheet Information at end of period

 

 

 

 

 

 

 

 

 

 

 

Gross investments in real estate

 

$

7,331,578

 

$

7,225,073

 

$

7,299,613

 

$

7,154,359

 

$

7,030,723

 

Total assets

 

$

7,379.289

 

$

7,090,919

 

$

7,150,116

 

$

6,965,017

 

$

6,841,739

 

Total unsecured debt

 

$

2,248,395

 

$

2,453,816

 

$

2,465,805

 

$

2,312,794

 

$

2,278,783

 

Total debt

 

$

2,959,424

 

$

3,184,530

 

$

3,181,949

 

$

3,032,114

 

$

2,998,760

 

Net debt

 

$

2,626,305

 

$

3,067,521

 

$

3,001,031

 

$

2,892,377

 

$

2,875,926

 

Total liabilities

 

$

3,379,814

 

$

3,595,638

 

$

3,647,058

 

$

3,448,397

 

$

3,385,154

 

Common shares outstanding (in thousands)

 

70,997

 

63,317

 

63,245

 

63,161

 

62,250

 

Total market capitalization

 

$

8,005,581

 

$

8,066,072

 

$

7,953,348

 

$

8,064,386

 

$

7,912,286

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Data

 

 

 

 

 

 

 

 

 

 

 

Total revenues

 

$

154,235

 

$

150,380

 

$

151,554

 

$

142,850

 

$

145,593

 

Rental operations

 

$

46,323

 

$

45,224

 

$

46,176

 

$

44,203

 

$

42,102

 

Operating margins

 

70%

 

70%

 

70%

 

69%

 

71%

 

General and administrative expense as a percentage of total revenues

 

8.1%

 

7.7%

 

8.3%

 

8.7%

 

8.4%

 

Capitalized interest

 

$

15,690

 

$

14,021

 

$

14,897

 

$

16,763

 

$

15,825

 

Weighted average interest rate used for capitalization during period

 

4.13%

 

3.97%

 

4.10%

 

4.35%

 

4.41%

 

Adjusted EBITDA – quarter annualized

 

$

399,708

 

$

395,764

 

$

408,876

 

$

382,608

 

$

403,168

 

Adjusted EBITDA – trailing 12 months

 

$

396,739

 

$

397,606

 

$

393,124

 

$

385,393

 

$

384,033

 

Adjusted EBITDA margins – quarter annualized

 

65%

 

66%

 

67%

 

67%

 

69%

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income, FFO, and AFFO

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Alexandria’s common stockholders – diluted

 

$

25,483

 

$

22,442

 

$

21,000

 

$

10,646

(1)

$

17,616

 

FFO attributable to Alexandria’s common stockholders – diluted

 

$

71,023

 

$

70,042

 

$

70,905

 

$

67,101

 

$

69,964

 

FFO attributable to Alexandria’s common stockholders – diluted, as adjusted

 

$

71,571

 

$

70,042

 

$

72,936

 

$

67,101

 

$

65,790

 

AFFO attributable to Alexandria’s common stockholders – diluted

 

$

66,778

 

$

67,965

 

$

66,295

 

$

65,016

 

$

63,967

 

 

 

 

 

 

 

 

 

 

 

 

 

Per Share Data

 

 

 

 

 

 

 

 

 

 

 

Earnings per share – diluted

 

$

0.38

 

$

0.36

 

$

0.33

 

$

0.17

(1)

$

0.29

 

FFO per share – diluted

 

$

1.06

 

$

1.11

 

$

1.12

 

$

1.08

 

$

1.13

 

FFO per share – diluted, as adjusted

 

$

1.07

 

$

1.11

 

$

1.16

 

$

1.08

 

$

1.07

 

AFFO per share – diluted

 

$

1.00

 

$

1.08

 

$

1.05

 

$

1.04

 

$

1.04

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset Base Statistics at end of period

 

 

 

 

 

 

 

 

 

 

 

Number of properties at end of period

 

173

 

174

 

179

 

178

 

183

 

Rentable square feet at end of period

 

17,035,097

 

17,075,268

 

17,521,772

 

17,101,966

 

17,385,572

 

Occupancy of operating properties at end of period

 

93.3%

 

93.0%

 

93.4%

 

93.0%

 

92.9%

 

Occupancy of operating and redevelopment properties at end of period

 

91.2%

 

90.1%

 

89.8%

 

88.3%

 

86.9%

 

 

 

 

 

 

 

 

 

 

 

 

 

Leasing Activity and Same Property Performance

 

 

 

 

 

 

 

 

 

 

 

Leasing activity – rentable square feet

 

767,935

 

702,901

 

677,781

 

732,094

 

959,295

 

Leasing activity – change in average new rental rates over expiring rates – cash basis

 

6.7%

 

5.9%

 

(2.9%

)

(2.9%

)

(0.8%

)

Leasing activity – change in average new rental rates over expiring rates – GAAP basis

 

12.7%

 

12.7%

 

2.6%

 

7.6%

 

5.8%

 

Same property – change in NOI over comparable quarter from prior year – cash basis

 

7.2%

 

8.8%

 

6.3%

 

4.3%

 

1.6%

 

Same property – change in NOI over comparable quarter from prior year – GAAP basis

 

3.2%

 

0.4%

 

0.7%

 

(0.9%

)

(0.2%

)

 

(1)                         Net income attributable to Alexandria’s common stockholders – diluted excluding $9.8 million, or $0.16 per share, impairment of real estate, was $20.4 million, or $0.33 per share.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

11

 

 



 

 

 

 

 

 

CORE OPERATING METRICS

 

 

 

 

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Core Operating Metrics

(Unaudited)

 

Quarterly percentage change in same property NOI

 

GRAPHIC

 

Percentage change in rental rates on renewed/re-leased space

 

GRAPHIC

 

Occupancy percentage

 

GRAPHIC

 

Solid leasing capabilities – rentable square feet leased (in thousands)

 

GRAPHIC

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

13

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Summary of Same Property Comparisons

(Dollars in thousands)

(Unaudited)

 

 

 

Three Months Ended

 

Six Months Ended

Same property data

 

June 30, 2013

 

June 30, 2013

Percentage change in net operating income – cash basis

 

7.2%

 

8.3%

Percentage change in net operating income – GAAP basis

 

3.2%

 

2.0%

Number of properties

 

137

 

135

Rentable square feet

 

11,182,003

 

11,032,453

Occupancy – current period

 

93.4%

 

93.1%

Occupancy – same period prior year

 

92.5%

 

92.5%

 

The following table presents a comparison of the components of same property and non-same property NOI for the three months and six months ended June 30, 2013, compared to the three months and six months ended June 30, 2012, and a reconciliation of NOI to income from continuing operations, the most directly comparable GAAP financial measure:

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

Revenues:

 

2013

 

2012

 

% Change

 

2013

 

2012

 

% Change

 

Rental – same properties

 

$

96,605

 

$

92,794

 

4.1

%

 

$

190,681

 

$

185,022

 

3.1

%

 

Rental – non-same properties

 

18,138

 

11,535

 

57.2

 

 

35,838

 

20,508

 

74.8

 

 

Total rental – GAAP basis

 

114,743

 

104,329

 

10.0

 

 

226,519

 

205,530

 

10.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tenant recoveries – same properties

 

29,830

 

29,282

 

1.9

 

 

60,087

 

58,034

 

3.5

 

 

Tenant recoveries – non-same properties

 

6,093

 

2,599

 

134.4

 

 

11,447

 

5,729

 

99.8

 

 

Total tenant recoveries

 

35,923

 

31,881

 

12.7

 

 

71,534

 

63,763

 

12.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income – same properties

 

203

 

24

 

745.8

 

 

323

 

82

 

293.9

 

 

Other income – non-same properties

 

3,366

 

9,359

 

(64.0

)

 

6,239

 

11,929

 

(47.7

)

 

Total other income

 

3,569

 

9,383

 

(62.0

)

 

6,562

 

12,011

 

(45.4

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total revenues – same properties

 

126,638

 

122,100

 

3.7

 

 

251,091

 

243,138

 

3.3

 

 

Total revenues – non-same properties

 

27,597

 

23,493

 

17.5

 

 

53,524

 

38,166

 

40.2

 

 

Total revenues

 

154,235

 

145,593

 

5.9

 

 

304,615

 

281,304

 

8.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental operations – same properties

 

39,143

 

37,291

 

5.0

 

 

78,234

 

73,672

 

6.2

 

 

Rental operations – non-same properties

 

7,180

 

4,811

 

49.2

 

 

13,313

 

8,883

 

49.9

 

 

Total rental operations

 

46,323

 

42,102

 

10.0

 

 

91,547

 

82,555

 

10.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net operating income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOI – same properties

 

87,495

 

84,809

 

3.2

 

 

172,857

 

169,466

 

2.0

 

 

NOI – non-same properties

 

20,417

 

18,682

 

9.3

 

 

40,211

 

29,283

 

37.3

 

 

Total NOI – GAAP basis

 

107,912

 

103,491

 

4.3

 

 

213,068

 

198,749

 

7.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

12,472

 

12,298

 

1.4

 

 

24,120

 

22,655

 

6.5

 

 

Interest

 

15,978

 

17,922

 

(10.8

)

 

33,998

 

34,148

 

(0.4

)

 

Depreciation and amortization

 

46,580

 

50,741

 

(8.2

)

 

92,645

 

92,527

 

0.1

 

 

Loss on early extinguishment of debt

 

560

 

1,602

 

(65.0

)

 

560

 

2,225

 

(74.8

)

 

Total other expenses

 

75,590

 

82,563

 

(8.4

)

 

151,323

 

151,555

 

(0.2

)

 

Income from continuing operations

 

$

32,322

 

$

20,928

 

54.4

%

 

$

61,745

 

$

47,194

 

30.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOI – same properties – GAAP basis

 

$

87,495

 

$

84,809

 

3.2

%

 

$

172,857

 

$

169,466

 

2.0

%

 

Less: straight-line rent adjustments

 

(1,807

)

(4,897

)

(63.1

)

 

(2,306

)

(11,952

)

(80.7

)

 

NOI – same properties – cash basis

 

$

85,688

 

$

79,912

 

7.2

%

 

$

170,551

 

$

157,514

 

8.3

%

 

 

The following table reconciles same properties to total properties for the six months ended June 30, 2013:

 

Development – active

 

Properties

 

Development – deliveries since January 1, 2012

 

Properties

 

 

 

Properties

 

225 Binney Street

 

1

 

259 East Grand Avenue

 

1

 

Development – active

 

6

 

499 Illinois Street

 

1

 

400/450 East Jamie Court

 

2

 

Redevelopment – active

 

7

 

269 East Grand Avenue

 

1

 

Canada

 

1

(1)

Development – deliveries

 

6

 

430 East 29th Street

 

1

 

4755 Nexus Center Drive

 

1

 

Redevelopment – deliveries

 

9

 

75/125 Binney Street

 

1

 

5200 Illumina Way

 

1

(1)

 

 

 

 

360 Longwood Avenue (JV)

 

1

 

 

 

6

 

Development/Redevelopment – Asia

 

7

(2)

 

 

6

 

Redevelopment – deliveries since January 1, 2012

 

 

 

 

 

 

 

Redevelopment – active

 

 

 

10300 Campus Point Drive

 

1

 

Acquisitions in North America since January 1, 2012

 

9800 Medical Center Drive

 

3

 

20 Walkup Drive

 

1

 

6 Davis Drive

 

1

 

1616 Eastlake Avenue

 

1

 

11119 North Torrey Pines Road

 

1

 

 

 

 

 

285 Bear Hill Road

 

1

 

3530/3550 John Hopkins Court

 

2

 

Properties held for sale

 

2

 

343 Oyster Point Boulevard

 

1

 

620 Professional Drive

 

1

 

Total properties excluded from same

 

38

 

4757 Nexus Center Drive

 

1

 

6275 Nancy Ridge Drive

 

1

 

properties

 

 

 

 

 

7

 

1551 Eastlake Avenue

 

1

 

 

 

 

 

 

 

 

 

400 Technology Square

 

1

 

Same properties

 

135

 

 

 

 

 

 

 

9

 

Total consolidated and unconsolidated  properties as of June 30, 2013

 

173

 

 

(1)

These properties each represent multiple buildings, a portion of which are included in our same property results. As a result, 26,426 RSF and 127,373 RSF for Canada and 5200 Illumina Way, respectively, have been excluded from our same property results.

(2)

Property count in Asia includes one development delivery, one property acquired since January 1, 2012, and five active development and redevelopment properties.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

14

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Same Property Performance Historical Results

(Unaudited)

 

The charts below provide two alternative calculations of same property performance in comparison to our historical same property performance. Our reported same property performance has been based upon a pool of operating assets and completed developed and redeveloped assets to the extent that those assets were operating for the entirety of the comparable same property period presented. The alternative calculations presented below include 1) same property performance for the operating portfolio excluding assets that were recently developed or redeveloped and 2) the same property performance for the operating portfolio including those assets that were either under active redevelopment or previously completed redevelopments. From 2008 through 2012, our same property performance was generally consistent in each of the three calculations. For the six months ended June 30, 2013, same property performance including redevelopment properties, as shown in the table, would have been meaningfully higher than our traditional method of reporting same property performance. Same property performance including redevelopment properties will, from time to time, have significant growth in net operating income as a result of the completion of the conversion of non-laboratory space (with lower net operating income) to laboratory space (with higher net operating income) through redevelopment.  We believe our traditional method of reporting same property performance is a more useful presentation since it excludes the potential significant increases in performance as a result of completion of significant redevelopment projects.

 

Percentage change in same property NOI over preceding period - cash basis

 

GRAPHIC

 

Percentage change in same property NOI over preceding period - GAAP basis

 

GRAPHIC

 

(1)

Recently delivered developments and redevelopments are included in the same property data in the periods after their completion only if the property was operating during the entire same property periods. For example, projects completed in 2010 are included in 2012 vs. 2011 same property performance. Additionally, projects completed in 2011 are excluded from the 2012 vs. 2011 same property performance but included in the six months ended June 30, 2013, vs. six months ended June 30, 2012, same property performance.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

15

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Summary of Leasing Activity

(Unaudited)

 

 

 

Three Months Ended

 

Six Months Ended

 

Year Ended

 

 

 

June 30, 2013

 

June 30, 2013

 

December 31, 2012

 

Leasing activity:

 

Cash

 

GAAP

 

Cash

 

GAAP

 

Cash

 

GAAP

 

Renewed/re-leased space

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental rate changes

 

6.7%

 

12.7%

 

6.5%

 

12.7%

 

(2.0%)

 

5.2%

 

New rates

 

$33.22

 

$33.61

 

$32.65

 

$33.00

 

$29.86

 

$30.36

 

Expiring rates

 

$31.12

 

$29.82

 

$30.66

 

$29.28

 

$30.47

 

$28.87

 

Rentable square footage

 

331,043

 

 

 

486,924

 

 

 

1,475,403

 

 

 

Number of leases

 

33

 

 

 

50

 

 

 

102

 

 

 

TI’s/lease commissions per square foot

 

$9.03

 

 

 

$7.95

 

 

 

$6.22

 

 

 

Average lease terms

 

4.8 years

 

 

 

4.1 years

 

 

 

4.7 years

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed/redeveloped/previously vacant space leased

 

 

 

 

 

 

 

 

 

 

 

 

 

New rates

 

$46.73

 

$54.11

 

$49.04

 

$53.24

 

$30.66

 

$32.56

 

Rentable square footage

 

436,892

 

 

 

983,912

 

 

 

1,805,693

 

 

 

Number of leases

 

33

 

 

 

58

 

 

 

85

 

 

 

TI’s/lease commissions per square foot

 

$31.40

 

 

 

$18.12

 

 

 

$11.02

 

 

 

Average lease terms

 

11.2 years

 

 

 

10.7 years

 

 

 

9.0 years

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Leasing activity summary:

 

 

 

 

 

 

 

 

 

 

 

 

 

Totals (1)

 

 

 

 

 

 

 

 

 

 

 

 

 

New rates

 

$40.91

 

$45.27

 

$43.62

 

$46.54

 

$30.30

 

$31.57

 

Rentable square footage

 

767,935

 

 

 

1,470,836

 

 

 

3,281,096

 

 

 

Number of leases

 

66

 

 

 

108

 

 

 

187

 

 

 

TI’s/lease commissions per square foot

 

$21.76

 

 

 

$14.75

 

 

 

$8.87

 

 

 

Average lease terms

 

8.4 years

 

 

 

8.6 years

 

 

 

7.1 years

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Lease expirations

 

 

 

 

 

 

 

 

 

 

 

 

 

Expiring rates

 

$31.15

 

$29.86

 

$31.44

 

$29.42

 

$30.03

 

$27.65

 

Rentable square footage

 

440,712

 

 

 

747,722

 

 

 

2,350,348

 

 

 

Number of leases

 

50

 

 

 

81

 

 

 

162

 

 

 

 

(1)                Excludes 10 month-to-month leases for 37,011 RSF at June 30, 2013.

 

During the three months ended June 30, 2013, we granted tenant concessions/free rent averaging approximately 1.8 months with respect to the 767,935 RSF leased.  During the six months ended June 30, 2013, we granted tenant concessions/free rent averaging approximately 1.8 months with respect to the 1,470,836 RSF leased.

 

Lease Structure

 

June 30, 2013

 

Percentage of triple net leases

 

94%

 

Percentage of leases containing annual rent escalations

 

95%

 

Percentage of leases providing for the recapture of capital expenditures

 

92%

 

 

The following chart presents our total RSF leased (in thousands) by development/redevelopment/previously vacant space and renewed/re-leased space:

 

GRAPHIC

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2013

16

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Summary of Lease Expirations

(Unaudited)

 

Year of Lease Expiration

 

Number of Leases Expiring

 

RSF of Expiring Leases

 

Percentage of
Aggregate Total RSF

 

Annualized Base Rent of
Expiring Leases (per RSF)

 

2013

 

43

 (1)

 

410,254

 (1)

 

3.0

%

 

$31.83

 

 

2014

 

102

 

 

1,176,749

 

 

8.6

%

 

$28.93

 

 

2015

 

77

 

 

1,411,738

 

 

10.3

%

 

$32.45

 

 

2016

 

66

 

 

1,413,108

 

 

10.3

%

 

$30.38

 

 

2017

 

64

 

 

1,585,740

 

 

11.5

%

 

$30.67

 

 

2018

 

36

 

 

1,296,499

 

 

9.4

%

 

$39.48

 

 

2019

 

24

 

 

690,566

 

 

5.0

%

 

$32.83

 

 

2020

 

17

 

 

789,909

 

 

5.8

%

 

$39.93

 

 

2021

 

20

 

 

828,009

 

 

6.0

%

 

$37.02

 

 

2022

 

16

 

 

567,703

 

 

4.1

%

 

$29.32

 

 

Thereafter

 

29

 

 

2,318,276

 

 

16.9

%

 

$39.73

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annualized

 

 

 

2013 RSF of Expiring Leases

 

Base Rent of

 

 

 

 

 

Negotiating/

 

Targeted for

 

Remaining

 

 

 

Expiring Leases

 

Market

 

Leased

 

Anticipating

 

Redevelopment

 

Expiring Leases

 

Total

 

(per RSF)

 

Greater Boston

 

47,160

 

21,396

 

 

33,620

 

102,176

 

$

38.04

 

San Francisco Bay Area

 

12,313

 

16,818

 

 

36,003

 

65,134

 

22.13

 

San Diego

 

 

 

 

34,013

 

34,013

 

29.51

 

Greater NYC

 

 

 

 

 

 

 

Suburban Washington, D.C.

 

 

114,568

 (2)

 

54,352

 

168,920

 

34.53

 

Seattle

 

 

1,350

 

 

9,574

 

10,924

 

27.46

 

Research Triangle Park

 

 

16,587

 

 

1,603

 

18,190

 

25.24

 

Canada

 

 

 

 

 

 

 

Non-cluster markets

 

 

3,508

 

 

1,000

 

4,508

 

12.35

 

Asia

 

 

4,069

 

 

2,320

 

6,389

 

12.00

 (3)

Total

 

59,473

 

178,296

 

 

172,485

 

410,254

 (1)

$

31.83

 

Percentage of expiring leases

 

15

 %

43

 %

 %

42

 %

100

 %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annualized

 

 

 

2014 RSF of Expiring Leases

 

Base Rent of

 

 

 

 

 

Negotiating/

 

Targeted for

 

Remaining

 

 

 

Expiring Leases

 

Market

 

Leased

 

Anticipating

 

Redevelopment

 

Expiring Leases

 

Total

 

(per RSF)

 

Greater Boston

 

 

87,516

 

 

237,327

 

324,843

 

$

38.03

 

San Francisco Bay Area

 

19,291

 

31,760

 

 

280,164

 

331,215

 

27.08

 

San Diego

 

 

 

 

52,153

 

52,153

 

23.25

 

Greater NYC

 

 

48,281

 

 

42,487

 

90,768

 

38.65

 

Suburban Washington, D.C.

 

 

8,319

 

85,297

 (4)

74,017

 

167,633

 

19.18

 

Seattle

 

 

13,401

 

 

9,571

 

22,972

 

43.57

 

Research Triangle Park

 

 

10,527

 

 

45,812

 

56,339

 

22.91

 

Canada

 

 

 

 

81,870

 

81,870

 

21.51

 

Non-cluster markets

 

 

 

 

22,407

 

22,407

 

18.35

 

Asia

 

 

15,760

 

 

10,789

 

26,549

 

11.89

 (3)

Total

 

19,291

 

215,564

 

85,297

 

856,597

 

1,176,749

 

$

28.93

 

Percentage of expiring leases

 

2

 %

18

 %

7

 %

73

 %

100

 %

 

 

 

(1)

Excludes 10 month-to-month leases for approximately 37,011 RSF.

(2)

Includes approximately 55,000 RSF at 5 Research Court. We expect the tenant to extend their lease beyond their 2013 lease expiration date. This property consists of non-laboratory space and upon rollover will likely undergo conversion into laboratory space through redevelopment subsequent to the final lease expiration.

(3)

Expirations relate to two properties with an average investment of $101 per RSF.

(4)

Represents projects containing approximately 60,000 RSF and 25,000 RSF at 930 Clopper Road and 1500 East Gude Drive, respectively, which we expect to convert from non-laboratory space to laboratory space through redevelopment.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2013

17

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Summary of Properties and Occupancy

(Unaudited)

 

Summary of properties

 

 

Rentable Square Feet

 

Number of

 

Annualized Base Rent

 

Market

 

Operating

 

Development

 

Redevelopment

 

Total

 

% Total

 

Properties

 

(dollars in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston

 

3,093,019

 

691,487

 

26,270

 

3,810,776

 

22

%

 

36

 

$

119,616

 

27

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay Area

 

2,504,258

 

330,030

 

36,473

 

2,870,761

 

17

 

 

26

 

95,849

 

22

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Diego

 

2,575,382

 

 

68,423

 

2,643,805

 

16

 

 

33

 

84,267

 

20

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater NYC

 

494,656

 

419,806

 

 

914,462

 

5

 

 

6

 

32,048

 

7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban Washington, D.C.

 

2,088,291

 

 

67,055

 

2,155,346

 

13

 

 

29

 

43,627

 

10

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Seattle

 

720,496

 

 

26,020

 

746,516

 

4

 

 

10

 

29,170

 

7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research Triangle Park

 

941,807

 

 

 

941,807

 

6

 

 

14

 

18,764

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Canada

 

1,103,507

 

 

 

1,103,507

 

7

 

 

5

 

9,397

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-cluster markets

 

61,002

 

 

 

61,002

 

 

 

2

 

609

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

13,582,418

 

1,441,323

 

224,241

 

15,247,982

 

90

 

 

161

 

433,347

 

99

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia

 

617,602

 

618,976

 

85,728

 

1,322,306

 

8

 

 

9

 

4,736

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

14,200,020

 

2,060,299

 

309,969

 

16,570,288

 

98

 

 

170

 

$

438,083

 

100

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discontinued operations

 

51,273

 

 

 

51,273

 

 

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated

 

14,251,293

 

2,060,299

 

309,969

 

16,621,561

 

98

 

 

172

 

$

438,083

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston - unconsolidated

 

 

413,536

 

 

413,536

 

2

 

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total consolidated and unconsolidated

 

14,251,293

 

2,473,835

 

309,969

 

17,035,097

 

100

%

 

173

 

 

 

 

 

 

 

Summary of occupancy percentages

 

 

Operating Properties

 

Operating and Redevelopment Properties

 

Market

 

June 30, 2013

 

March 31, 2013

 

June 30, 2012

 

June 30, 2013

 

March 31, 2013

 

June 30, 2012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston

 

95.5

%

 

95.8

%

 

93.1

%

 

94.7

%

 

93.5

%

 

84.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay Area

 

97.3

 

 

95.8

 

 

97.0

 

 

95.9

 

 

93.8

 

 

94.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Diego

 

94.2

 

 

93.4

 

 

95.5

 

 

91.7

 

 

91.0

 

 

85.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater NYC

 

98.4

 

 

98.4

 

 

94.2

 

 

98.4

 

 

98.4

 

 

94.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban Washington, D.C.

 

92.3

 

 

90.8

 

 

90.1

 

 

89.4

 

 

88.0

 

 

86.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Seattle

 

93.1

 (1)

 

96.7

 

 

96.1

 

 

89.9

 

 

88.2

 

 

90.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research Triangle Park

 

91.4

 (2)

 

93.6

 

 

95.5

 

 

91.4

 

 

93.6

 

 

95.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Canada

 

96.8

 

 

94.7

 

 

92.7

 

 

96.8

 

 

94.7

 

 

92.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-cluster markets

 

54.0

 

 

54.0

 

 

51.4

 

 

54.0

 

 

54.0

 

 

51.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

94.6

 

 

94.2

 

 

93.9

 

 

92.9

 

 

91.8

 

 

88.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia

 

68.1

 

 

67.1

 

 

67.4

 

 

59.8

 

 

57.7

 

 

55.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

93.3

%

 

93.0

%

 

92.9

%

 

91.2

%

 

90.1

%

 

86.9

%

 

 

(1)

Decrease primarily attributable to the delivery of 39,661 vacant RSF at our redevelopment project at 1551 Eastlake Avenue in the Lake Union submarket. Excluding this delivery, the occupancy percentage of operating properties was 98.5%.

(2)

We anticipate an increase in occupancy during the fourth quarter of 2013.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2013

18

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Top 20 Client Tenants and Client Tenant Mix

(Dollars in thousands)

(Unaudited)

 

Top 20 client tenants

 

 

 

 

 

 

Remaining

 

Aggregate

 

Percentage of
Aggregate

 

 

 

Percentage of
Aggregate

 

Investment-Grade
Client Tenants

 

 

 

 

 

Client Tenant

 

Number
of Leases

 

Lease Term
in Years (1)

 

Rentable
Square Feet

 

Total Square
Feet

 

Annualized
Base Rent

 

Annualized
Base Rent

 

Fitch
Rating

 

Moody’s
Rating

 

S&P
Rating

 

Education/
Research

 

1

 

Novartis AG

 

13

 

3.7

 

 

635,917

 

3.8

%

 

$

31,993

 

7.3

%

 

AA

 

Aa3

 

AA-

 

 

2

 

Illumina, Inc.

 

1

 

18.3

 

 

497,078

 

3.0

 

 

19,531

 

4.5

 

 

-

 

 

 

 

3

 

Bristol-Myers Squibb Company

 

6

 

4.6

 

 

419,624

 

2.5

 

 

15,840

 

3.6

 

 

A-

 

A2

 

A+

 

 

4

 

Eli Lilly and Company

 

6

 

9.7

 

 

290,132

 

1.7

 

 

15,563

 

3.6

 

 

A

 

A2

 

AA-

 

 

5

 

FibroGen, Inc.

 

1

 

10.4

 

 

234,249

 

1.4

 

 

14,197

 

3.3

 

 

 

 

 

 

6

 

Roche

 

3

 

4.8

 

 

348,918

 

2.1

 

 

13,867

 

3.2

 

 

AA

 

A1

 

AA

 

 

7

 

United States Government

 

9

 

4.8

 

 

332,578

 

2.0

 

 

13,119

 

3.0

 

 

AAA

 

Aaa

 

AA+

 

 

8

 

GlaxoSmithKline plc

 

5

 

6.1

 

 

208,394

 

1.3

 

 

10,187

 

2.3

 

 

A+

 

A1

 

A+

 

 

9

 

Celgene Corporation

 

3

 

8.1

 

 

250,586

 

1.5

 

 

9,340

 

2.1

 

 

 

Baa2

 

BBB+

 

 

10

 

Onyx Pharmaceuticals, Inc.

 

2

 

9.0

 

 

228,373

 

1.4

 

 

8,498

 

1.9

 

 

 

 

 

 

11

 

Massachusetts Institute of Technology

 

4

 

3.8

 

 

185,403

 

1.1

 

 

8,496

 

1.9

 

 

 

Aaa

 

AAA

 

ü

 

12

 

NYU-Neuroscience Translational Research Institute

 

2

 

10.5

 

 

86,756

 

0.5

 

 

8,012

 

1.8

 

 

 

Aa3

 

AA-

 

ü

 

13

 

The Regents of the University of California

 

3

 

8.2

 

 

188,654

 

1.1

 

 

7,787

 

1.8

 

 

AA

 

Aa1

 

AA

 

ü

 

14

 

Alnylam Pharmaceuticals, Inc.

 

1

 

3.3

 

 

129,424

 

0.8

 

 

6,081

 

1.4

 

 

 

 

 

 

15

 

Gilead Sciences, Inc.

 

1

 

7.0

 

 

109,969

 

0.7

 

 

5,824

 

1.3

 

 

 

Baa1

 

A-

 

 

16

 

Pfizer Inc.

 

2

 

5.7

 

 

116,518

 

0.7

 

 

5,502

 

1.3

 

 

A+

 

A1

 

AA

 

 

17

 

The Scripps Research Institute

 

2

 

3.4

 

 

101,775

 

0.6

 

 

5,200

 

1.2

 

 

AA-

 

Aa3

 

 

ü

 

18

 

Theravance, Inc. (2)

 

2

 

6.9

 

 

130,342

 

0.8

 

 

4,895

 

1.1

 

 

 

 

 

 

19

 

Infinity Pharmaceuticals, Inc.

 

2

 

1.6

 

 

68,020

 

0.4

 

 

4,423

 

1.0

 

 

 

 

 

 

20

 

Quest Diagnostics Incorporated

 

1

 

3.5

 

 

248,186

 

1.5

 

 

4,341

 

1.0

 

 

BBB+

 

Baa2

 

BBB+

 

 

 

 

Total/weighted average top 20

 

69

 

7.3

 

 

4,810,896

 

28.9

%

 

$

212,696

 

48.6

%

 

 

 

 

 

 

 

 

 

 

(1)

Represents remaining lease term in years based on percentage of aggregate annualized base rent in effect as of June 30, 2013.

(2)

As of April 25, 2013, GlaxoSmithKline plc owned approximately 27% of the outstanding stock of Theravance, Inc.

 

GRAPHIC

 

Multinational Pharmaceutical

 

Institutional: University,
Non-Profit, and Government

 

Life Science Product and Service,
Medical Device, and Industrial Biotech

 

Biotechnology: Public & Private

· Astellas Pharma Inc.

· AstraZeneca PLC

· Bayer AG

· Bristol-Myers Squibb Company

· Eisai Co., Ltd.

· Eli Lilly and Company

· Genomics Institute of the Novartis Research Foundation

· GlaxoSmithKline plc

· Novartis AG

· Pfizer Inc.

· Roche

· Sanofi

· Shire plc

· UCB S.A.

 

 

· California Institute of Technology

· Dana-Farber Cancer Institute, Inc.

· Duke University

· Environmental Protection Agency

· Fred Hutchinson Cancer Research Center

· Massachusetts Institute of Technology

· National Institutes of Health

· NYU-Neuroscience Translational Research Institute

· Sanford-Burnham Medical Research Institute

· Stanford University

· The Regents of the University of California

· The Scripps Research Institute

· UMass Memorial Health Care, Inc.

· UNC Health Care System

· United States Government

· University of Washington

 

· Aramco Services Company, Inc.

· Canon U.S. Life Sciences, Inc.

· Covance Inc.

· DSM N.V.

· Fluidigm Corporation

· Illumina, Inc.

· Laboratory Corporation of America Holdings

· Life Technologies Corporation

· Monsanto Company

· Qiagen N.V.

· Quest Diagnostics Incorporated

· Sapphire Energy, Inc.

· Thermo Fisher Scientific, Inc.

 

 

· Alnylam Pharmaceuticals, Inc.

· Amgen Inc.

· ARIAD Pharmaceuticals, Inc.

· Biogen Idec Inc.

· Celgene Corporation

· Constellation Pharmaceuticals, Inc.

· Epizyme, Inc.

· Fate Therapeutics, Inc.

· FibroGen, Inc.

· FORMA Therapeutics, Inc.

· Gilead Sciences, Inc.

· Infinity Pharmaceuticals, Inc.

· Kadmon Corporation, LLC

· Medicago Inc.

· Nektar Therapeutics

· Onyx Pharmaceuticals, Inc.

· Proteostasis Therapeutics, Inc.

· Quanticel Pharmaceuticals, Inc.

· Theravance, Inc.

· Warp Drive Bio, LLC

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2013

19

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Property Listing

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Occupancy Percentage

 

 

 

 

 

Rentable Square Feet

 

Number of

 

Annualized

 

 

 

Operating and

 

Address

 

Submarket

 

Operating

 

Development

 

Redevelopment

 

Total

 

Properties

 

Base Rent

 

Operating

 

Redevelopment

 

Greater Boston

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100 Technology Square

 

Cambridge/Inner Suburbs

 

255,441

 

 

 

255,441

 

1

 

$

17,369

 

100.0%

 

100.0%

 

200 Technology Square

 

Cambridge/Inner Suburbs

 

177,101

 

 

 

177,101

 

1

 

10,569

 

100.0

 

100.0

 

300 Technology Square

 

Cambridge/Inner Suburbs

 

175,609

 

 

 

175,609

 

1

 

8,611

 

100.0

 

100.0

 

400 Technology Square

 

Cambridge/Inner Suburbs

 

212,124

 

 

 

212,124

 

1

 

9,928

 

85.7

 

85.7

 

500 Technology Square

 

Cambridge/Inner Suburbs

 

184,207

 

 

 

184,207

 

1

 

10,159

 

100.0

 

100.0

 

600 Technology Square

 

Cambridge/Inner Suburbs

 

128,224

 

 

 

128,224

 

1

 

4,474

 

99.6

 

99.6

 

700 Technology Square

 

Cambridge/Inner Suburbs

 

48,930

 

 

 

48,930

 

1

 

1,584

 

82.4

 

82.4

 

161 First Street

 

Cambridge/Inner Suburbs

 

46,356

 

 

 

46,356

 

1

 

2,083

 

100.0

 

100.0

 

167 Sidney Street

 

Cambridge/Inner Suburbs

 

26,589

 

 

 

26,589

 

1

 

1,392

 

100.0

 

100.0

 

215 First Street

 

Cambridge/Inner Suburbs

 

366,719

 

 

 

366,719

 

1

 

11,038

 

89.5

 

89.5

 

225 Binney Street

 

Cambridge/Inner Suburbs

 

 

305,212

 

 

305,212

 

1

 

 

N/A

 

N/A

 

75/125 Binney Street

 

Cambridge/Inner Suburbs

 

 

386,275

 

 

386,275

 

1

 

 

N/A

 

N/A

 

300 Third Street

 

Cambridge/Inner Suburbs

 

131,963

 

 

 

131,963

 

1

 

6,534

 

100.0

 

100.0

 

480 Arsenal Street

 

Cambridge/Inner Suburbs

 

140,744

 

 

 

140,744

 

1

 

4,644

 

100.0

 

100.0

 

500 Arsenal Street

 

Cambridge/Inner Suburbs

 

93,516

 

 

 

93,516

 

1

 

3,402

 

100.0

 

100.0

 

780/790 Memorial Drive

 

Cambridge/Inner Suburbs

 

99,350

 

 

 

99,350

 

2

 

6,674

 

100.0

 

100.0

 

79/96 Charlestown Navy Yard

 

Cambridge/Inner Suburbs

 

25,309

 

 

 

25,309

 

1

 

620

 

100.0

 

100.0

 

99 Erie Street

 

Cambridge/Inner Suburbs

 

27,960

 

 

 

27,960

 

1

 

1,143

 

100.0

 

100.0

 

100 Beaver Street

 

Route 128

 

82,330

 

 

 

82,330

 

1

 

1,949

 

85.7

 

85.7

 

285 Bear Hill Road

 

Route 128

 

 

 

26,270

 

26,270

 

1

 

 

N/A

 

 

19 Presidential Way

 

Route 128

 

128,325

 

 

 

128,325

 

1

 

3,398

 

100.0

 

100.0

 

29 Hartwell Avenue

 

Route 128

 

59,000

 

 

 

59,000

 

1

 

2,049

 

100.0

 

100.0

 

3 Preston Court

 

Route 128

 

30,123

 

 

 

30,123

 

1

 

395

 

44.4

 

44.4

 

35 Hartwell Avenue

 

Route 128

 

46,700

 

 

 

46,700

 

1

 

1,650

 

100.0

 

100.0

 

35 Wiggins Avenue

 

Route 128

 

48,640

 

 

 

48,640

 

1

 

878

 

100.0

 

100.0

 

44 Hartwell Avenue

 

Route 128

 

26,828

 

 

 

26,828

 

1

 

 

 

 

45/47 Wiggins Avenue

 

Route 128

 

38,000

 

 

 

38,000

 

1

 

1,114

 

100.0

 

100.0

 

60 Westview Street

 

Route 128

 

40,200

 

 

 

40,200

 

1

 

1,147

 

100.0

 

100.0

 

6/8 Preston Court

 

Route 128

 

54,391

 

 

 

54,391

 

1

 

752

 

100.0

 

100.0

 

111 Forbes Boulevard

 

Route 495/Worcester

 

58,280

 

 

 

58,280

 

1

 

544

 

100.0

 

100.0

 

130 Forbes Boulevard

 

Route 495/Worcester

 

97,566

 

 

 

97,566

 

1

 

871

 

100.0

 

100.0

 

20 Walkup Drive

 

Route 495/Worcester

 

91,045

 

 

 

91,045

 

1

 

649

 

100.0

 

100.0

 

30 Bearfoot Road

 

Route 495/Worcester

 

60,759

 

 

 

60,759

 

1

 

2,765

 

100.0

 

100.0

 

306 Belmont Street

 

Route 495/Worcester

 

78,916

 

 

 

78,916

 

1

 

1,139

 

100.0

 

100.0

 

350 Plantation Street

 

Route 495/Worcester

 

11,774

 

 

 

11,774

 

1

 

92

 

42.5

 

42.5

 

Greater Boston

 

 

 

3,093,019

 

691,487

 

26,270

 

3,810,776

 

36

 

$

119,616

 

95.5%

 

94.7%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay Area

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1500 Owens Street

 

Mission Bay

 

158,267

 

 

 

158,267

 

1

 

$

7,029

 

97.8%

 

97.8%

 

1700 Owens Street

 

Mission Bay

 

157,340

 

 

 

157,340

 

1

 

9,102

 

99.9

 

99.9

 

455 Mission Bay Boulevard South

 

Mission Bay

 

210,398

 

 

 

210,398

 

1

 

8,241

 

97.8

 

97.8

 

409/499 Illinois Street

 

Mission Bay

 

234,249

 

222,780

 

 

457,029

 

2

 

14,197

 

100.0

 

100.0

 

249/259 East Grand Avenue

 

South San Francisco

 

300,119

 

 

 

300,119

 

2

 

11,473

 

100.0

 

100.0

 

269 East Grand Avenue

 

South San Francisco

 

 

107,250

 

 

107,250

 

1

 

 

N/A

 

N/A

 

341/343 Oyster Point Boulevard

 

South San Francisco

 

71,487

 

 

36,473

 

107,960

 

2

 

1,740

 

100.0

 

66.2

 

400/450 East Jamie Court

 

South San Francisco

 

163,035

 

 

 

163,035

 

2

 

5,249

 

100.0

 

100.0

 

500 Forbes Boulevard

 

South San Francisco

 

155,685

 

 

 

155,685

 

1

 

5,540

 

100.0

 

100.0

 

600/630/650 Gateway Boulevard

 

South San Francisco

 

150,960

 

 

 

150,960

 

3

 

3,762

 

91.0

 

91.0

 

681 Gateway Boulevard

 

South San Francisco

 

126,971

 

 

 

126,971

 

1

 

6,161

 

100.0

 

100.0

 

7000 Shoreline Court

 

South San Francisco

 

136,395

 

 

 

136,395

 

1

 

4,252

 

99.7

 

99.7

 

901/951 Gateway Boulevard

 

South San Francisco

 

170,244

 

 

 

170,244

 

2

 

5,276

 

88.3

 

88.3

 

2425 Garcia Avenue & 2400/2450 Bayshore Parkway

 

Peninsula

 

98,964

 

 

 

98,964

 

1

 

3,035

 

88.2

 

88.2

 

2625/2627/2631 Hanover Street

 

Peninsula

 

32,074

 

 

 

32,074

 

1

 

872

 

65.7

 

65.7

 

3165 Porter Drive

 

Peninsula

 

91,644

 

 

 

91,644

 

1

 

3,884

 

100.0

 

100.0

 

3350 West Bayshore Road

 

Peninsula

 

60,000

 

 

 

60,000

 

1

 

1,817

 

100.0

 

100.0

 

75/125 Shoreway Road

 

Peninsula

 

82,815

 

 

 

82,815

 

1

 

1,996

 

100.0

 

100.0

 

849/863 Mitten Road & 866 Malcolm Road

 

Peninsula

 

103,611

 

 

 

103,611

 

1

 

2,223

 

96.8

 

96.8

 

San Francisco Bay Area

 

 

 

2,504,258

 

330,030

 

36,473

 

2,870,761

 

26

 

$

95,849

 

97.3%

 

95.9%

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

20

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Property Listing

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Occupancy Percentage

 

 

 

 

 

Rentable Square Feet

 

Number of

 

Annualized

 

 

 

Operating and

 

Address

 

Submarket

 

Operating

 

Development

 

Redevelopment

 

Total

 

Properties

 

Base Rent

 

Operating

 

Redevelopment

 

San Diego

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10931/10933 North Torrey Pines Rd

 

Torrey Pines

 

96,641

 

 

 

96,641

 

1

 

$

3,084

 

95.7%

 

95.7%

 

10975 North Torrey Pines Road

 

Torrey Pines

 

44,733

 

 

 

44,733

 

1

 

1,595

 

100.0

 

100.0

 

11119 North Torrey Pines Road

 

Torrey Pines

 

72,506

 

 

 

72,506

 

1

 

1,577

 

63.5

 

63.5

 

3010 Science Park Road

 

Torrey Pines

 

74,557

 

 

 

74,557

 

1

 

3,215

 

100.0

 

100.0

 

3115/3215 Merryfield Row

 

Torrey Pines

 

158,645

 

 

 

158,645

 

2

 

7,125

 

100.0

 

100.0

 

3530/3550 John Hopkins Court & 3535/3565 General Atomics Court

 

Torrey Pines

 

241,191

 

 

 

241,191

 

4

 

7,815

 

96.3

 

96.3

 

10300 Campus Point Drive

 

University Town Center

 

449,759

 

 

 

449,759

 

1

 

15,783

 

96.1

 

96.1

 

4755/4757/4767 Nexus Center Drive

 

University Town Center

 

110,535

 

 

68,423

 

178,958

 

3

 

4,252

 

100.0

 

61.8

 

5200 Illumina Way

 

University Town Center

 

497,078

 

 

 

497,078

 

1

 

19,531

 

100.0

 

100.0

 

9363/9373/9393 Towne Centre Drive

 

University Town Center

 

138,578

 

 

 

138,578

 

3

 

3,559

 

95.3

 

95.3

 

9880 Campus Point Drive

 

University Town Center

 

71,510

 

 

 

71,510

 

1

 

2,774

 

100.0

 

100.0

 

5810/5820 Nancy Ridge Drive

 

Sorrento Mesa

 

87,298

 

 

 

87,298

 

1

 

1,204

 

55.2

 

55.2

 

5871 Oberlin Drive

 

Sorrento Mesa

 

33,817

 

 

 

33,817

 

1

 

973

 

100.0

 

100.0

 

6138/6150 Nancy Ridge Drive

 

Sorrento Mesa

 

56,698

 

 

 

56,698

 

1

 

1,586

 

100.0

 

100.0

 

6175/6225/6275 Nancy Ridge Drive

 

Sorrento Mesa

 

105,812

 

 

 

105,812

 

3

 

1,202

 

55.5

 

55.5

 

7330 Carroll Road

 

Sorrento Mesa

 

66,244

 

 

 

66,244

 

1

 

2,341

 

100.0

 

100.0

 

10505 Roselle Street & 3770 Tansy Street

 

Sorrento Valley

 

33,013

 

 

 

33,013

 

2

 

1,001

 

100.0

 

100.0

 

11025/11035/11045 Roselle Street

 

Sorrento Valley

 

66,442

 

 

 

66,442

 

3

 

1,621

 

100.0

 

100.0

 

3985 Sorrento Valley Boulevard

 

Sorrento Valley

 

60,545

 

 

 

60,545

 

1

 

1,534

 

100.0

 

100.0

 

13112 Evening Creek Drive

 

I-15 Corridor

 

109,780

 

 

 

109,780

 

1

 

2,495

 

100.0

 

100.0

 

San Diego

 

 

 

2,575,382

 

 

68,423

 

2,643,805

 

33

 

$

84,267

 

94.2%

 

91.7%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater NYC

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

430/450 East 29th Street

 

Manhattan

 

309,141

 

419,806

 

 

728,947

 

2

 

$

25,481

 

99.8%

 

99.8%

 

100 Phillips Parkway

 

Bergen County

 

78,501

 

 

 

78,501

 

1

 

2,213

 

90.8

 

90.8

 

102 Witmer Road

 

Pennsylvania

 

50,000

 

 

 

50,000

 

1

 

3,345

 

100.0

 

100.0

 

5100 Campus Drive

 

Pennsylvania

 

21,859

 

 

 

21,859

 

1

 

274

 

100.0

 

100.0

 

701 Veterans Circle

 

Pennsylvania

 

35,155

 

 

 

35,155

 

1

 

735

 

100.0

 

100.0

 

Greater NYC

 

 

 

494,656

 

419,806

 

 

914,462

 

6

 

$

32,048

 

98.4%

 

98.4%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban Washington, D.C.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12301 Parklawn Drive

 

Rockville

 

49,185

 

 

 

49,185

 

1

 

$

1,169

 

100.0%

 

100.0%

 

1330 Piccard Drive

 

Rockville

 

131,511

 

 

 

131,511

 

1

 

2,877

 

94.0

 

94.0

 

1405 Research Boulevard

 

Rockville

 

71,669

 

 

 

71,669

 

1

 

2,119

 

100.0

 

100.0

 

1500/1550 East Gude Drive (1)

 

Rockville

 

90,489

 

 

 

90,489

 

2

 

1,511

 

90.5

 

90.5

 

14920 Broschart Road

 

Rockville

 

48,500

 

 

 

48,500

 

1

 

1,073

 

100.0

 

100.0

 

15010 Broschart Road

 

Rockville

 

38,203

 

 

 

38,203

 

1

 

741

 

85.8

 

85.8

 

5 Research Court

 

Rockville

 

54,906

 

 

 

54,906

 

1

 

1,425

 

100.0

 

100.0

 

5 Research Place

 

Rockville

 

63,852

 

 

 

63,852

 

1

 

2,364

 

100.0

 

100.0

 

9800 Medical Center Drive

 

Rockville

 

214,531

 

 

67,055

 

281,586

 

4

 

7,354

 

90.0

 

68.6

 

9920 Medical Center Drive

 

Rockville

 

58,733

 

 

 

58,733

 

1

 

455

 

100.0

 

100.0

 

1300 Quince Orchard Road

 

Gaithersburg

 

54,874

 

 

 

54,874

 

1

 

997

 

100.0

 

100.0

 

16020 Industrial Drive

 

Gaithersburg

 

71,000

 

 

 

71,000

 

1

 

1,048

 

100.0

 

100.0

 

19/20/22 Firstfield Road

 

Gaithersburg

 

132,639

 

 

 

132,639

 

3

 

3,103

 

93.6

 

93.6

 

401 Professional Drive

 

Gaithersburg

 

63,154

 

 

 

63,154

 

1

 

1,063

 

88.7

 

88.7

 

620 Professional Drive

 

Gaithersburg

 

27,950

 

 

 

27,950

 

1

 

495

 

100.0

 

100.0

 

708 Quince Orchard Road

 

Gaithersburg

 

49,624

 

 

 

49,624

 

1

 

1,145

 

99.3

 

99.3

 

9 West Watkins Mill Road

 

Gaithersburg

 

92,449

 

 

 

92,449

 

1

 

2,766

 

100.0

 

100.0

 

910 Clopper Road

 

Gaithersburg

 

180,650

 

 

 

180,650

 

1

 

3,343

 

91.3

 

91.3

 

930/940 Clopper Road (2)

 

Gaithersburg

 

104,302

 

 

 

104,302

 

2

 

1,654

 

93.4

 

93.4

 

950 Wind River Lane

 

Gaithersburg

 

50,000

 

 

 

50,000

 

1

 

1,082

 

100.0

 

100.0

 

8000/9000/10000 Virginia Manor Rd

 

Beltsville

 

191,884

 

 

 

191,884

 

1

 

1,502

 

58.8

 

58.8

 

14225 Newbrook Drive

 

Northern Virginia

 

248,186

 

 

 

248,186

 

1

 

4,341

 

100.0

 

100.0

 

Suburban Washington, D.C.

 

 

 

2,088,291

 

 

67,055

 

2,155,346

 

29

 

$

43,627

 

92.3%

 

89.4%

 

 

(1)             Includes 25,000 RSF of non-laboratory space, which we intend to convert into laboratory space through redevelopment in 2014.

(2)             Includes 60,000 RSF of non-laboratory space, which we intend to convert into laboratory space through redevelopment in 2014.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

21

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Property Listing

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Occupancy Percentage

 

 

 

 

 

Rentable Square Feet

 

Number of

 

Annualized

 

 

 

Operating and

 

Address

 

Submarket

 

Operating

 

Development

 

Redevelopment

 

Total

 

Properties

 

Base Rent

 

Operating

 

Redevelopment

 

Seattle

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1201/1208 Eastlake Avenue

 

Lake Union

 

203,369

 

 

 

203,369

 

2

 

$

8,748

 

100.0%

 

100.0%

 

1551 Eastlake Avenue

 

Lake Union

 

117,482

 

 

 

117,482

 

1

 

2,322

 

66.2

 

66.2

 

1600 Fairview Avenue

 

Lake Union

 

27,991

 

 

 

27,991

 

1

 

1,569

 

100.0

 

100.0

 

1616 Eastlake Avenue

 

Lake Union

 

142,688

 

 

26,020

 

168,708

 

1

 

6,083

 

96.8

 

81.9

 

199 East Blaine Street

 

Lake Union

 

115,084

 

 

 

115,084

 

1

 

6,163

 

100.0

 

100.0

 

219 Terry Avenue North

 

Lake Union

 

30,961

 

 

 

30,961

 

1

 

1,490

 

99.2

 

99.2

 

3000/3018 Western Avenue

 

Elliott Bay

 

47,746

 

 

 

47,746

 

1

 

1,839

 

100.0

 

100.0

 

410 West Harrison Street & 410 Elliott Avenue West

 

Elliott Bay

 

35,175

 

 

 

35,175

 

2

 

956

 

85.2

 

85.2

 

Seattle

 

 

 

720,496

 

 

26,020

 

746,516

 

10

 

$

29,170

 

93.1%

 

89.9%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research Triangle Park

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100 Capitola Drive

 

Research Triangle Park

 

65,965

 

 

 

65,965

 

1

 

$

1,065

 

100.0%

 

100.0%

 

108/110/112/114 Alexander Drive

 

Research Triangle Park

 

158,417

 

 

 

158,417

 

1

 

4,996

 

100.0

 

100.0

 

2525 East NC Highway 54

 

Research Triangle Park

 

81,580

 

 

 

81,580

 

1

 

1,673

 

100.0

 

100.0

 

5 Triangle Drive

 

Research Triangle Park

 

32,120

 

 

 

32,120

 

1

 

824

 

100.0

 

100.0

 

601 Keystone Park Drive

 

Research Triangle Park

 

77,395

 

 

 

77,395

 

1

 

1,309

 

100.0

 

100.0

 

6101 Quadrangle Drive

 

Research Triangle Park

 

30,122

 

 

 

30,122

 

1

 

445

 

79.1

 

79.1

 

7 Triangle Drive

 

Research Triangle Park

 

96,626

 

 

 

96,626

 

1

 

3,157

 

100.0

 

100.0

 

7010/7020/7030 Kit Creek Road

 

Research Triangle Park

 

133,654

 

 

 

133,654

 

3

 

1,707

 

70.0

 

70.0

 

800/801 Capitola Drive

 

Research Triangle Park

 

120,905

 

 

 

120,905

 

2

 

1,912

 

87.6

 

87.6

 

6 Davis Drive

 

Research Triangle Park

 

100,000

 

 

 

100,000

 

1

 

1,062

 

100.0

 

100.0

 

555 Heritage Drive

 

Palm Beach

 

45,023

 

 

 

45,023

 

1

 

614

 

55.9

 

55.9

 

Research Triangle Park

 

 

 

941,807

 

 

 

941,807

 

14

 

$

18,764

 

91.4%

 

91.4%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Canada

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Canada

 

 

 

46,032

 

 

 

46,032

 

1

 

$

1,823

 

100.0%

 

100.0%

 

Canada

 

 

 

66,000

 

 

 

66,000

 

1

 

1,193

 

100.0

 

100.0

 

Canada

 

 

 

142,935

 

 

 

142,935

 

1

 

3,259

 

92.8

 

92.8

 

Canada

 

 

 

68,000

 

 

 

68,000

 

1

 

3,122

 

100.0

 

100.0

 

Canada (1)

 

 

 

780,540

 

 

 

780,540

 

1

 

 

N/A

 

N/A

 

Total Canada

 

 

 

1,103,507

 

 

 

1,103,507

 

5

 

$

9,397

 

28.3%

 

28.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-cluster markets

 

 

 

61,002

 

 

 

61,002

 

2

 

$

609

 

54.0%

 

54.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

 

 

13,582,418

 

1,441,323

 

224,241

 

15,247,982

 

161

 

$433,347

 

94.6%

 

92.9%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia

 

 

 

617,602

 

618,976

 

85,728

 

1,322,306

 

9

 

$

4,736

 

68.1%

 

59.8%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

 

 

14,200,020

 

2,060,299

 

309,969

 

16,570,288

 

170

 

$

438,083

 

93.3%

 

91.2%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Properties “held for sale”

 

 

 

51,273

 

 

 

51,273

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total consolidated

 

 

 

14,251,293

 

2,060,299

 

309,969

 

16,621,561

 

172

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment in unconsolidated JV — 360 Longwood Avenue

 

Longwood

 

 

413,536

 

 

413,536

 

1

 

 

 

 

 

 

 

Total consolidated and unconsolidated

 

 

 

14,251,293

 

2,473,835

 

309,969

 

17,035,097

 

173

 

 

 

 

 

 

 

 

(1)     Represents land and improvements subject to a ground lease with a client tenant.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

22

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

VALUE-ADDED OPPORTUNITIES

AND EXTERNAL GROWTH

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Summary of Investments in Real Estate

(Dollars in thousands, except per square foot amounts)

(Unaudited)

 

Summary of investments in real estate

 

 

 

June 30, 2013

 

March 31, 2013

 

 

 

 

Book Value

 

Square Feet

 

Cost per
Square
Foot

 

Book Value

 

Square Feet

 

Cost per
Square Foot

 

Rental properties:

 

 

 

 

 

 

 

 

 

 

 

 

 

Land (related to rental properties)

 

$

512,915

 

 

 

 

 

$

516,957

 

 

 

 

 

Buildings and building improvements

 

5,006,987

 

 

 

 

 

4,955,207

 

 

 

 

 

Other improvements

 

166,894

 

 

 

 

 

163,864

 

 

 

 

 

Rental properties

 

5,686,796

 

14,251,293

 

$

399

 

5,636,028

 

14,168,626

 

$

398

 

Less: accumulated depreciation

 

(878,199

)

 

 

 

 

(849,891

)

 

 

 

 

Rental properties, net

 

4,808,597

 

 

 

 

 

4,786,137

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Construction in progress (“CIP”)/current value-added projects:

 

 

 

 

 

 

 

 

 

 

 

 

 

Active development in North America

 

673,461

 

1,441,323

 

467

 

579,273

 

1,441,323

 

402

 

Investment in unconsolidated JV

 

33,838

(1)

413,536

 

 

(1)

30,730

 

413,536

 

 

(1)

Active redevelopment in North America

 

104,994

 

224,241

 

468

 

141,470

 

331,380

 

427

 

Active development and redevelopment in Asia

 

98,949

 

704,704

 

140

 

101,357

 

718,119

 

141

 

Generic infrastructure/building improvement projects in North America

 

53,333

(2)

 

 

 

 

62,869

 

 

 

 

 

 

 

964,575

 

2,783,804

 

346

 

915,699

 

2,904,358

 

315

 

Subtotal

 

5,773,172

 

17,035,097

 

339

 

5,701,836

 

17,072,984

 

334

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Land/future value-added projects:

 

 

 

 

 

 

 

 

 

 

 

 

 

Land undergoing predevelopment activities (CIP) in North America (3)

 

313,498

 

1,917,667

 

163

 

305,300

 

1,917,667

 

159

 

Land held for future development in North America

 

211,292

 

3,531,843

 

60

 

238,933

 

3,792,181

 

63

 

Land held for future development /undergoing predevelopment activities (CIP) in Asia

 

79,105

 

6,828,864

 

12

 

83,735

 

6,828,864

 

12

 

Land subject to sale negotiations

 

76,312

 

458,724

 

166

 

45,378

 

399,888

 

113

 

 

 

680,207

 

12,737,098

 

53

 

673,346

 

12,938,600

 

52

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in real estate, net

 

6,453,379

 

29,772,195

 

$

217

 

6,375,182

 

30,011,584

 

$

212

 

Add: accumulated depreciation

 

878,199

 

 

 

 

 

849,891

 

 

 

 

 

Gross investments in real estate (3)

 

$

7,331,578

 

29,772,195

 

 

 

$

7,225,073

 

30,011,584

 

 

 

 

(1)          The book value for this unconsolidated joint venture represents our equity investment in the project.   The gross investment in real estate at the joint venture level was approximately $408 and $359 per square foot as of June 30, 2013, and March 31, 2013, respectively.

(2)          Represents the book value associated with approximately 96,372 square feet at four projects undergoing construction of generic laboratory improvements, of which approximately 81% was leased, but not delivered, as of June 30, 2013.

(3)          In addition to assets included in our gross investment in real estate, we hold options/rights for parcels supporting the future ground-up development of approximately 420,000 RSF in Alexandria CenterTM for Life Science - New York City related to an option under our ground lease. Also, our asset base contains additional embedded development opportunities aggregating approximately 715,000 RSF which represents additional development and expansion rights related to existing rental properties.

 

Non-income-producing real estate assets as a percentage of gross investments in real estate

 

GRAPHIC

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

24

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Summary of Capital Expenditures

(Dollars in thousands, except per square foot amounts)

(Unaudited)

 

 

 

Projected

Projected construction spending

 

Six Months Ended
December 31, 2013

 

Thereafter

 

Development projects – North America

 

$

202,148

 

$

340,612

 

Redevelopment projects – North America

 

27,562

 

10,451

 

Development and redevelopment projects – Asia

 

14,185

 

37,798

 

Future value-added construction projects

 

41,237

(1)

TBD

 

Total development and redevelopment projects

 

285,132

 

388,861

 

 

 

 

 

 

 

Value-added predevelopment (2)

 

43,024

(3)

TBD

 

Generic infrastructure/building improvement projects in North America (4)

 

29,534

 

TBD

 

 

 

 

 

 

 

 

 

 

 

 

 

Maintenance building improvements

 

3,549

 

TBD

 

 

 

 

 

 

 

Total construction spending

 

$

361,239

 

$

388,861

 

 

 

 

 

 

 

 

 

Guidance range for development, redevelopment, and construction for the six months ended December 31, 2013

 

$346,000 - $376,000

(5)

 

 

 

 

(1)          Includes future value-added projects, including among others, 3033 Science Park Road, and remaining construction costs related to certain value-added projects recently transferred into rental properties upon substantial completion.  The recently completed projects include certain spaces, generally less than 10% of the project, that may require additional construction prior to occupancy.  For example, this includes our recently delivered redevelopments at 400 Technology Square, 1551 Eastlake Avenue, and 10300 Campus Point Drive which generally have 15,000 to 30,000 RSF of value added activities to complete in connection with the lease-up of the space.

(2)          Refer to the land undergoing predevelopment activities (additional CIP) section in the definition of future value-added projects.

(3)          Includes traditional preconstruction costs plus predevelopment costs related to: i) approximately $16 million related to site and infrastructure costs for the 1.2 million RSF related to 50 Binney Street, 100 Binney Street and the 228,000 RSF of residential at the Alexandria Center™ at Kendall Square, including utility access and roads, installation of storm drain lines, infiltration systems, water lines, traffic lighting/signals, streets, and sidewalks, and ii) approximately $5 million related to the design, permitting, and construction of the building foundation for a new residential building adjacent to the 75/125 Binney Street development project at the Alexandria Center™ at Kendall Square.  Site and infrastructure costs related to 75/125 Binney Street and 225 Binney Street are included in our estimate of cost at completion and initial stabilized yields for each project.

(4)          Includes, among others, generic infrastructure building improvement projects in North America, including 2625/2627/2631 Hanover Street, 7030 Kit Creek Road, 1300 Quince Orchard Boulevard, 44 Hartwell Avenue, 215 First Street, and 300 Technology Square.

(5)          The estimated development, redevelopment and construction amounts for the six months ended December 31, 2013 represent the mid-point of our guidance for total spending.  Our guidance provides a range for the total construction spending for 2013 primarily to accommodate timing of construction activity.

 

Historical construction spending

 

Six Months Ended
June 30, 2013

 

Development projects – North America

 

$

152,955

 

Redevelopment projects – North America

 

53,779

 

Development and redevelopment projects – Asia

 

4,461

 

Total development and redevelopment projects

 

211,195

 

 

 

 

 

Value-added predevelopment (1)

 

28,194

 

Generic infrastructure/building improvement projects in North America (2)

 

13,197

 

Total construction spending

 

$

252,586

 

 

(1)          Includes traditional preconstruction costs plus predevelopment costs related to the 1.2 million RSF related to 50 Binney Street, 100 Binney Street and the 228,000 RSF of residential at the Alexandria Center™ at Kendall Square including: i) site and infrastructure costs for, including utility access and roads, installation of storm drain lines, infiltration systems, water lines, traffic lighting/signals, streets, and sidewalks, ii) building design, and iii) other related project costs including capitalized interest.

(2)          Includes revenue-enhancing projects and amounts shown in the table below related to non-revenue-enhancing capital expenditures.

 

The table below shows the average per square foot of property-related non-revenue-enhancing capital expenditures, tenant improvements, and leasing costs (excluding capital expenditures and tenant improvements that are recoverable from client tenants, revenue-enhancing, or related to properties that have undergone redevelopment).

 

 

 

Six Months Ended

 

 

 

June 30, 2013

 

Non-revenue enhancing capital expenditures (1)

 

$

933

 

Square feet in asset base

 

14,010,754

 

Non-revenue enhancing capital expenditures per square foot

 

$

0.07

 

Tenant improvements and leasing costs:

 

 

 

Re-tenanted space (2)

 

 

 

Tenant improvements and leasing costs

 

$

2,231

 

Re-tenanted square feet

 

132,585

 

Per square foot

 

$

16.83

 

Renewal space

 

 

 

Tenant improvements and leasing costs

 

$

1,641

 

Renewal square feet

 

354,339

 

Per square foot

 

$

4.63

 

 

(1)          Includes, among other costs, capital expenditures such as roof and HVAC system replacements.

(2)          Excludes space that has undergone redevelopment before re-tenanting.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

25

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

All Active Development Projects in North America

(Dollars in thousands, except per square foot amounts)

(Unaudited)

 

 

 

 

 

Leased Status

 

 

 

Initial

 

 

 

 

 

 

 

 

 

Leased

 

Negotiating

 

Total Leased/Negotiating

 

Project

 

Occupancy

 

Stabilization

 

 

 

Property/Market Submarket

 

CIP RSF

 

RSF

 

%

 

RSF

 

%

 

RSF

 

%

 

Start Date

 

Date

 

Date

 

Client Tenants

 

Consolidated development projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

75/125 Binney Street/Greater Boston – Cambridge

 

386,275

 

244,123

 

63%

 

139,374

 (1)

36%

 

383,497

 

99%

 

1Q13

 

1Q15

 

2015

 

ARIAD Pharmaceuticals, Inc.

 

225 Binney Street/Greater Boston – Cambridge

 

305,212

 

305,212

 

100%

 

 

%

 

305,212

 

100%

 

4Q11

 

Oct 2013

 

Oct 2013

 

Biogen Idec Inc.

 

499 Illinois Street/San Francisco Bay Area – Mission Bay

 

222,780

 

97,702

 

44%

 

64,848

 (2)

29%

 

162,550

 

73%

 

2Q11

 

2Q14

 

2014

 

Illumina, Inc.

 

269 East Grand Avenue/San Francisco Bay Area – So. San Francisco

 

107,250

 

107,250

 

100%

 

 

%

 

107,250

 

100%

 

1Q13

 

4Q14

 

2014

 

Onyx Pharmaceuticals, Inc.

 

430 East 29th Street/Greater NYC – Manhattan

 

419,806

 

182,448

 

44%

 

52,257

 

12%

 

234,705

 

56%

 

4Q12

 

Dec 2013

 

2015

 

Roche/Investment-grade entity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated development projects in North America

 

1,441,323

 

936,735

 

65%

 

256,479

 

18%

 

1,193,214

 

83%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unconsolidated joint venture

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

360 Longwood Avenue/Greater Boston – Longwood

 

413,536

 

154,100

 

37%

 

70,000

 

17%

 

224,100

 

54%

 

2Q12

 

4Q14

 

2016

 

Dana-Farber Cancer Institute, Inc.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total/weighted average

 

1,854,859

 

1,090,835

 

59%

 

326,479

 

17%

 

1,417,314

 

76%

 

 

 

 

 

 

 

 

 

 

 

 

Investment

 

 

 

 

 

 

 

 

 

 

 

Cost To Complete

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2014 and Thereafter

 

 

 

 

 

Initial Stabilized

 

 

 

 

 

 

 

Construction

 

Internal

 

Construction

 

Internal

 

Total at

 

Cost

 

Yield (unlevered)

 

Average

 

Property/Market Submarket

 

CIP

 

Loans

 

Funding

 

Loans

 

Funding

 

Completion

 

Per RSF

 

Cash

 

GAAP

 

Cash Yield

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated development projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

75/125 Binney Street/Greater Boston – Cambridge

 

$

123,218

 

$

57,173

 

$

 

$

171,048

 

$

 

$

351,439

 (3)

$

910

 

8.0%

 

8.2%

 

9.1%

 

225 Binney Street/Greater Boston – Cambridge

 

$

145,172

 

$

 

$

35,101

 

$

 

$

 

$

180,273

 

$

591

 

7.5%

 

8.1%

 

8.1%

 

499 Illinois Street/San Francisco Bay Area – Mission Bay

 

$

116,776

 

$

 

$

14,033

 

$

 

$

22,400

 

$

153,209

 

$

688

 

6.4%

 

7.2%

 

7.3%

 

269 East Grand Avenue/San Francisco Bay Area – So. San Francisco

 

$

9,626

 

$

1,572

 

$

5,674

 

$

34,428

 

$

 

$

51,300

 

$

478

 

8.1%

 

9.3%

 

9.3%

 

430 East 29th Street/Greater NYC – Manhattan

 

$

278,669

 

$

 

$

75,035

 

$

 

$

109,541

 

$

463,245

 

$

1,103

 

6.6%

 

6.5%

 

7.1%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated development projects in North America

 

$

673,461

 

$

58,745

 

$

129,843

 

$

205,476

 

$

131,941

 

$

1,199,466

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Property/Market Submarket

 

CIP

 

Construction
Loans and
JV Capital

 

Internal
Funding

 

Construction
Loans and
JV Capital

 

Internal
Funding

 

Total at
Completion

 

 

 

 

 

 

 

 

 

Unconsolidated joint venture

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100% of JV: 360 Longwood Avenue/Greater Boston – Longwood

 

$

168,776

 

$

38,934

 

$

13,560

 

$

125,535

 

$

3,195

 

$

350,000

 

$

846

 

8.3%

 

8.9%

 

9.3%

 

Less: Funding from Secured Construction Loans and JV Partner Capital (4)

 

$

(134,938

)

$

(38,934

)

$

 

$

(125,535

)

$

 

$

(299,407

)

 

 

 

 

 

 

 

 

ARE investment in 360 Longwood Avenue (27.5% interest)

 

$

33,838

 

$

 

$

13,560

 

$

 

$

3,195

 

$

50,593

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total ARE investment

 

$

707,299

 

$

58,745

 

$

143,403

 

$

205,476

 

$

135,136

 

$

1,250,059

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total 2013 and Thereafter

 

 

 

 

 

$

202,148

 

 

 

$

340,612

 

 

 

 

 

 

 

 

 

 

 

 

(1)             ARIAD Pharmaceuticals, Inc. executed an LOI at 75/125 Binney Street for 139,374 RSF of expansion space.  An amendment to their lease is in process to increase their RSF to 383,497, or 99%, of the development.

(2)             Includes 30,000 RSF subject to an executed LOI and lease negotiations.  The remaining 34,848 RSF is under negotiation.

(3)             We expect to close a construction loan financing in the third quarter of 2013 to provide funding for 65% of the total cost at completion.

(4)             Includes non-recourse secured construction loan of approximately $213.2 million, at a rate of L+3.75% with a floor of 5.25%, of which approximately $75.0 million was drawn as of June 30, 2013.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

26

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

All Active Development Projects in North America

 

Property

75/125 Binney Street

225 Binney Street

499 Illinois Street

Submarket/Market

Cambridge/Greater Boston

Cambridge/Greater Boston

Mission Bay/San Francisco Bay Area

RSF

386,275

305,212

222,780

Photograph/ Rendering

 

GRAPHIC

 

GRAPHIC

GRAPHIC

 

 

 

 

Property

269 East Grand Avenue

430 East 29th Street

360 Longwood Avenue

Submarket/Market

South San Francisco/San Francisco Bay Area

New York City/Greater New York

Cambridge/Greater Boston

RSF

107,250

419,806

413,536

Photograph/ Rendering

 

GRAPHIC

 

GRAPHIC

GRAPHIC

 

GRAPHIC

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

27

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

All Active Redevelopment Projects in North America

(Dollars in thousands, except per square foot amounts)

(Unaudited)

 

All project information, including rentable square feet; investment; Initial Stabilized Yields; Average Cash Yields; and project start, occupancy and stabilization dates, relates to the discrete portion of each property undergoing active redevelopment.  A redevelopment project does not necessarily represent the entire property or the entire vacant portion of a property.

 

 

 

Project RSF

 

Leased Status

 

 

 

 

 

 

 

 

 

In

 

 

 

 

 

Leased

 

Negotiating

 

Total Leased/Negotiating

 

Former

 

Use After

 

 

 

Property/Market - Submarket

 

Service

 

CIP

 

Total

 

RSF

 

%

 

RSF

 

%

 

RSF

 

%

 

Use

 

Conversion

 

Client Tenants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

285 Bear Hill Road/Greater Boston – Route 128

 

 

26,270

 

26,270

 

26,270

 

100%

 

 

%

 

26,270

 

100%

 

Office/

Manufacturing

 

Laboratory

 

Intelligent Medical Devices, Inc.

 

343 Oyster Point/San Francisco Bay Area – South San Francisco

 

17,507

 

36,473

 

53,980

 

42,445

 

79%

 

 

%

 

42,445

 

79%

 

Office

 

Laboratory

 

Calithera BioSciences, Inc.;
CytomX Therapeutics, Inc.

 

4757 Nexus Center Drive/San Diego – University Town Center

 

 

68,423

(1)

68,423

 

68,423

 

100%

 

 

%

 

68,423

 

100%

 

Office/R&D/
Manufacturing/
Warehouse

 

Laboratory

 

Genomatica, Inc.

 

9800 Medical Center Drive/Suburban Washington, D.C. – Rockville

 

8,001

 

67,055

 

75,056

 

75,056

 

100%

 

 

%

 

75,056

 

100%

 

Office/
Laboratory

 

Laboratory

 

National Institutes of Health

 

1616 Eastlake Avenue/Seattle – Lake Union

 

40,756

 

26,020

 

66,776

 

40,756

 

61%

 

 

%

 

40,756

 

61%

 

Office

 

Laboratory

 

Infectious Disease Research Institute

 

Total/weighted average

 

66,264

 

224,241

 

290,505

 

252,950

 

87%

 

 

%

 

252,950

 

87%

 

 

 

 

 

 

 

 

 

 

Investment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30, 2013

 

To Complete

 

 

 

 

 

Initial Stabilized

 

 

 

 

 

Initial

 

 

 

 

 

In

 

 

 

 

 

2014 and

 

Total at

 

Cost

 

Yield (unlevered)

 

Average

 

Project

 

Occupancy

 

Stabilization

 

Property/Market - Submarket

 

Service

 

CIP

 

2013

 

Thereafter

 

Completion

 

Per RSF

 

Cash

 

GAAP

 

Cash Yield

 

Start Date

 

Date

 

Date

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

285 Bear Hill Road/Greater Boston – Route 128

 

$

 

$

5,173

 

$

4,023

 

$

 

$

9,196

 

$

350

 

8.4%

 

8.8%

 

9.2%

 

4Q11

 

3Q13

 

3Q13

 

343 Oyster Point/San Francisco Bay Area – South San Francisco

 

$

5,222

 

$

9,882

 

$

1,317

 

$

918

 

$

17,339

 

$

321

 

9.6%

 

9.8%

 

10.1%

 

1Q12

 

3Q13

 

4Q13

 

4757 Nexus Center Drive/San Diego – University Town Center

 

$

 

$

10,619

 

$

18,694

 

$

5,516

 

$

34,829

 

$

509

 

7.6%

 

7.8%

 

8.5%

 

4Q12

 

4Q13

 

4Q13 (1)

 

9800 Medical Center Drive/Suburban Washington, D.C. – Rockville

 

$

8,275

 

$

69,279

 

$

3,150

 

$

 

$

80,704

 

$

1,075

(2)

5.4%

 

5.4%

 

5.4%

 

3Q09

 

1Q13

 

3Q13

 

1616 Eastlake Avenue/Seattle – Lake Union

 

$

23,380

 

$

10,041

 

$

378

 

$

4,017

 

$

37,816

 

$

566

 

8.4%

 

8.6%

 

9.4%

 

4Q12

 

2Q13

 

2014

 

Total/weighted average

 

$

36,877

 

$

104,994

 

$

27,562

 

$

10,451

 

$

179,884

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)             We expect to deliver 54,102 RSF, or 79% of the total project, to Genomatica, Inc. in the fourth quarter of 2013.  Genomatica, Inc. is contractually required to lease the remaining 14,411 RSF 18 to 24 months following the delivery of the initial 54,102 rentable square foot space.

(2)             Our multi-tenant four building property at 9800 Medical Center Drive contains an aggregate of 281,586 RSF.  Our total cash investment in the entire four building property upon completion of the redevelopment will approximate $580 per square foot.   Our total expected cash investment for the four building property of approximately $580 per square foot includes our expected total investment at completion related to the 75,056 rentable square foot redevelopment of approximately $1,075 per square foot.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

28

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

All Active Redevelopment Projects in North America

 

Property

285 Bear Hill Road

343 Oyster Point Boulevard

4757 Nexus Center Drive

Submarket/Market

Route 128/Greater Boston

South San Francisco/San Francisco Bay Area

University Town Center/San Diego

RSF

26,270

53,980

68,423

Photograph/ Rendering

 

GRAPHIC

 

GRAPHIC

GRAPHIC

Year Acquired/ Built

 

Acquired in 2011

 

Built in 2000

Acquired in 1998

Redevelopment Opportunity Identified at Acquisition

Yes

N/A

Yes

 

Former Use

 

Office/Manufacturing

Office

Manufacturing/Warehouse/Office/R&D

 

Use After Conversion

 

Laboratory

Laboratory

Laboratory

Projected GAAP NOI per RSF

$31

$31

$40

Projected Redevelopment Budget per RSF

$197

$135

$470

 

Key Tenants

 

Intelligent Medical Devices, Inc.

Calithera Biosciences, Inc.; CytomX Therapeutics, Inc.

Genomatica, Inc.

Other Key Attributes

Conversion of office/manufacturing space through redevelopment. This portion of the building was originally developed by prior owner as office/manufacturing space in 1999.

Conversion of office space through redevelopment. This portion of the building was originally developed primarily as office in 2000.

Campus has approximately 50,000 of additional developable square feet to accommodate growth by Genomatica, Inc. and other client tenants.

 

GRAPHIC

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

29

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

All Active Redevelopment Projects in North America

 

Property

9800 Medical Center Drive

1616 Eastlake Avenue

Submarket/Market

Rockville/Suburban Washington, D.C.

Lake Union/Seattle

RSF

75,056

66,776

Photograph/ Rendering

 

GRAPHIC

 

GRAPHIC

Year Acquired/ Built

Acquired in 2004

Built in 2003

Redevelopment Opportunity Identified at Acquisition

Yes

N/A

 

Former Use

 

Office/Laboratory

Office

 

Use After Conversion

 

Laboratory

Laboratory

 

Projected GAAP NOI per RSF

 

$58

$49

Projected Redevelopment Budget per RSF

$525

$132

 

Key Tenants

 

National Institutes of Health

Infectious Disease Research Institute

 

Other Key Attributes

 

NIH initially leased space at the campus in 2005. Expansion into the redevelopment space extends their tenancy at property to a total term of approximately 23 years.

Conversion of office space through redevelopment. This portion of the building was originally developed as office space in 2003.

 

GRAPHIC

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

30

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Future Value-Added Projects in North America

Future Redevelopment in North America

(Unaudited)

 

 

 

Land Undergoing Predevelopment Activities
(Additional CIP)

 

Land Held for Future Development

 

Total

Market: Property - Submarket

 

Book Value
(in thousands)

 

Rentable
Square Feet

 

Cost per
Square Foot

 

Book Value
(in thousands)

 

Rentable
Square Feet

 

Cost per
Square Foot

 

Book Value
(in thousands)

 

Rentable
Square Feet

 

Cost per
Square Foot

Greater Boston:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Alexandria Center™ at Kendall Square-Lab/Office - Cambridge/Inner Suburbs

 

$

258,442

 

974,264

 

$

265

 

$

 

 

$

 

$

258,442

 

974,264

 

$

265

Alexandria Center™ at Kendall Square-Residential - Cambridge/Inner Suburbs

 

1,956

 

78,000

 

25

 

3,413

 

150,000

 

23

 

5,369

 

228,000

 

24

Subtotal - Alexandria Center™ at Kendall Square

 

260,398

 

1,052,264

 

247

 

3,413

 

150,000

 

23

 

263,811

 

1,202,264

 

219

Technology Square - Cambridge/Inner Suburbs

 

 

 

 

7,721

 

100,000

 

77

 

7,721

 

100,000

 

77

Greater Boston

 

$

260,398

 

1,052,264

 

$

247

 

$

11,134

 

250,000

 

$

45

 

$

271,532

 

1,302,264

 

$

209

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay Area:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Grand Ave - South San Francisco

 

$

 

 

$

 

$

42,853

 

397,132

 

$

108

 

$

42,853

 

397,132

 

$

108

Rozzi/Eccles - South San Francisco

 

 

 

 

72,864

 

514,307

 

142

 

72,864

 

514,307

 

142

San Francisco Bay Area

 

$

 

 

$

 

$

115,717

 

911,439

 

$

127

 

$

115,717

 

911,439

 

$

127

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Diego:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Science Park Road - Torrey Pines

 

$

16,635

 

176,500

 

$

94

 

$

 

 

$

 

$

16,635

 

176,500

 

$

94

5200 Illumina Way - University Town Center

 

14,719

 

392,983

 

37

 

 

 

 

14,719

 

392,983

 

37

10300 Campus Point - University Town Center

 

3,992

 

140,000

 

29

 

 

 

 

3,992

 

140,000

 

29

Executive Drive - University Town Center

 

3,995

 

49,920

 

80

 

 

 

 

3,995

 

49,920

 

80

San Diego

 

$

39,341

 

759,403

 

$

52

 

$

 

 

$

 

$

39,341

 

759,403

 

$

52

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban Washington D.C.:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Medical Center Drive - Rockville

 

$

 

 

$

 

$

7,548

 

321,721

 

$

23

 

$

7,548

 

321,721

 

$

23

Research Boulevard - Rockville

 

 

 

 

6,905

 

347,000

 

20

 

6,905

 

347,000

 

20

Firstfield Road - Gaithersburg

 

 

 

 

4,052

 

95,000

 

43

 

4,052

 

95,000

 

43

Suburban Washington D.C.

 

$

 

 

$

 

$

18,505

 

763,721

 

$

24

 

$

18,505

 

763,721

 

$

24

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Seattle:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dexter/Terry Ave - Lake Union

 

$

 

 

$

 

$

18,747

 

232,300

 

$

81

 

$

18,747

 

232,300

 

$

81

Eastlake Ave - Lake Union

 

13,759

 

106,000

 

130

 

15,248

 

160,266

 

95

 

29,007

 

266,266

 

109

Seattle

 

$

13,759

 

106,000

 

$

130

 

$

33,995

 

392,566

 

$

87

 

$

47,754

 

498,566

 

$

96

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Markets

 

$

 

 

$

 

$

31,941

 

1,214,117

 

$

26

 

$

31,941

 

1,214,117

 

$

26

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Future value-added projects in North America

 

$

313,498

 

1,917,667

 

$

163

 

$

211,292

 

3,531,843

 

$

60

 

$

524,790

 

5,449,510

 

$

96

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2013

31

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Future Value-Added Projects in North America

Land Undergoing Predevelopment Activities or Held for Future Development

Overview of Greater Boston Market

 

GRAPHIC

 

GRAPHIC

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

32

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Future Value-Added Projects in North America

Land Undergoing Predevelopment Activities or Held for Future Development in Greater Boston Market

 

GRAPHIC

 

Property

Alexandria Center at Kendall Square

 

Submarket/Market

 

Cambridge/Greater Boston

Aerial

 

GRAPHIC

 

Background

 

Alexandria received final approval from the City of Cambridge to develop the Alexandria Center at Kendall Square, a fully-integrated life science campus featuring four world-class laboratory/office facilities, high-quality amenities, and green space. Alexandria’s entitlement efforts resulted in an increase of 1.1 million developable square feet over the original entitlements in place at acquisition.

 

Update

 

·      4Q11: Commenced development of a build-to-suit for Biogen Idec Inc. at 225 Binney Street

·      1Q13: Commenced development of build-to-suit for ARIAD Pharmaceuticals, Inc. at 75/125 Binney Street

 

Near-Term Opportunity

Laboratory ground-up development projects at 50 and 100 Binney Street aggregating approximately 1.0 million RSF plus 228,000 RSF of residential; subject to market conditions, we expect to commence development of these opportunities over the next one to three years and we may consider financing these projects with joint venture capital. We believe the estimated investment, excluding land, to develop laboratory buildings, with an underground parking garage, on these parcels ranges from $660 to $825 per square foot.

 

 

GRAPHIC

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

33

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Future Value-Added Projects in North America

Land Undergoing Predevelopment Activities

Overview of San Diego Market

 

GRAPHIC

 

GRAPHIC

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

34

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Future Value-Added Projects in North America

Land Undergoing Predevelopment Activities in San Diego Market

 

GRAPHIC

 

Property

10300 Campus Point Drive

5200 Illumina Way

Submarket/Market

University Town Center/San Diego

University Town Center/San Diego

Aerial

 

GRAPHIC

 

GRAPHIC

Background

10300 Campus Point Drive is Alexandria’s flagship 449,759 rentable square foot, multi-tenant campus in University Town Center.

Alexandria owns and operates the headquarters campus of Illumina, Inc., the leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function with a YE12 market capitalization

of $6.9 billion.

Update

 

·    4Q10: Acquired as a manufacturing facility and began redeveloping it into a state-of-the-art laboratory property

·    3Q12: Completed redevelopment of 10300 Campus Point Drive, a 96% leased project with leading tenants including Eli Lilly and Company, Celgene Corporation, Covance Inc., and the Regents of the University of California

 

·      4Q10: Acquired world-class campus from Biogen Idec Inc.

·      4Q10: Leased entire 3 building campus to Illumina, Inc.

·      4Q12: Completed development of fourth building with 127,373 RSF for Illumina, Inc.

·      1Q13: Completed development of fifth building with 23,124 RSF for Illumina, Inc.

Near-Term
Opportunity

Ground-up development projects aggregating approximately 140,000 RSF; subject to market conditions, we expect to commence development of these opportunities over the next one to three years. We believe the estimated investment, excluding land, to develop laboratory buildings on these parcels ranges from $450 to $500 per square foot.

Future ground-up development projects for two buildings (building 6 and 7) aggregating 392,983 RSF; subject to market conditions, we expect to commence development of these opportunities over the next one to three years.  We believe the estimated investment, excluding land, to develop laboratory buildings on these parcels ranges from $450 to $500 per square foot.  Additionally, the site supports an above ground parking garage which Illumina, Inc. may elect to lease at a similar return to the Company as a new building.

 

GRAPHIC

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

35

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Future Value-Added Projects in North America

Land Undergoing Predevelopment Activities in San Diego Market

 

GRAPHIC

 

Property

3013/3033 Science Park Road

Submarket/Market

Torrey Pines/San Diego

Aerial

 

GRAPHIC

 

Background

 

ARE Spectrum is Alexandria’s 335,145 rentable square foot, multi-tenant campus located in Torrey Pines.  The existing operating laboratory properties are fully leased to the Scripps Research Institute and Sapphire Energy, Inc.

 

Update

 

·      2Q12 - Acquired the 3013/3033 Science Park Road sites with a short-term lease in-place.

·      2013 - Commenced predevelopment activities to design future laboratory product in a highly desirable and dense lab market.

 

Near-Term
Opportunity

 

Ground-up development and possible redevelopment opportunities aggregating 176,500 RSF for either multi-tenant use or a large campus user.  Subject to market conditions, we expect to commence construction of these opportunities over the next one to three years.  We believe the estimated investment, excluding land, to construct laboratory buildings on these parcels ranges from $350 to $500 per square foot.

 

 

GRAPHIC

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

36

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Future Value-Added Projects in North America

Land Undergoing Predevelopment Activities or Held for Future Development

Overview of Seattle Market

 

GRAPHIC

 

GRAPHIC

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

37

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Future Value-Added Projects in North America

Land Undergoing Predevelopment Activities or Held for Future Development in Seattle Market

 

GRAPHIC

 

Property

Dexter/Terry Avenue and Eastlake Avenue

Submarket/Market

Lake Union/Seattle

Aerial

 

GRAPHIC

 

Background

 

Alexandria’s Dexter/Terry Avenue and Eastlake Avenue assets are located at Lake Union, home to numerous highly renowned medical research institutions, including the Fred Hutchinson Cancer Research Center and the University of Washington.

 

Update

 

·      2010: Completed 115,084 rentable square foot build-to-suit for Gilead Sciences, Inc.

·      2011: Commenced redevelopment of 117,482 square foot project at 1551 Eastlake Avenue

·      2012: Commenced redevelopment of 66,776 square foot project at 1616 Eastlake Avenue

·      2012: Sold two assets to residential developers for an average sales price per square foot of approximately $72

·      2014: Sale of 810 Dexter Avenue North is expected to close in the next two to three quarters

 

Near-Term
Opportunity

 

Build-to suit opportunities, as well as expansion opportunities related to existing client tenants.  Subject to market conditions, we expect to monetize these land sites through dispositions or commencement of development over the next one to three years.  We believe the estimated investment, excluding land, to develop laboratory buildings on these parcels ranges from $375 to $550 per square foot.

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

38

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Future Value-Added Projects in North America

Land Held for Future Development

Overview of San Francisco Bay Area Market

 

GRAPHIC

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

39

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Future Value-Added Projects in North America

Land Held for Future Development in San Francisco Market

 

GRAPHIC

 

Property

East Grand Avenue

Submarket/Market

South San Francisco/San Francisco Bay Area

Aerial

GRAPHIC

Background

 

Alexandria owns and operates the headquarters campus of Onyx Pharmaceuticals, Inc., the cutting-edge global commercial-stage oncology company.

 

Update

 

·    2010: Completed development of 249 East Grand Avenue, 100% leased to Onyx Pharmaceuticals, Inc.

·    4Q12: Completed development of 259 East Grand Avenue, 100% leased to Onyx Pharmaceuticals, Inc.

·    1Q13: Commenced construction on 269 East Grand Avenue, 100% pre-leased to Onyx Pharmaceuticals, Inc.

 

Near-Term
Opportunity

 

Ground-up development projects aggregating 121,632 RSF on the Onyx campus; subject to market conditions.  We believe the estimated investment, excluding land, to develop a laboratory building on this parcel ranges from $375 to $430 per square foot. This site supports an above ground parking garage which Onyx may elect to lease at a similar return to the Company as a new building. Additionally, we also have approximately 790,000 RSF of future opportunities at other sites in South San Francisco.

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

40

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Future Value-Added Projects in North America

Land Undergoing Predevelopment Activities or Held for Future Development

Overview of Suburban Washington, D.C. Market

 

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2013

41

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Future Value-Added Projects in North America

Land Undergoing Predevelopment Activities or Held for Future Development in Washington, D.C. Market

 

GRAPHIC

 

Property

9800 Medical Center Drive

Submarket/

Market

Rockville/Suburban Washington, D.C.

Aerial

 

GRAPHIC

 

Background

 

Alexandria’s 9800 Medical Center Drive campus is located in the heart of the Shady Grove Life Sciences Center.

 

Update

 

·    2013: Alexandria expects to complete redevelopment of 75,056 RSF; 100% pre-leased to National Institutes of Health for 15 years

·    2013: Upon completion of the redevelopment, the National Institutes of Health will occupy approximately 135,000 RSF, or 48% of the campus

 

Near-Term
Opportunity

 

Future development projects for expansion opportunities of 260,721 RSF at 9800 Medical Center Drive plus 408,000 RSF at other well-located sites in Rockville.  We are not likely to commence ground-up development in the near-term given current market conditions.

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2013

42

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Summary of Real Estate Investment in Asia

(Unaudited)

 

Property listing

 

 

 

 

 

 

 

 

 

 

 

 

 

Annualized

 

Occupancy Percentage

 

 

 

Rentable Square Feet

 

Number of

 

Base Rent

 

 

 

Operating and

 

Country

 

Operating

 

Development

 

Redevelopment

 

Total

 

Properties

 

(in thousands)

 

Operating

 

Redevelopment

 

China

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

China

 

299,484

 

 

 

299,484

 

1

 

$

452

 

46.7

%

 

46.7

%

China

 

 

309,476

 

 

309,476

 

1

 

 

N/A

 

 

N/A

 

Total China

 

299,484

 

309,476

 

 

608,960

 

2

 

452

 

46.7

 

 

46.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

India

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

India

 

33,698

 

 

 

33,698

 

1

 

220

 

40.4

 

 

40.4

 

India

 

143,260

 

 

 

143,260

 

1

 

2,498

 

87.7

 

 

87.7

 

India

 

 

134,500

 

 

134,500

 

1

 

 

N/A

 

 

N/A

 

India

 

 

175,000

 

 

175,000

 

1

 

 

N/A

 

 

N/A

 

India

 

54,960

 

 

41,068

 

96,028

 

1

 

668

 

100.0

 

 

57.2

 

India

 

 

 

44,660

 

44,660

 

1

 

 

N/A

 

 

 

India

 

86,200

 

 

 

86,200

 

1

 

898

 

100.0

 

 

100.0

 

Total India

 

318,118

 

309,500

 

85,728

 

713,346

 

7

 

4,284

 

88.1

 

 

69.4

 

Total Asia

 

617,602

 

618,976

 

85,728

 

1,322,306

 

9

 

$

4,736

 

68.1

%

 

59.8

%

 

(1)             Represents annualized base rent for non-laboratory use.

 

Summary of investments in real estate

 

 

 

June 30, 2013

 

March 31, 2013

 

 

Book Value
(in thousands)

 

Rentable
Square Feet

 

Cost per
Square Foot

 

Book Value
(in thousands)

 

Rentable
Square Feet

 

Cost per
Square Foot

Rental properties, net, in China

 

$

21,233

 

299,484

 

$

71

 

$

21,352

 

299,484

 

$

71

Rental properties, net, in India

 

34,077

 

318,118

 

107

 

35,337

 

304,503

 

116

 

 

 

 

 

 

 

 

 

 

 

 

 

CIP/current value-added projects:

 

 

 

 

 

 

 

 

 

 

 

 

Active development projects in China

 

59,584

 

309,476

 

193

 

58,500

 

309,476

 

189

Active development projects in India

 

28,875

 

309,500

 

93

 

29,713

 

309,500

 

96

Active redevelopment projects in India

 

10,490

 

85,728

 

122

 

13,144

 

99,143

 

133

 

 

98,949

 

704,704

 

140

 

101,357

 

718,119

 

141

 

 

 

 

 

 

 

 

 

 

 

 

 

Land held for future development/land undergoing predevelopment activities (additional CIP) - India

 

79,105

 

6,828,864

 

12

 

83,735

 

6,828,864

 

12

Total investments in real estate, net, in Asia

 

$

233,364

 

8,151,170

 

$

29

 

$

241,781

 

8,150,970

 

$

30

 

Active development and redevelopment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment (in thousands)

 

 

Project RSF

 

Leased Status RSF

 

 

 

 

 

To Complete

 

 

 

 

In

 

 

 

 

 

Leased

 

Negotiating

 

Total Leased/Negotiating

 

June 30, 2013

 

 

 

2014 and

 

Total at

Description

 

Service

 

CIP

 

Total

 

RSF

 

%

 

RSF

 

%

 

RSF

 

%

 

In Service

 

CIP

 

2013

 

Thereafter

 

Completion

China development project

 

 

309,476

 

309,476

 

 

–%

 

 

–%

 

 

–%

 

$

 

$

59,584

 

$

1,776

 

$

20,940

 

$

82,300

India development projects

 

 

309,500

 

309,500

 

203,000

 

66%

 

 

–%

 

203,000

 

66%

 

 

28,875

 

10,186

 

12,724

 

51,785

India redevelopment projects

 

54,960

 

85,728

 

140,688

 

55,160

 

39%

 

6,400

 

5%

 

61,560

 

44%

 

5,862

 

10,490

 

2,223

 

4,134

 

22,709

Total active development and redevelopment in Asia

 

54,960

 

704,704

 

759,664

 

 

 

 

 

 

 

 

 

 

 

 

 

$

5,862

 

$

98,949

 

$

14,185

 

$

37,798

 

$

156,794

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

43

 

 



 

 

 

 

 

 

 

 

 

 

BALANCE SHEET

 

 

 

 

 

 

 

 

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Credit Metrics

(Unaudited)

 

Net Debt/Adjusted EBITDA

 

Net Debt to Gross Assets (Excluding Cash and Restricted Cash)

 

 

 

 

 

 

GRAPHIC

 

GRAPHIC

 

 

 

Fixed Charge Coverage Ratio

 

Interest Coverage Ratio

 

 

 

 

 

 

GRAPHIC

 

GRAPHIC

 

 

 

Unencumbered NOI as a % of Total NOI

 

Unencumbered Assets Gross Book Value as a % of Gross Assets

 

 

 

GRAPHIC

 

GRAPHIC

 

 

 

Liquidity

 

Unhedged Variable Rate Debt as a % of Total Debt

 

 

 

 

GRAPHIC

 

 

GRAPHIC

 

(1)

Periods represent quarter annualized metrics.  We believe key credit metrics for the three months ended June 30, 2013, annualized, reflect the completion of many development and redevelopment projects and are indicative of the Company’s current operating trends.

(2)

Certain encumbered properties under redevelopment were completed just prior to or during the three months ended June 30, 2013, including 400 Technology Square, 9800 Medical Center Drive, and 259 East Grand Avenue.  The additional lease commencements generated incremental encumbered NOI relative to the existing base of unencumbered NOI and resulted in a decrease in our ratio of unencumbered NOI as a percentage of total NOI.  We expect the ratio of unencumbered NOI to increase by 12%-to-14% in the first quarter of 2014 when the $211 million secured loan related to our properties at Alexandria Technology Square matures and is refinanced with the issuance of unsecured notes payable.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

45

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Summary of Debt

(Dollars in thousands)

(Unaudited)

 

Fixed rate/hedged and unhedged variable rate debt

 

 

 

Fixed Rate/Hedged
Variable Rate

 

Unhedged
Variable Rate

 

Total
Consolidated

 

Percentage of
Total

 

Weighted Average
Interest Rate at
End of Period (1)

 

Weighted Average
Remaining Term
(including extension
options, in years)

 

Secured notes payable, net

 

$

591,623

 

$

119,406

 

$

711,029

 

24.0%

 

5.48%

 

2.7

 

Unsecured senior notes payable, net

 

1,048,395

 

 

1,048,395

 

35.4

 

4.29

 

9.3

 

$1.5 billion unsecured senior line of credit

 

 

 

 

 

1.39

 

3.8

 

2016 Unsecured Senior Bank Term Loan

 

400,000

 

200,000

 

600,000

 

20.3

 

2.24

 

3.0

 

2017 Unsecured Senior Bank Term Loan

 

600,000

 

 

600,000

 

20.3

 

3.93

 

3.6

 

Total debt / weighted average

 

$

2,640,018

 

$

319,406

 

$

2,959,424

 

100.0%

 

4.09%

 

5.3

 

Percentage of total debt

 

89%

 

11%

 

100%

 

 

 

 

 

 

 

 

(1)

Represents the weighted average contractual interest rate as of the end of the period plus the impact of debt premiums/discounts and our interest rate swap agreements. The effective interest rate excludes bank fees and amortization of loan fees.

 

Debt maturities

 

 

 

 

 

Weighted
Average
Interest

 

Maturity

 

Remaining for the Period Ending December 31,

 

 

 

 

 

Debt

 

Stated Rate

 

Rate (1)

 

Date (2)

 

2013

 

2014

 

2015

 

2016

 

2017

 

Thereafter

 

Total

 

Secured notes payable

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston

 

5.26

%

 

5.59%

 

4/1/14

 

$

1,945

 

$

208,683

 

$

 

$

 

$

 

$

 

$

210,628

 

Suburban Washington, D.C.

 

2.18

 

 

2.18

 

4/20/14

(3)

 

76,000

 

 

 

 

 

76,000

 

San Diego

 

6.05

 

 

4.88

 

7/1/14

 

59

 

6,458

 

 

 

 

 

6,517

 

San Diego

 

5.39

 

 

4.00

 

11/1/14

 

74

 

7,495

 

 

 

 

 

7,569

 

Seattle

 

6.00

 

 

6.00

 

11/18/14

 

120

 

240

 

 

 

 

 

360

 

Suburban Washington, D.C.

 

5.64

 

 

4.50

 

6/1/15

 

54

 

138

 

5,788

 

 

 

 

5,980

 

Greater Boston, San Francisco Bay Area, and San Diego

 

5.73

 

 

5.73

 

1/1/16

 

814

 

1,713

 

1,816

 

75,501

 

 

 

79,844

 

Greater Boston, San Diego, and Greater NYC

 

5.82

 

 

5.82

 

4/1/16

 

438

 

931

 

988

 

29,389

 

 

 

31,746

 

San Francisco Bay Area

 

6.35

 

 

6.35

 

8/1/16

 

1,149

 

2,487

 

2,652

 

126,715

 

 

 

133,003

 

San Francisco Bay Area

 

LIBOR+1.50

 

1.70

 

7/1/17

(4)

 

 

43,046

 

 

 

 

43,046

 

San Diego, Suburban Washington, D.C., and Seattle

 

7.75

 

 

7.75

 

4/1/20

 

685

 

1,453

 

1,570

 

1,696

 

1,832

 

108,469

 

115,705

 

San Francisco Bay Area

 

6.50

 

 

6.50

 

6/1/37

 

 

17

 

18

 

19

 

20

 

773

 

847

 

Average/Total

 

5.42

%

 

5.48

 

 

 

5,338

 

305,615

 

55,878

 

233,320

 

1,852

 

109,242

 

711,245

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$1.5 billion unsecured senior line of credit (6)

 

LIBOR+1.20%(5)

 

1.39

 

4/30/17

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016 Unsecured Senior Bank Term Loan (6)

 

LIBOR+1.75%

 

2.24

 

6/30/16

(3)

 

 

 

600,000

 

 

 

600,000

 

2017 Unsecured Senior Bank Term Loan (6)

 

LIBOR+1.50%

 

3.93

 

1/31/17

(3)

 

 

 

 

600,000

 

 

600,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unsecured senior notes payable

 

4.60

%

 

4.61

 

4/1/22

 

 

250

 

 

 

 

550,000

 

550,250

 

Unsecured senior notes payable

 

3.90

%

 

3.94

 

6/15/23

 

 

 

 

 

 

500,000

 

500,000

 

Average/Subtotal

 

 

 

 

4.09

 

 

 

5,338

 

305,865

 

55,878

 

833,320

 

601,852

 

1,159,242

 

2,961,495

 

Unamortized discounts

 

 

 

 

 

 

 

(294

)

(200

)

(139

)

(177

)

(184

)

(1,077

)

(2,071

)

Average/Total

 

 

 

 

4.09%

 

 

 

$

5,044

 

$

305,665

 

$

55,739

 

$

833,143

 

$

601,668

 

$

1,158,165

 

$

2,959,424

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balloon payments

 

 

 

 

 

 

 

 

$

 

$

297,330

 

$

48,774

 

$

830,029

 

$

600,000

 

$

654,352

 

$

2,430,485

 

Principal amortization

 

 

 

 

 

 

 

 

5,044

 

8,335

 

6,965

 

3,114

 

1,668

 

503,813

 

528,939

 

Total consolidated debt

 

 

 

 

 

 

 

 

$

5,044

 

$

305,665

 

$

55,739

 

$

833,143

 

$

601,668

 

$

1,158,165

 

$

2,959,424

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed rate/hedged variable rate debt

 

 

 

 

 

 

 

 

$

4,924

 

$

229,425

 

$

12,693

 

$

633,143

 

$

601,668

 

$

1,158,165

 

$

2,640,018

 

Unhedged variable rate debt

 

 

 

 

 

 

 

 

120

 

76,240

 

43,046

 

200,000

 

 

 

319,406

 

Total consolidated debt

 

 

 

 

 

 

 

 

$

5,044

 

$

305,665

 

$

55,739

 

$

833,143

 

$

601,668

 

$

1,158,165

 

$

2,959,424

 

 

(1)

Represents the weighted average contractual interest rate as of the end of the period plus the impact of debt premiums/discounts and our interest rate swap agreements. The weighted average interest rate excludes bank fees and amortization of loan fees.

(2)

Includes any extension options that we control.

(3)

This loan may be prepaid without any prepayment penalty.

(4)

We have two, one year options to extend the stated maturity date of July 1, 2015

(5)

In addition to the stated rate, we are subject to an annual facility fee of 0.25%.

(6)

Does not reflect amendments completed or in progress subsequent to June 30, 2013, that will reduce our borrowing costs and/or extend our maturity as noted on page 2 of our accompanying earnings press release.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

46

 

 


 


 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Summary of Debt

(Dollars in thousands)

(Unaudited)

 

Debt covenants

 

 

Unsecured Senior Notes Payable

 

Unsecured Senior Line of Credit and
Unsecured Senior Bank Term Loans

 

Debt Covenant Ratios

 

Requirement

 

Actual (1)

 

Current Requirement

 

Actual (1)

 

Total Debt to Total Assets

 

< 60%

 

36%

 

< 60%

 

33%

 

Secured Debt to Total Assets

 

< 40%

 

9%

 

< 40%

 

8%

 

Consolidated EBITDA to Interest Expense

 

> 1.50x

 

5.28x

 

> 1.50x

 

2.5x

 

Unencumbered Total Asset Value to Unsecured Debt

 

>150%

 

284%

 

N/A

 

N/A

 

Unsecured Leverage Ratio

 

N/A

 

N/A

 

< 60%

 

37%

 

Unsecured Interest Coverage Ratio

 

N/A

 

N/A

 

> 1.75x

 

7.2x

 

 

(1)          Actual covenants are calculated pursuant to the specific terms as detailed in each agreement.

 

Summary of interest rate swap agreements

 

 

 

 

 

 

Interest Pay

 

Fair Value as of

 

Notional Amount in Effect as of

 

Transaction Date

 

Effective Date

 

Termination Date

 

Rate (1)

 

June 30, 2013

 

June 30, 2013

 

December 31, 2013

 

December 2006

 

December 29, 2006

 

March 31, 2014

 

4.990%

 

$

(1,804

)

$

50,000

 

$

50,000

 

October 2007

 

October 31, 2007

 

September 30, 2013

 

4.642%

 

(563

)

50,000

 

 

December 2006

 

November 30, 2009

 

March 31, 2014

 

5.015%

 

(2,721

)

75,000

 

75,000

 

December 2006

 

November 30, 2009

 

March 31, 2014

 

5.023%

 

(2,725

)

75,000

 

75,000

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.640%

 

(553

)

250,000

 

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.640%

 

(553

)

250,000

 

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.644%

 

(279

)

125,000

 

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.644%

 

(279

)

125,000

 

 

December 2011

 

December 31, 2013

 

December 31, 2014

 

0.977%

 

(1,536

)

 

250,000

 

December 2011

 

December 31, 2013

 

December 31, 2014

 

0.976%

 

(1,534

)

 

250,000

 

Total

 

 

 

 

 

 

 

$

(12,547

)

$

1,000,000

 

$

700,000

 

 

(1)

In addition to the interest pay rate, borrowings outstanding under our unsecured senior bank term loans include an applicable margin ranging from 1.50% to 1.75% as of June 30, 2013.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2013

47

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Assets Held for Sale and Summary of Real Estate Sales

(Dollars in thousands)

(Unaudited)

 

Non-income-producing land sales

 

Description

 

Sales Price

 

 

 

 

 

Completed

 

 

 

Land sold during the second quarter of 2013

 

$

18,050

 

 

 

 

 

Projected

 

 

 

Land subject to purchase and sale agreement

 

$

55,000

 

Land subject to sale negotiations

 

30,000

 

Additional land sales

 

46,000 - 86,000

 

Total projected non-income producing land sales for the six months ended December 31, 2013

 

$

131,000 - 171,000

 

 

Net assets of discontinued operations

 

Description

 

June 30, 2013

 

 

 

 

 

Properties “held for sale,” net

 

$

4,180

 

Other assets

 

7

 

Total assets

 

4,187

 

 

 

 

 

Total liabilities

 

(8

)

Net assets of discontinued operations

 

$

4,179

 

 

Income from discontinued operations, net

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2013

 

2012

 

2013

 

2012

 

Total revenues

 

$

241

 

$

8,831

 

$

3,737

 

$

18,138

 

Operating expenses

 

217

 

2,506

 

1,629

 

5,549

 

NOI from discontinued operations

 

24

 

6,325

 

2,108

 

12,589

 

Interest expense

 

 

 

 

 

Depreciation expense

 

 

1,614

 

930

 

3,233

 

(Gain) loss on sale of real estate

 

(219

)

(2

)

121

 

(2

)

Income from discontinued operations, net

 

$

243

 

$

4,713

 

$

1,057

 

$

9,358

 

 

Income-producing assets sold in second quarter

 

Property

 

Location

 

Date of
Purchase

 

Date of Sale

 

RSF

 

Annualized
GAAP
NOI (1)

 

Sales Price

 

Sales Price
per RSF

 

Gain
on Sale (2)

 

Unlevered
IRR

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

702 Electronic Drive

 

Horsham, PA

 

June 1998

 

April 2013

 

40,171

 

$

438

 

$

4,362

 

$

109

 

$

219

 

10.0%

 

 

(1)

Annualized using actual year-to-date results as of the quarter ended prior to date of sale or June 30, 2013, whichever is earlier.

(2)

Excludes impairment charges aggregating $2.1 million recognized during the year ended December 31, 2012.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2013

48

 

 



 

 

 

 

 

 

 

 

DEFINITIONS AND

OTHER INFORMATION

 

 

 

 

 

 

 

 

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Definitions and Other Information

(Unaudited)

 

This section contains additional information for sections throughout this supplemental information package as well as explanations of certain non-GAAP financial measures and the reasons why we use these supplemental measures of performance.  Additional detail can be found in our most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q, as well as other documents filed with or furnished to the SEC from time to time.

 

Adjusted EBITDA and Adjusted EBITDA margins

 

EBITDA represents earnings before interest, taxes, depreciation, and amortization (“EBITDA”), a non-GAAP financial measure, and is used by us and others as a supplemental measure of performance.  We use adjusted EBITDA (“Adjusted EBITDA”) and Adjusted EBITDA margins to assess the performance of our core operations, for financial and operational decision making, and as a supplemental or additional means of evaluating period-to-period comparisons on a consistent basis.  Adjusted EBITDA also serves as a proxy for a component of a financial covenant under certain of our debt obligations.  Adjusted EBITDA is calculated as EBITDA excluding net stock compensation expense, gains or losses on early extinguishment of debt, gains or losses on sales of real estate, gains or losses on sales of land parcels, impairments of real estate, and impairments of land parcels.  We believe Adjusted EBITDA and Adjusted EBITDA margins provide investors relevant and useful information because they permit investors to view income from our operations on an unleveraged basis before the effects of taxes, non-cash depreciation and amortization, net stock compensation expense, gains or losses on early extinguishment of debt, gains or losses on sales of real estate, gains or losses on sales of land parcels, impairments of real estate, and impairments of land parcels.  By excluding interest expense and gains or losses on early extinguishment of debt, EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins allow investors to measure our performance independent of our capital structure and indebtedness and, therefore, allow for a more meaningful comparison of our performance to that of other companies, both in the real estate industry and in other industries.  We believe that excluding non-cash charges related to share -based compensation facilitates a comparison of our operations across periods and among other equity REITs without the variances caused by different valuation methodologies, the volatility of the expense (which depends on market forces outside our control), and the assumptions and the variety of award types that a company can use.  We believe that adjusting for the effects of gains or losses on sales of real estate, gains or losses on sales of land parcels, impairments of real estate, and impairments of land parcels provides useful information by excluding certain items that are not representative of our core operating results.  These items are dependent upon historical costs, and are subject to judgmental inputs and the timing of our decisions.  EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins have limitations as measures of our performance.  EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins do not reflect our historical cash expenditures or future cash requirements for capital expenditures or contractual commitments.  While EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins are relevant and widely used measures of performance, they do not represent net income or cash flows from operations as defined by GAAP, and they should not be considered as alternatives to those indicators in evaluating performance or liquidity.  Further, our computation of EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins may not be comparable to similar measures reported by other companies.

 

The following table reconciles net income, the most directly comparable financial measure calculated and presented in accordance with GAAP, to EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins:

 

 

 

Three Months Ended

 

Six Months Ended

 

(dollars in thousands)

 

6/30/13

 

3/31/13

 

12/31/12

 

9/30/12

 

6/30/12

 

6/30/13

 

6/30/12

 

Net income

 

$

33,337

 

$

30,237

 

$

28,807

 

$

18,305

 

$

25,641

 

$

63,574

 

$

58,416

 

Interest expense – continuing operations

 

15,978

 

18,020

 

17,941

 

17,092

 

17,922

 

33,998

 

34,148

 

Depreciation and amortization – continuing operations

 

46,580

 

46,065

 

47,515

 

46,584

 

50,741

 

92,645

 

92,527

 

Depreciation and amortization – discontinued operations

 

 

930

 

557

 

1,589

 

1,614

 

930

 

3,233

 

EBITDA

 

95,895

 

95,252

 

94,820

 

83,570

 

95,918

 

191,147

 

188,324

 

Stock compensation expense

 

4,463

 

3,349

 

3,748

 

3,845

 

3,274

 

7,812

 

6,567

 

Loss on early extinguishment of debt

 

560

 

 

 

 

1,602

 

560

 

2,225

 

(Gain) loss on sale of real estate

 

(219

)

340

 

 

(1,562

)

(2

)

121

 

(2

)

Gain on sale of land parcel

 

(772

)

 

 

 

 

(772

)

(1,864

)

Impairment of real estate

 

 

 

1,601

 

9,799

 

 

 

 

Impairment of land parcel

 

 

 

2,050

 

 

 

 

 

Adjusted EBITDA

 

$

99,927

 

$

98,941

 

$

102,219

 

$

95,652

 

$

100,792

 

$

198,868

 

$

195,250

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total revenues

 

$

154,235

 

$

150,380

 

$

151,554

 

$

142,850

 

$

145,593

 

$

304,615

 

$

281,304

 

Adjusted EBITDA margins

 

65%

 

66%

 

67%

 

67%

 

69%

 

65%

 

69%

 

 

Adjusted funds from operations

 

AFFO is a non-GAAP financial measure that we use as a supplemental measure of our performance.  We compute AFFO by adding to or deducting from FFO, as adjusted: (1) maintenance building improvements, and non-revenue-enhancing tenant improvements and leasing commissions (excludes development and redevelopment expenditures); (2) effects of straight-line rent and straight-line rent on ground leases; (3) capitalized income from development projects; (4) amortization of acquired above and below market leases, loan fees, and debt premiums/discounts; (5) non-cash compensation expense; and (6) allocation of AFFO attributable to unvested restricted stock awards.

 

We believe that AFFO is a useful supplemental performance measure because it further adjusts to: (1) deduct certain expenditures that, although capitalized and classified in depreciation expense, do not enhance the revenue or cash flows of our properties; (2) eliminate the effect of straight-lining our rental income and capitalizing income from development projects in order to reflect the actual amount of contractual rents due in the period presented; and (3) eliminate the effect of non-cash items that are not indicative of our core operations and do not actually reduce the amount of cash generated by our operations.  We believe that eliminating the effect of non-cash charges related to share-based compensation facilitates a comparison of our operations across periods and among other equity REITs without the variances caused by different valuation methodologies, the volatility of the expense (which depends on market forces outside our control), and the assumptions and the variety of award types that a company can use.  We believe that AFFO provides useful information by excluding certain items that are not representative of our core operating results because such items are dependent upon historical costs or subject to judgmental valuation inputs and the timing of our decisions.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

50

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Definitions and Other Information

(Unaudited)

 

AFFO is not intended to represent cash flow for the period, and is intended only to provide an additional measure of performance.  We believe that net income attributable to Alexandria’s common stockholders is the most directly comparable GAAP financial measure to AFFO.  We believe that AFFO is a widely recognized measure of the operations of equity REITs, and presenting AFFO will enable investors to assess our performance in comparison to other equity REITs.  However, other equity REITs may use different methodologies for calculating AFFO and, accordingly, our AFFO may not be comparable to AFFO calculated by other equity REITs.  AFFO should not be considered as an alternative to net income (determined in accordance with GAAP) as an indication of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as a measure of our liquidity, nor is it indicative of funds available to fund our cash needs, including our ability to make distributions.

 

Annualized base rent

 

Annualized base rent means the annualized fixed base rental amount in effect as of the end of the period, related to our operating rentable square feet (using rental revenue computed on a straight-line basis in accordance with GAAP).

 

Average cash yield

 

See definition of Initial Stabilized Yield (unlevered).

 

Capitalized interest

 

A key component of our business model is our value-added development and redevelopment projects.  These programs are focused on providing high-quality generic life science laboratory space to meet the real estate requirements of and are reusable by various life science industry client tenants.  Upon completion, each value-added project is expected to generate significant revenues and cash flows.  Our development and redevelopment projects are generally in locations that are highly desirable to life science entities which we believe results in higher occupancy levels, longer lease terms, and higher rental income and returns.  Development projects consist of the ground-up development of generic life science laboratory facilities.  Redevelopment projects consist of the permanent change in use of office, warehouse, and shell space into generic life science laboratory space.  We also have certain significant value-added projects undergoing important and substantial predevelopment activities to bring these assets to their intended use.  These critical activities add significant value and are required for the construction of buildings.  The projects will provide high-quality facilities for the life science industry and are expected to generate significant revenue and cash flows for the Company.  In accordance with GAAP, we capitalize project costs clearly related to the construction, development, and redevelopment as a cost of the project.  Indirect project costs such as construction administration, legal fees, and office costs that clearly relate to projects under construction, development, and redevelopment are also capitalized as a cost of the project.  We capitalize project costs only during periods in which activities necessary to prepare an asset for its intended use are in progress.  We also capitalize interest cost as a cost of the project only during the period for which activities necessary to prepare an asset for its intended use are ongoing, provided that expenditures for the asset have been made and interest cost is incurred.  Additionally, should activities necessary to prepare an asset for its intended use cease, interest, taxes, insurance, and certain other direct project costs related to these assets would be expensed as incurred.

 

Cash interest

 

Cash interest is equal to interest expense calculated in accordance with GAAP, plus capitalized interest, less amortization of loan fees, and amortization of debt premiums/discounts.

 

Construction in progress/current value-added projects

 

Active development/active redevelopment projects

 

A key component of our business model is our value-added development and redevelopment projects.  These programs are focused on providing high-quality, generic, and reusable life science laboratory space to meet the real estate requirements of a wide range of clients in the life science industry.  Upon completion, each value-added project is expected to generate significant revenues and cash flows.  Our development and redevelopment projects are generally in locations that are highly desirable to life science entities, which we believe results in higher occupancy levels, longer lease terms, and higher rental income and returns.  Development projects consist of the ground-up development of generic and reusable life science laboratory facilities.  We generally will not commence new development projects for aboveground vertical construction of new life science laboratory space without first securing pre-leasing for such space except when there is significant market demand for high-quality laboratory facilities.  Redevelopment projects consist of the permanent change in use of office, warehouse, and shell space into generic life science laboratory space.

 

Dividend payout ratio

 

Dividend payout ratio (common stock) is the ratio of the absolute dollar amount of dividends on our common stock (shares of common stock outstanding on the respective record date multiplied by the related dividend per share) to FFO attributable to Alexandria’s common stockholders on a diluted basis, as adjusted.

 

Dividend yield

 

Dividend yield for the quarter represents the annualized quarter dividend divided by the closing common stock price at the end of the quarter.

 

EBITDA

 

See Adjusted EBITDA and Adjusted EBITDA margins

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

51

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Definitions and Other Information

(Unaudited)

 

Fixed charge coverage ratio

 

The fixed charge coverage ratio is useful to investors as a supplemental measure of our ability to satisfy fixed financing obligations and preferred stock dividends.  The following table presents a reconciliation of interest expense, the most directly comparable GAAP financial measure to cash interest and fixed charges:

 

 

 

Three Months Ended

 

(dollars in thousands)

 

6/30/13

 

3/31/13

 

12/31/12

 

9/30/12

 

6/30/12

 

Adjusted EBITDA

 

$

99,927

 

$

98,941

 

$

102,219

 

$

95,652

 

$

100,792

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense – continuing operations

 

$

15,978

 

$

18,020

 

$

17,941

 

$

17,092

 

$

17,922

 

Add: capitalized interest

 

15,690

 

14,021

 

14,897

 

16,763

 

15,825

 

Less: amortization of loan fees

 

(2,427

)

(2,386

)

(2,505

)

(2,470

)

(2,214

)

Less: amortization of debt premium/discounts

 

(123

)

(115

)

(110

)

(112

)

(110

)

Cash interest

 

29,118

 

29,540

 

30,223

 

31,273

 

31,423

 

Dividends on preferred stock

 

6,471

 

6,471

 

6,471

 

6,471

 

6,903

 

Fixed charges

 

$

35,589

 

$

36,011

 

$

36,694

 

$

37,744

 

$

38,326

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed charge coverage ratio – quarter annualized

 

2.8x

 

2.7x

 

2.8x

 

2.5x

 

2.6x

 

Fixed charge coverage ratio – trailing 12 months

 

2.7x

 

2.7x

 

2.6x

 

2.6x

 

2.7x

 

 

Funds from operations and funds from operations, as adjusted

 

GAAP basis accounting for real estate assets utilizes historical cost accounting and assumes that real estate values diminish over time.  In an effort to overcome the difference between real estate values and historical cost accounting for real estate assets, the Board of Governors of the National Association of Real Estate Investment Trusts (“NAREIT”) established the measurement tool of FFO.  Since its introduction, FFO has become a widely used non-GAAP financial measure among equity REITs.  We believe that FFO is helpful to investors as an additional measure of the performance of an equity REIT.  Moreover, we believe that FFO, as adjusted, is also helpful because it allows investors to compare our performance to the performance of other real estate companies between periods, and on a consistent basis, without having to account for differences caused by investment and disposition decisions, financing decisions, terms of securities, capital structures, and capital market transactions.  We compute FFO in accordance with standards established by the Board of Governors of NAREIT in its April 2002 White Paper and related implementation guidance (“NAREIT White Paper”).  The NAREIT White Paper defines FFO as net income (computed in accordance with GAAP), excluding gains (losses) from sales of depreciable real estate and land parcels and impairments of depreciable real estate (excluding land parcels), plus real estate related depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures.  Impairments of real estate relate to decreases in the estimated fair value of real estate due to changes in general market conditions and do not necessarily reflect the operating performance of the properties during the corresponding period.  Impairments of real estate represent the non-cash write-down of assets when fair value over the recoverability period is less than the carrying value.  We compute FFO, as adjusted, as FFO calculated in accordance with the NAREIT White Paper, plus losses on early extinguishment of debt, preferred stock redemption charges, and impairments of land parcels, less realized gain on equity investment primarily related to one non-tenant life science entity, and the amount of such items that is allocable to our unvested restricted stock awards.  Our calculations of both FFO and FFO, as adjusted, may differ from those methodologies utilized by other equity REITs for similar performance measurements, and, accordingly, may not be comparable to those of other equity REITs.  Neither FFO nor FFO, as adjusted, should be considered as an alternative to net income (determined in accordance with GAAP) as an indication of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as a measure of liquidity, nor are they indicative of the availability of funds for our cash needs, including funds available to make distributions.

 

Future value-added projects

 

Land held for future development

 

All predevelopment efforts have been advanced to appropriate stages and no further predevelopment activities are ongoing and therefore, interest, property taxes, and other costs related to these assets are expensed as incurred.  We generally will not commence new development projects for aboveground vertical construction of new life science laboratory space without first securing pre-leasing for such space.

 

Land undergoing predevelopment activities (additional CIP)

 

Land undergoing predevelopment activities includes activities prior to commencement of vertical construction of aboveground building improvements and is classified as construction in progress.  We generally will not commence ground-up development of any parcels undergoing predevelopment activities without first securing pre-leasing for such space.  If vertical aboveground construction is not initiated at completion predevelopment activities, the land parcel will be classified as land held for future development.  Our objective with predevelopment is to reduce the time it takes to deliver projects to prospective client tenants.  The largest project included in land undergoing predevelopment consists of substantially all of our 1.2 million developable square feet at the Alexandria Center™ at Kendall Square in East Cambridge, Massachusetts.

 

We are required to capitalize project costs, including interest, property taxes, insurance, and other costs directly related and essential to the development or construction of a project during periods when activities necessary to prepare an asset for its intended use are in progress.  Predevelopment costs generally include the following activities prior to commencement of vertical construction:

 

·        Traditional preconstruction costs including entitlement, design, construction drawings, Building Information Modeling (3-D virtual modeling), budgeting, sustainability and energy optimization reviews, permitting, and planning for all aspects of the project prior to vertical construction of aboveground building improvements including infrastructure, belowground site work, utility connections, land grading and egress and regress access points.   Traditional preconstruction costs also include interest, property taxes, and insurance.

 

·       Site and infrastructure construction costs including belowground site work,  utility connections, land grading, drainage, egress and regress access points, foundation, and other costs to prepare the site for vertical construction of aboveground building improvements. For example, site and infrastructure costs for the 1.2 million RSF related to 50 Binney Street, 100 Binney Street, and 228,000 RSF of residential of the Alexandria Center™ at Kendall Square are classified as preconstruction prior to commencement of vertical construction. Site and infrastructure costs related to 75/125 Binney Street and 225 Binney Street are included in our estimate of cost of completion and initial stabilized yields for each project.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

52

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Definitions and Other Information

(Unaudited)

 

Gross assets

 

Gross assets are equal to total assets plus accumulated depreciation, less cash, cash equivalents, and restricted cash.

 

Initial stabilized yield (unlevered)

 

Initial Stabilized Yield is calculated as the quotient of the estimated amounts of NOI and our investment in the property at stabilization.  Our Initial Stabilized Yield excludes the impact of leverage.  Our cash rents related to our value-added projects are expected to increase over time and our Average Cash Yields are expected, in general, to be greater than our Initial Stabilized Yields on a cash basis.  Our estimates for initial cash and GAAP yields, and total costs at completion, represent our initial estimates at the commencement of the project.  We expect to update this information upon completion of the project, or sooner if there are significant changes to the expected project yields or costs.

 

·       Initial Stabilized Yield - cash basis: reflects cash rents at the date of stabilization and does not reflect contractual rent escalations beyond the stabilization date.

·       Initial Stabilized Yield - GAAP basis: reflects cash rents, including contractual rent escalations and any rent concessions over the term of the lease, calculated on a straight-line basis.

 

Average Cash Yield reflects cash rents, including contractual rent escalations, over the term of the initial leases at stabilization, calculated on a straight-line basis, but excludes any rent concessions.

 

Interest coverage ratio

 

Interest coverage ratio is the ratio of Adjusted EBITDA to cash interest.  This ratio is useful to investors as an indicator of our ability to service our cash interest obligations.  See fixed charge coverage ratio for calculation of cash interest.  The following table summarizes the calculation of the interest coverage ratio:

 

 

 

Three Months Ended

 

(dollars in thousands)

 

6/30/13

 

3/31/13

 

12/31/12

 

9/30/12

 

6/30/12

 

Adjusted EBITDA

 

$

99,927

 

$

98,941

 

$

102,219

 

$

95,652

 

$

100,792

 

Cash interest

 

$

29,118

 

$

29,540

 

$

30,223

 

$

31,273

 

$

31,423

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest coverage ratio – quarter annualized

 

3.4x

 

3.3x

 

3.4x

 

3.1x

 

3.2x

 

Interest coverage ratio – trailing 12 months

 

3.3x

 

3.2x

 

3.2x

 

3.2x

 

3.3x

 

 

Net debt

 

Net debt is equal to the sum of total debt less cash, cash equivalents, and restricted cash.

 

NOI

 

NOI is a non-GAAP financial measure equal to income from continuing operations, the most directly comparable GAAP financial measure, plus loss (gain) on early extinguishment of debt, impairment of land parcel, depreciation and amortization, interest expense, and general and administrative expense.  We believe NOI provides useful information to investors regarding our financial condition and results of operations because it reflects primarily those income and expense items that are incurred at the property level.  Therefore, we believe NOI is a useful measure for evaluating the operating performance of our real estate assets.  NOI on a cash basis is NOI on a GAAP basis, adjusted to exclude the effect of straight-line rent adjustments required by GAAP.  We believe that NOI on a cash basis is helpful to investors as an additional measure of operating performance because it eliminates straight-line rent adjustments to rental revenue.

 

Further, we believe NOI is useful to investors as a performance measure, because when compared across periods, NOI reflects the impact on operations from trends in occupancy rates, rental rates, and operating costs, providing perspective not immediately apparent from income from continuing operations.  NOI excludes certain components from income from continuing operations in order to provide results that are more closely related to the results of operations of our properties.  For example, interest expense is not necessarily linked to the operating performance of a real estate asset and is often incurred at the corporate level rather than at the property level.  In addition, depreciation and amortization, because of historical cost accounting and useful life estimates, may distort operating performance at the property level.  Real estate impairments have been excluded in deriving NOI because we do not consider impairment losses to be property level operating expenses.  Real estate impairment losses relate to changes in the values of our assets and do not reflect the current operating performance with respect to related revenues or expenses.  Our real estate impairments represent the write down in the value of the assets to the estimated fair value less cost to sell.  These impairments result from investing decisions and the deterioration in market conditions that adversely impact underlying real estate values.  Our calculation of NOI also excludes charges incurred from changes in certain financing decisions, such as losses on early extinguishment of debt, as these charges often relate to the timing of corporate strategy.  Property operating expenses that are included in determining NOI consist of costs that are related to our operating properties, such as utilities, repairs and maintenance, rental expense related to ground leases, contracted services, such as janitorial, engineering, and landscaping, property taxes and insurance, and property level salaries.  General and administrative expenses consist primarily of accounting and corporate compensation, corporate insurance, professional fees, office rent, and office supplies that are incurred as part of corporate office management.  NOI presented by us may not be comparable to NOI reported by other equity REITs that define NOI differently.  We believe that in order to facilitate a clear understanding of our operating results, NOI should be examined in conjunction with income from continuing operations as presented in our condensed consolidated statements of income.  NOI should not be considered as an alternative to income from continuing operations as an indication of our performance, or as an alternative to cash flows as a measure of liquidity, or our ability to make distributions.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

53

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

June 30, 2013

 

Definitions and Other Information

(Unaudited)

 

Same property comparisons

 

As a result of changes within our total property portfolio, the financial data presented in the Summary of Same Property Comparisons shows significant changes in revenue and expenses from period to period.  In order to supplement an evaluation of our results of operations over a given period, we analyze the operating performance for all properties that were fully operating for the entire periods presented for the quarter periods (herein referred to as “Same Properties”) separate from properties acquired subsequent to the first day in the first period presented, properties undergoing active development and active redevelopment, and corporate entities (legal entities performing general and administrative functions), which are excluded from same property results (herein referred to as “Non-Same Properties”).  Additionally, rental revenues from lease termination fees, if any, are excluded from the results of the Same Properties.

 

Total market capitalization

 

Total market capitalization is equal to the sum of outstanding shares of Series E Preferred Stock and common stock multiplied by the related closing price of each class at the end of each period presented, the liquidation value of the series D cumulative convertible preferred stock and total debt.

 

Unencumbered NOI as a percentage of total NOI

 

Unencumbered NOI as a percentage of total NOI is a non-GAAP financial measure that we believe is useful to investors as a performance measure of our results of operations of our unencumbered real estate assets, as it reflects primarily those income and expense items that are incurred at the unencumbered property level.  We use unencumbered NOI as a percentage of total NOI in order to assess our compliance with our financial covenants under our debt obligations because the measure serves as a proxy for a financial measure under such debt obligations.  Unencumbered NOI is derived from assets classified in continuing operations which are not subject to any mortgage, deed of trust, lien, or other security interest as of the period for which income is presented.  Unencumbered NOI for periods prior to the three months ended June 30, 2013, has been reclassified to conform to current period presentation related to discontinued operations.

 

 

 

Three Months Ended

 

Six Months Ended

 

(dollars in thousands)

 

6/30/13

 

3/31/13

 

12/31/12

 

9/30/12

 

6/30/12

 

6/30/13

 

6/30/12

 

Unencumbered NOI

 

$

75,225

 

$

71,402

 

$

74,680

 

$

71,349

 

$

74,823

 

$

146,627

 

$

141,022

 

Encumbered NOI

 

32,687

 

33,754

 

30,698

 

27,298

 

28,668

 

66,441

 

57,727

 

Total NOI from continuing operations

 

$

107,912

 

$

105,156

 

$

105,378

 

$

98,647

 

$

103,491

 

$

213,068

 

$

198,749

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unencumbered NOI as a percentage of total NOI

 

70%

 

68%

 

71%

 

72%

 

72%

 

69%

 

71%

 

 

Unlevered IRR

 

We believe Unlevered IRR is a useful supplemental performance measure used by investors to evaluate the performance of a specific real estate investment.  Unlevered IRR is the annualized implied discount rate calculated from the cash flows of a real estate asset over the holding period for such asset.  Unlevered IRR represents the return that equates the present value of all capital invested in a real estate asset to the present value of all cash flows generated by that real estate asset, or the discount rate that provides a net present value of all cash flows related to a real estate asset to zero. Unlevered IRR is calculated based upon the actual timing of cash flows, including among others i) the initial cash purchase price; ii) cash NOI (GAAP NOI excluding the impact of straight-line rents); iii) capital expenditures; iv) leasing costs, and v) the net sales proceeds of each respective real estate asset.  Losses incurred upon sale or non-cash impairment charges recognized during our ownership period are reflected in the unlevered IRR through the net sales proceeds of each real estate asset.  The calculation of Unlevered IRR does not include general and administrative costs of the Company or interest expense related to the Company’s financing costs, because they are not directly related or attributable to the operations of the real estate asset.

 

Weighted average interest rate for capitalization

 

The weighted average interest rate for calculating capitalization of interest required pursuant to GAAP represents a weighted average rate based on the rates applicable to borrowings outstanding during the period and includes the impact of our interest rate swap agreements, amortization of debt discounts/premiums, amortization of loan fees, and other bank fees.  A separate calculation is performed each month to determine our weighted average interest rate for capitalization for the month.  The rate will vary each month due to changes in variable interest rates, outstanding debt balances, the proportion of variable rate debt to fixed rate debt, the amount and terms of effective interest rate swap agreements, and the amount of loan fee amortization.

 

Weighted average shares for calculating FFO, FFO, as adjusted, and AFFO per share

 

Weighted average shares represent the weighted average of common shares outstanding during the period.  The following calculation of weighted average shares was applied to arrive at FFO per share attributable to Alexandria’s common stockholders, FFO per share attributable to Alexandria’s common stockholders, as adjusted, and AFFO per share attributable to Alexandria’s common stockholders:

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

6/30/13

 

3/31/13

 

12/31/12

 

9/30/12

 

6/30/12

 

6/30/13

 

6/30/12

 

Weighted average shares of common stock outstanding for calculating FFO, FFO, as adjusted, and AFFO per share attributable to Alexandria’s common stockholders – basic

 

66,972,892

 

63,161,319

 

63,091,781

 

62,364,210

 

61,663,367

 

65,077,635

 

61,585,587

 

Effect of assumed conversion and dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assumed conversion of 8.00% Unsecured Senior Convertible Notes

 

6,146

 

6,146

 

6,146

 

6,087

 

6,087

 

6,146

 

6,087

 

Dilutive effect of stock options

 

 

 

 

 

173

 

 

667

 

Weighted average shares of common stock outstanding for calculating FFO, FFO, as adjusted, and AFFO per share attributable to Alexandria’s common stockholders – diluted

 

66,979,038

 

63,167,465

 

63,097,927

 

62,370,297

 

61,669,627

 

65,083,781

 

61,592,341

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2013

54